Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific AAAS ENSG00000094914 Achalasia, adrenocortical insufficiency, alacrimia 12 53307456-53324864 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040086 Approved Approved Nuclear membrane
Centrosome
Cytosol Expressed in all parathyroid gland: 44.9 ABCA1 ABC1, HDLDT1, TGD ENSG00000165029 ATP-binding cassette, sub-family A (ABC1), member 1 9 104781002-104928237 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057283, CAB069889 Approved Approved Nucleoplasm
Vesicles Mixed adrenal gland: 38.1 ABCA10 EST698739 ENSG00000154263 ATP-binding cassette, sub-family A (ABC1), member 10 17 69147214-69244846 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014535 Uncertain Mixed ovary: 13.7 ABCA2 ABC2 ENSG00000107331 ATP-binding cassette, sub-family A (ABC1), member 2 9 137007227-137028922 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042886 Approved Tissue enriched 6 cerebral cortex: 98.2 thyroid gland: 17.0 ABCA3 ABC-C, ABC3, EST111653, LBM180 ENSG00000167972 ATP-binding cassette, sub-family A (ABC1), member 3 16 2275881-2340746 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007884 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 lung: 135.8 cerebral cortex: 51.7 ABCA5 EST90625 ENSG00000154265 ATP-binding cassette, sub-family A (ABC1), member 5 17 69244311-69327244 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA022032 Approved Expressed in all skin: 28.0 ABCA6 EST155051 ENSG00000154262 ATP-binding cassette, sub-family A (ABC1), member 6 17 69078702-69141888 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064878, HPA067180 Approved Nucleoplasm Tissue enhanced 0 liver: 41.4 ovary: 37.2 ABCA7 ABCX ENSG00000064687 ATP-binding cassette, sub-family A (ABC1), member 7 19 1040101-1065572 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041564 Supported Supported Golgi apparatus
Plasma membrane
Cell Junctions Mixed spleen: 25.8 ABCA8 KIAA0822 ENSG00000141338 ATP-binding cassette, sub-family A (ABC1), member 8 17 68867292-68955392 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044914 Approved Approved Nucleoplasm
Cytosol Mixed ovary: 67.2 ABCA9 EST640918 ENSG00000154258 ATP-binding cassette, sub-family A (ABC1), member 9 17 68974488-69061064 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054823 Uncertain Mixed ovary: 33.3 ABCB1 ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1 ENSG00000085563 ATP-binding cassette, sub-family B (MDR/TAP), member 1 7 87503633-87713323 Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001716, HPA002199 Approved Approved Nucleoplasm
Focal adhesion sites
Cytosol Tissue enhanced 0 adrenal gland: 138.6;small intestine: 83.9 kidney: 37.0 ABCB10 EST20237, M-ABC2, MTABC2 ENSG00000135776 ATP-binding cassette, sub-family B (MDR/TAP), member 10 1 229516582-229558695 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB044063, CAB044065, HPA055175 Uncertain Expressed in all bone marrow: 36.6 ABCB11 ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP ENSG00000073734 ATP-binding cassette, sub-family B (MDR/TAP), member 11 2 168922938-169031322 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019035 Supported Uncertain Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 13 liver: 19.1 testis: 1.4 ABCB4 ABCB4, GBD1, MDR2, MDR3 , PFIC-3, PGY3 ENSG00000005471 ATP-binding cassette, sub-family B (MDR/TAP), member 4 7 87401697-87480435 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049395, HPA053288 Approved Approved Nucleoplasm
Plasma membrane
Actin filaments
Focal adhesion sites Tissue enriched 6 liver: 69.2 adrenal gland: 10.7 ABCB5 ABCB5alpha, ABCB5beta, EST422562 ENSG00000004846 ATP-binding cassette, sub-family B (MDR/TAP), member 5 7 20615207-20777038 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026975 Uncertain Tissue enriched 7 epididymis: 31.7 gallbladder: 4.3 ABCB6 EST45597, MTABC3, umat ENSG00000115657 ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group) 2 219209768-219218990 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046723, HPA058011 Approved Validated Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol Expressed in all testis: 32.5 ABCB7 ABC7, ASAT, Atm1p, EST140535 ENSG00000131269 ATP-binding cassette, sub-family B (MDR/TAP), member 7 X 75053172-75156732 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034982 Approved Supported Mitochondria Expressed in all parathyroid gland: 21.3 ABCB8 EST328128, M-ABC1, MABC1 ENSG00000197150 ATP-binding cassette, sub-family B (MDR/TAP), member 8 7 151028422-151047782 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045187 Approved Supported Nucleus
Mitochondria Expressed in all thyroid gland: 17.0 ABCB9 EST122234 ENSG00000150967 ATP-binding cassette, sub-family B (MDR/TAP), member 9 12 122920951-122981649 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033052, HPA035113, HPA035114 Approved Supported Vesicles Tissue enhanced 0 testis: 23.9 cerebral cortex: 12.1 ABCC1 GS-X, MRP, MRP1 ENSG00000103222 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 16 15949577-16143074 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002380 Uncertain Supported Plasma membrane Mixed parathyroid gland: 18.1 ABCC10 EST182763, MRP7, SIMRP7 ENSG00000124574 ATP-binding cassette, sub-family C (CFTR/MRP), member 10 6 43427366-43450430 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041607, HPA045464 Approved Expressed in all smooth muscle: 12.4 ABCC12 MRP9 ENSG00000140798 ATP-binding cassette, sub-family C (CFTR/MRP), member 12 16 48082973-48156018 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043100 Uncertain Tissue enhanced 0 testis: 2.9 breast: 0.5 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Approved Group enriched 10 duodenum: 44.7;gallbladder: 42.8;kidney: 20.8;liver: 67.6;small intestine: 50.5 breast: 4.3 ABCC3 cMOAT2, EST90757, MLP2, MOAT-D, MRP3 ENSG00000108846 ATP-binding cassette, sub-family C (CFTR/MRP), member 3 17 50634777-50692252 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037136, HPA048483 Approved Approved Plasma membrane Mixed adrenal gland: 20.8 ABCC4 EST170205, MOAT-B, MOATB, MRP4 ENSG00000125257 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 13 95019829-95301446 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002476 Supported Approved Nucleoli
Plasma membrane
Cytosol Tissue enhanced 0 prostate: 68.5 epididymis: 23.3 ABCC5 EST277145, MOAT-C, MRP5, SMRP ENSG00000114770 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 3 183919934-184018015 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044067, HPA052295 Uncertain Supported Nucleus
Plasma membrane
Cell Junctions Expressed in all stomach: 72.0 ABCC6 ARA, EST349056, MLP1, MRP6, PXE, URG7 ENSG00000091262 ATP-binding cassette, sub-family C (CFTR/MRP), member 6 16 16148928-16223522 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038105 Supported Plasma membrane Tissue enhanced 0 kidney: 15.2;liver: 19.1 duodenum: 11.6 ABCC8 ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2 ENSG00000006071 ATP-binding cassette, sub-family C (CFTR/MRP), member 8 11 17392885-17476845 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011451, HPA042318 Approved Approved Nucleoli
Golgi apparatus
Cytosol Tissue enhanced 0 cerebral cortex: 11.7 adrenal gland: 7.6 ABCC9 CMD1O, SUR2 ENSG00000069431 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 12 21797401-21941402 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007279 Uncertain Approved Nucleoplasm
Cytosol Mixed smooth muscle: 34.9 ABCD3 PMP70, PXMP1, ZWS2 ENSG00000117528 ATP-binding cassette, sub-family D (ALD), member 3 1 94418455-94518666 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032026, HPA032027, CAB032516, CAB075749 Supported Validated Peroxisomes Expressed in all liver: 66.4 ABCD4 EST352188, P70R, PMP69, PXMP1L ENSG00000119688 ATP-binding cassette, sub-family D (ALD), member 4 14 74285423-74303056 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003396 Approved Expressed in all fallopian tube: 13.6 ABCG1 ABC8 ENSG00000160179 ATP-binding cassette, sub-family G (WHITE), member 1 21 42199689-42297244 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031470, HPA031471 Approved Supported Golgi apparatus
Vesicles Expressed in all spleen: 43.7 ABCG4 WHITE2 ENSG00000172350 ATP-binding cassette, sub-family G (WHITE), member 4 11 119149012-119162653 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040312 Uncertain Group enriched 6 cerebral cortex: 6.6;parathyroid gland: 4.0;testis: 5.1 seminal vesicle: 0.8 ABCG5 STSL ENSG00000138075 ATP-binding cassette, sub-family G (WHITE), member 5 2 43812472-43838865 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA016514 Approved Approved Nucleus Group enriched 32 duodenum: 58.0;liver: 28.3;small intestine: 57.4 gallbladder: 1.4 ABCG8 GBD4 ENSG00000143921 ATP-binding cassette, sub-family G (WHITE), member 8 2 43838964-43878466 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019556 Uncertain Uncertain Vesicles Group enriched 25 duodenum: 51.4;liver: 34.1;small intestine: 56.7 gallbladder: 1.8 ACIN1 ACINUS, fSAP152, KIAA0670 ENSG00000100813 Apoptotic chromatin condensation inducer 1 14 23058564-23095614 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000657 Supported Supported Nucleoplasm
Plasma membrane
Cytosol Expressed in all parathyroid gland: 76.7 ACOT12 Cach, STARD15, THEAL ENSG00000172497 Acyl-CoA thioesterase 12 5 81330005-81394179 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037723, HPA037724 Uncertain Approved Nucleoplasm
Cytosol Tissue enriched 19 liver: 51.3 kidney: 2.7 ADCYAP1R1 PAC1, PAC1R, PACAPR ENSG00000078549 Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I 7 31052461-31111479 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049877 Approved Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 137.5;fallopian tube: 46.5 cervix: 20.6 ADGRB2 BAI2 ENSG00000121753 Adhesion G protein-coupled receptor B2 1 31727117-31764893 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052612, HPA054617 Supported Centrosome Tissue enriched 14 cerebral cortex: 72.5 adrenal gland: 5.1 ADGRE1 EMR1, TM7LN3 ENSG00000174837 Adhesion G protein-coupled receptor E1 19 6887566-6940459 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052809 Uncertain Tissue enhanced 0 appendix: 10.2;spleen: 20.1 lung: 6.8 ADGRE5 CD97, TM7LN1 ENSG00000123146 Adhesion G protein-coupled receptor E5 19 14380501-14408725 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013707 Supported Approved Cytosol Expressed in all spleen: 142.8 ADGRL4 ELTD1, ETL ENSG00000162618 Adhesion G protein-coupled receptor L4 1 78889764-79006718 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA025229 Supported Mixed adipose tissue: 67.6 ADGRV1 DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1 ENSG00000164199 Adhesion G protein-coupled receptor V1 5 90529344-91164221 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067503 Approved Group enriched 6 adrenal gland: 56.5;cerebral cortex: 29.1 thyroid gland: 6.6 ADORA1 RDC7 ENSG00000163485 Adenosine A1 receptor 1 203090654-203167405 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044383 Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 46.5;testis: 23.4 parathyroid gland: 17.5 ADRB2 ADRB2R, ADRBR, B2AR, BAR ENSG00000169252 Adrenoceptor beta 2, surface 5 148825245-148828687 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003431, HPA075322 Uncertain Uncertain Cytosol Mixed lung: 16.3 AGTR1 AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R ENSG00000144891 Angiotensin II receptor, type 1 3 148697784-148743008 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA003596 Supported Uncertain Vesicles Tissue enhanced 0 placenta: 212.0 liver: 50.8 AHCTF1 ELYS ENSG00000153207 AT hook containing transcription factor 1 1 246839098-246931978 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031658 Uncertain Supported Nuclear membrane Expressed in all testis: 61.2 ANK2 LQT4 ENSG00000145362 Ankyrin 2, neuronal 4 112818109-113383740 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008007, CAB015178, HPA035970 Supported Tissue enhanced 0 cerebral cortex: 184.9 kidney: 124.2 ANKH ANK, CCAL2, CMDJ, CPPDD, HANK ENSG00000154122 ANKH inorganic pyrophosphate transport regulator 5 14704804-14871778 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA068104 Approved Cytosol Expressed in all prostate: 49.5 ANO1 DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A ENSG00000131620 Anoctamin 1, calcium activated chloride channel 11 70078302-70189528 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032148 Supported Tissue enhanced 0 epididymis: 217.7;seminal vesicle: 295.7 skin: 116.0 ANO2 C12orf3, TMEM16B ENSG00000047617 Anoctamin 2, calcium activated chloride channel 12 5531869-5946232 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA036276 Supported Nucleoplasm
Plasma membrane Tissue enhanced 0 testis: 17.7 placenta: 5.9 ANO3 C11orf25, DYT23, GENX-3947, TMEM16C ENSG00000134343 Anoctamin 3 11 26309599-26663288 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA041629 Uncertain Tissue enriched 6 epididymis: 61.3 cerebral cortex: 10.6 ANO5 GDD1, LGMD2L, TMEM16E ENSG00000171714 Anoctamin 5 11 22193176-22283357 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058857 Uncertain Tissue enhanced 0 parathyroid gland: 55.2 skeletal muscle: 23.6 ANO6 DKFZp313M0720, TMEM16F ENSG00000177119 Anoctamin 6 12 45215987-45440404 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038958 Approved Approved Plasma membrane
Cytosol Expressed in all adipose tissue: 90.8 ANO9 PIG5, TMEM16J, TP53I5 ENSG00000185101 Anoctamin 9 11 417933-442011 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039948, HPA040112 Approved Uncertain Golgi apparatus Tissue enhanced 0 duodenum: 32.4;small intestine: 31.6 skin: 21.6 ANXA1 ANX1, LPC1 ENSG00000135046 Annexin A1 9 73151757-73170393 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011271, HPA011272, CAB013023, CAB035987, CAB058693 Supported Validated Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 6 esophagus: 7577.8 tonsil: 1266.5 ANXA11 ANX11 ENSG00000122359 Annexin A11 10 80150889-80205572 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004851, HPA027545 Supported Supported Nucleoplasm
Cytosol Expressed in all esophagus: 203.9 ANXA2 ANX2, ANX2L4, CAL1H, LIP2, LPC2D ENSG00000182718 Annexin A2 15 60347134-60402883 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004311 Approved Expressed in all esophagus: 1494.3 ANXA6 ANX6 ENSG00000197043 Annexin A6 5 151100712-151157882 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002462, CAB005077, HPA009650 Supported Approved Nuclear speckles Expressed in all smooth muscle: 426.1 APCS MGC88159, PTX2, SAP ENSG00000132703 Amyloid P component, serum 1 159587825-159588865 Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007817, HPA053294 Supported Tissue enriched 25 liver: 1844.2 gallbladder: 73.9 APLNR AGTRL1, APJ, APJR, FLJ90771 ENSG00000134817 Apelin receptor 11 57233577-57237314 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025842 Approved Group enriched 5 cerebral cortex: 82.9;placenta: 145.6;spleen: 164.2 adipose tissue: 24.9 APP AD1 ENSG00000142192 Amyloid beta (A4) precursor protein 21 25880550-26171128 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000157, HPA001462 Supported Approved Golgi apparatus
Vesicles Expressed in all cerebral cortex: 1206.8 AQP1 CHIP28, CO ENSG00000240583 Aquaporin 1 (Colton blood group) 7 30911855-30925516 Blood group antigen proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001707, HPA019206 Supported Supported Plasma membrane Expressed in all kidney: 801.2 AQP10 ENSG00000143595 Aquaporin 10 1 154321090-154325325 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA065947 Supported Group enriched 8 duodenum: 70.3;small intestine: 50.1 fallopian tube: 7.1 AQP11 ENSG00000178301 Aquaporin 11 11 77589391-77610355 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042879 Approved Approved Nucleoplasm
Vesicles Tissue enhanced 0 duodenum: 24.8;small intestine: 23.6 adrenal gland: 10.1 AQP12A AQP12 ENSG00000184945 Aquaporin 12A 2 240691845-240698483 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA042216 Supported Tissue enriched 67 pancreas: 27.7 small intestine: 0.4 AQP2 ENSG00000167580 Aquaporin 2 (collecting duct) 12 49950741-49958881 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046834 Supported Group enriched 93 kidney: 432.9;seminal vesicle: 299.3 prostate: 3.9 AQP4 MIWC ENSG00000171885 Aquaporin 4 18 26852038-26865818 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005079, HPA014784, CAB058689 Supported Supported Supported Plasma membrane
Cell Junctions Group enriched 17 cerebral cortex: 631.8;lung: 172.2 thyroid gland: 24.3 AQP5 ENSG00000161798 Aquaporin 5 12 49961870-49965681 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065008 Supported Approved Plasma membrane Group enriched 8 salivary gland: 257.1;stomach: 54.0;testis: 176.5 breast: 21.0 AQP6 AQP2L ENSG00000086159 Aquaporin 6, kidney specific 12 49967194-49977139 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA015278 Supported Tissue enriched 9 kidney: 20.8 cerebral cortex: 2.3 AQP8 ENSG00000103375 Aquaporin 8 16 25215731-25228940 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046259 Approved Group enriched 132 colon: 325.1;pancreas: 269.4;rectum: 169.2 smooth muscle: 1.9 ARV1 ENSG00000173409 ARV1 homolog, fatty acid homeostasis modulator 1 230978981-231000595 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035709 Approved Approved Vesicles Expressed in all testis: 61.6 ASNA1 ARSA-I, GET3, TRC40 ENSG00000198356 ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial) 19 12737139-12748323 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045951, HPA048087 Approved Validated Nucleus
Nucleoli Expressed in all thyroid gland: 93.7 ATP11B ATPIF, ATPIR, KIAA0956 ENSG00000058063 ATPase, class VI, type 11B 3 182793500-182921635 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036237, HPA036238 Uncertain Approved Microtubule organizing center
Cytosol Expressed in all testis: 57.7 ATP11C ATPIG, ATPIQ ENSG00000101974 ATPase, class VI, type 11C X 139726346-139945276 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030830 Approved Mixed liver: 25.6 ATP12A ATP1AL1 ENSG00000075673 ATPase, H+/K+ transporting, nongastric, alpha polypeptide 13 24680411-24712493 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039526 Approved Tissue enhanced 0 esophagus: 12.8;placenta: 8.1;tonsil: 14.6 skin: 7.1 ATP13A1 ATP13A, CGI-152, FLJ31858, KIAA1825 ENSG00000105726 ATPase type 13A1 19 19645198-19663693 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031798, HPA049717 Approved Approved Vesicles Expressed in all parathyroid gland: 51.5 ATP13A2 CLN12, HSA9947, PARK9 ENSG00000159363 ATPase type 13A2 1 16985958-17011928 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037038, CAB037111, HPA050910, HPA054717 Approved Expressed in all cerebral cortex: 75.0 ATP1A1 ENSG00000163399 ATPase, Na+/K+ transporting, alpha 1 polypeptide 1 116372668-116410261 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018702, CAB069993 Supported Expressed in all parathyroid gland: 2441.5 ATP1A2 FHM2, MHP2 ENSG00000018625 ATPase, Na+/K+ transporting, alpha 2 polypeptide 1 160115759-160143591 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022230 Approved Group enriched 6 cerebral cortex: 435.6;skeletal muscle: 307.1 heart muscle: 59.1 ATP1A3 DYT12 ENSG00000105409 ATPase, Na+/K+ transporting, alpha 3 polypeptide 19 41966582-41997497 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033630, HPA045367, HPA056446 Supported Tissue enhanced 0 cerebral cortex: 376.4;heart muscle: 94.2 testis: 54.1 ATP1B1 ATP1B ENSG00000143153 ATPase, Na+/K+ transporting, beta 1 polypeptide 1 169105697-169132722 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012911 Supported Expressed in all kidney: 1327.1 ATP1B3 CD298, FLJ29027 ENSG00000069849 ATPase, Na+/K+ transporting, beta 3 polypeptide 3 141876124-141926514 CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020697, HPA048963 Supported Supported Plasma membrane Expressed in all skin: 310.5 ATP2A2 ATP2B, DAR, SERCA2 ENSG00000174437 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 12 110280756-110351093 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062605, HPA067892 Supported Supported Nucleoplasm Expressed in all skeletal muscle: 1006.6 ATP2B2 PMCA2 ENSG00000157087 ATPase, Ca++ transporting, plasma membrane 2 3 10324023-10708031 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005606 Supported Tissue enriched 7 cerebral cortex: 63.0 salivary gland: 9.2 ATP2B4 ATP2B2, MXRA1, PMCA4 ENSG00000058668 ATPase, Ca++ transporting, plasma membrane 4 1 203626561-203744081 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016118, HPA040431 Supported Supported Plasma membrane Expressed in all smooth muscle: 251.3 ATP2C1 ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1 ENSG00000017260 ATPase, Ca++ transporting, type 2C, member 1 3 130850595-131016712 Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010207, HPA035116, HPA069684 Supported Validated Golgi apparatus Expressed in all prostate: 136.8 ATP2C2 KIAA0703, SPCA2 ENSG00000064270 ATPase, Ca++ transporting, type 2C, member 2 16 84368527-84464187 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052262, HPA075812 Approved Approved Plasma membrane
Focal adhesion sites Tissue enhanced 0 rectum: 39.0 skin: 30.1 ATP4A ATP6A ENSG00000105675 ATPase, H+/K+ exchanging, alpha polypeptide 19 35550043-35563658 Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039154 Supported Tissue enriched 250 stomach: 537.7 pancreas: 2.1 ATP4B ATP6B ENSG00000186009 ATPase, H+/K+ exchanging, beta polypeptide 13 113648804-113658186 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045400, HPA052649 Supported Tissue enriched 85 stomach: 919.0 fallopian tube: 10.8 ATP6V0A1 a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1 ENSG00000033627 ATPase, H+ transporting, lysosomal V0 subunit a1 17 42458844-42522611 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA022144 Supported Approved Nuclear speckles
Golgi apparatus
Vesicles
Cytosol Expressed in all cerebral cortex: 201.5 ATP6V0A4 a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2 ENSG00000105929 ATPase, H+ transporting, lysosomal V0 subunit a4 7 138706295-138799560 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018029, HPA064555 Supported Approved Cytosol Group enriched 9 kidney: 69.1;salivary gland: 31.8 breast: 5.5 ATP6V0D1 ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD ENSG00000159720 ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 16 67438014-67481237 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016938 Uncertain Expressed in all cerebral cortex: 187.6 ATP6V1A ATP6A1, ATP6V1A1, VA68, Vma1, VPP2 ENSG00000114573 ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A 3 113747019-113812056 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006910, HPA035083, HPA035084 Approved Supported Nucleus
Vesicles
Cytosol Expressed in all cerebral cortex: 151.8 ATP6V1B2 ATP6B2, HO57, VATB, Vma2, VPP3 ENSG00000147416 ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 8 20197367-20226819 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008147 Supported Supported Vesicles Expressed in all cerebral cortex: 305.1 ATP6V1C1 ATP6C, ATP6D, VATC, Vma5 ENSG00000155097 ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 8 103021063-103073051 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023943, HPA057297 Approved Supported Nucleoplasm
Cytosol Expressed in all cerebral cortex: 123.4 ATP6V1C2 ATP6C2, VMA5 ENSG00000143882 ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 2 10721649-10785110 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034734, HPA034735 Uncertain Uncertain Mitochondria Tissue enhanced 0 cervix, uterine: 81.6;epididymis: 101.2;skin: 124.0 placenta: 54.5 ATP6V1E1 ATP6E, ATP6E2, ATP6V1E, P31, Vma4 ENSG00000131100 ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 22 17592136-17628818 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009528, CAB018699, HPA029196 Supported Approved Nucleoplasm Expressed in all cerebral cortex: 302.2 ATP6V1F ATP6S14, VATF, Vma7 ENSG00000128524 ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F 7 128862826-128865844 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009529, HPA048700, HPA062011 Supported Expressed in all cerebral cortex: 288.9 ATP6V1G1 ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10 ENSG00000136888 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 9 114587746-114598373 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004615, HPA042898 Supported Supported Nucleus
Nucleoli Expressed in all epididymis: 295.9 ATP6V1G3 ATP6G3, Vma10 ENSG00000151418 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 1 198523222-198540945 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA028701 Supported Tissue enriched 11 kidney: 21.1 epididymis: 1.9 ATP6V1H CGI-11, SFD, SFDalpha, SFDbeta, VMA13 ENSG00000047249 ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H 8 53715557-53843558 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009532, HPA023421 Approved Approved Actin filaments
Cytosol Expressed in all cerebral cortex: 126.9 ATP7A MNK ENSG00000165240 ATPase, Cu++ transporting, alpha polypeptide X 77910656-78050395 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012887, HPA048107 Approved Supported Golgi apparatus
Vesicles Mixed parathyroid gland: 15.0 ATP7B WND ENSG00000123191 ATPase, Cu++ transporting, beta polypeptide 13 51930436-52012125 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009137, HPA013187 Supported Supported Golgi apparatus Mixed testis: 14.0 ATP8A1 ATPIA ENSG00000124406 ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 4 42408373-42657105 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049948, HPA052935 Approved Supported Vesicles Tissue enhanced 0 parathyroid gland: 67.5;thyroid gland: 66.3 cerebral cortex: 58.4 ATP8B1 ATPIC, BRIC, FIC1, PFIC, PFIC1 ENSG00000081923 ATPase, aminophospholipid transporter, class I, type 8B, member 1 18 57646426-57803101 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018673, HPA018674 Supported Expressed in all colon: 96.9 AVPR2 DIR, DIR3, V2R ENSG00000126895 Arginine vasopressin receptor 2 X 153902531-153907166 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA046678 Approved Tissue enhanced 0 adipose tissue: 5.8 heart muscle: 2.8 BACE1 BACE ENSG00000186318 Beta-site APP-cleaving enzyme 1 11 117285207-117316259 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016358 Approved Supported Plasma membrane Expressed in all pancreas: 100.6 BAK1 BAK, BCL2L7, CDN1 ENSG00000030110 BCL2-antagonist/killer 1 6 33572547-33580293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005029 Supported Expressed in all duodenum: 49.2 BASP1 CAP-23, CAP23, NAP-22, NAP22 ENSG00000176788 Brain abundant, membrane attached signal protein 1 5 17065598-17276843 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045218, HPA050333 Supported Validated Plasma membrane Tissue enhanced 0 cerebral cortex: 420.3;epididymis: 364.8 prostate: 133.3 BAX BCL2L4 ENSG00000087088 BCL2-associated X protein 19 48954815-48961798 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004206, HPA027878 Approved Expressed in all appendix: 83.2 BCAP29 BAP29, DKFZp686M2086 ENSG00000075790 B-cell receptor-associated protein 29 7 107579977-107629170 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029215, HPA049694 Supported Approved Cytosol Expressed in all thyroid gland: 185.4 BCAP31 6C6-Ag, BAP31, CDM, DXS1357E ENSG00000185825 B-cell receptor-associated protein 31 X 153700497-153724697 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003906, CAB015350, CAB015424 Supported Approved Validated Endoplasmic reticulum Expressed in all adipose tissue: 272.6 BCL2L1 Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52 ENSG00000171552 BCL2-like 1 20 31664452-31723989 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035734, CAB072801 Approved Approved Mitochondria Expressed in all gallbladder: 100.9 BCL2L2 BCL-W, KIAA0271, PPP1R51 ENSG00000129473 BCL2-like 2 14 23298790-23311759 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB040539 Approved Expressed in all cerebral cortex: 89.1 BCL2L2-PABPN1 ENSG00000258643 BCL2L2-PABPN1 readthrough 14 23306835-23325369 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA000637 Approved Approved Mixed seminal vesicle: 28.8 BEST1 BEST, BMD, RP50, VMD2 ENSG00000167995 Bestrophin 1 11 61949821-61965515 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA057464 Supported Mixed cerebral cortex: 17.0 BEST2 FLJ20132, VMD2L1 ENSG00000039987 Bestrophin 2 19 12751702-12758458 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046229 Approved Tissue enhanced 0 colon: 15.8;rectum: 15.4 tonsil: 4.9 BNIP3 Nip3 ENSG00000176171 BCL2/adenovirus E1B 19kDa interacting protein 3 10 131966455-131982013 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003015, CAB011676 Supported Uncertain Cytosol Expressed in all cerebral cortex: 84.4 BNIP3L BNIP3a, Nix ENSG00000104765 BCL2/adenovirus E1B 19kDa interacting protein 3-like 8 26382898-26505636 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015652, CAB025371 Supported Approved Nuclear speckles
Mitochondria Expressed in all placenta: 150.7 BPI BPIFD1 ENSG00000101425 Bactericidal/permeability-increasing protein 20 38260149-38337505 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061284 Supported Tissue enriched 36 bone marrow: 963.1 testis: 27.0 BRI3BP BNAS1, HCCR-2, KG19 ENSG00000184992 BRI3 binding protein 12 124993700-125031231 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014957 Approved Approved Nucleoplasm
Mitochondria Mixed duodenum: 21.1 BSG CD147, EMMPRIN, OK ENSG00000172270 Basigin (Ok blood group) 19 571277-583493 Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002427, HPA036048, HPA074870 Supported Approved Vesicles Expressed in all heart muscle: 585.9 BSND BART, DFNB73 ENSG00000162399 Barttin CLCNK-type chloride channel accessory beta subunit 1 54998933-55010883 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053836 Supported Tissue enriched 6 kidney: 10.2 salivary gland: 1.5 C1QBP gC1Q-R, gC1qR, HABP1, p32, SF2p32 ENSG00000108561 Complement component 1, q subcomponent binding protein 17 5432777-5448830 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026483 Supported Approved Plasma membrane
Mitochondria Expressed in all rectum: 159.4 C6 ENSG00000039537 Complement component 6 5 41142234-41261438 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043823, CAB069427 Supported Group enriched 7 fallopian tube: 72.6;liver: 357.7 heart muscle: 30.6 CACFD1 C9orf7, D9S2135, flower ENSG00000160325 Calcium channel flower domain containing 1 9 133459965-133470848 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015280 Approved Nucleoplasm Expressed in all thyroid gland: 16.6 CACNA1A APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6 ENSG00000141837 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19 13206442-13623990 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064258 Supported Approved Nucleoplasm
Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 18.1 stomach: 6.4 CACNA1C CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS ENSG00000151067 Calcium channel, voltage-dependent, L type, alpha 1C subunit 12 1970786-2697950 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039796 Supported Tissue enhanced 0 smooth muscle: 30.9 endometrium: 26.2 CACNA1H Cav3.2 ENSG00000196557 Calcium channel, voltage-dependent, T type, alpha 1H subunit 16 1153241-1221771 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA039125 Approved Approved Nucleoplasm
Vesicles Tissue enhanced 0 ovary: 50.6 seminal vesicle: 46.9 CACNA2D1 CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3 ENSG00000153956 Calcium channel, voltage-dependent, alpha 2/delta subunit 1 7 81946444-82443798 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008213, HPA008621 Supported Mixed cerebral cortex: 35.5 CACNA2D2 KIAA0558 ENSG00000007402 Calcium channel, voltage-dependent, alpha 2/delta subunit 2 3 50362799-50504244 FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034771, HPA071829 Approved Approved Vesicles Tissue enriched 6 lung: 73.0 testis: 12.4 CACNA2D3 HSA272268 ENSG00000157445 Calcium channel, voltage-dependent, alpha 2/delta subunit 3 3 54122547-55074557 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030849, HPA030850 Uncertain Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 16.3 adrenal gland: 5.4 CACNB2 CACNLB2, MYSB ENSG00000165995 Calcium channel, voltage-dependent, beta 2 subunit 10 18140677-18541869 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035325, HPA035326 Uncertain Mixed cerebral cortex: 26.4 CACNB3 CACNLB3 ENSG00000167535 Calcium channel, voltage-dependent, beta 3 subunit 12 48813794-48828941 FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059515 Approved Golgi apparatus
Vesicles Mixed endometrium: 39.8 CACNB4 EJM4 ENSG00000182389 Calcium channel, voltage-dependent, beta 4 subunit 2 151832776-152099079 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015601 Approved Tissue enhanced 0 cerebral cortex: 34.8 skin: 11.2 CACNG3 ENSG00000006116 Calcium channel, voltage-dependent, gamma subunit 3 16 24255553-24362801 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059010 Approved Tissue enriched 28 cerebral cortex: 42.6 adrenal gland: 1.5 CACNG4 MGC11138, MGC24983 ENSG00000075461 Calcium channel, voltage-dependent, gamma subunit 4 17 66964910-67033398 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA005803, HPA065370 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 48.7;prostate: 18.8 lung: 9.3 CACNG6 ENSG00000130433 Calcium channel, voltage-dependent, gamma subunit 6 19 53992288-54012669 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA056615 Approved Nucleoli fibrillar center
Cytosol Group enriched 11 fallopian tube: 17.8;skeletal muscle: 33.9 lung: 2.3 CACNG8 ENSG00000142408 Calcium channel, voltage-dependent, gamma subunit 8 19 53963040-53990215 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041351 Supported Tissue enriched 32 cerebral cortex: 23.8 testis: 0.7 CALCRL CGRPR, CRLR ENSG00000064989 Calcitonin receptor-like 2 187343129-187448460 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008070, HPA046515 Uncertain Supported Plasma membrane Tissue enhanced 0 lung: 114.4 adipose tissue: 76.3 CALHM1 FAM26C ENSG00000185933 Calcium homeostasis modulator 1 10 103453387-103458888 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018317 Uncertain Tissue enhanced 0 cerebral cortex: 1.8 kidney: 0.6 CALHM2 FAM26B ENSG00000138172 Calcium homeostasis modulator 2 10 103446786-103452402 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014706 Approved Approved Nucleoplasm
Mitochondria
Cytosol Mixed ovary: 44.9 CALHM3 bA225H22.7, FAM26A ENSG00000183128 Calcium homeostasis modulator 3 10 103472804-103479240 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018205 Uncertain Approved Nucleoplasm Not detected testis: 0.4 CALM1 CALML2, CAMI, DD132, PHKD ENSG00000198668 Calmodulin 1 (phosphorylase kinase, delta) 14 90396502-90408261 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB018558, HPA044999 Supported Approved Vesicles Expressed in all cerebral cortex: 1329.9 CALM2 CAMII, PHKD ENSG00000143933 Calmodulin 2 (phosphorylase kinase, delta) 2 47160082-47176601 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB007790, HPA044999 Approved Expressed in all cerebral cortex: 1537.9 CALM3 PHKD ENSG00000160014 Calmodulin 3 (phosphorylase kinase, delta) 19 46601074-46610793 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA044999 Approved Expressed in all cerebral cortex: 1317.4 CAMLG CAML, GET2 ENSG00000164615 Calcium modulating ligand 5 134738501-134752160 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052636, HPA056472 Approved Approved Nucleus
Nucleoli
Vesicles Expressed in all testis: 99.0 CASC3 BTZ, MLN51 ENSG00000108349 Cancer susceptibility candidate 3 17 40140318-40172183 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024592, HPA050262 Approved Approved Nuclear membrane Expressed in all testis: 94.9 CASR FHH, GPRC2A, HHC, HHC1, NSHPT ENSG00000036828 Calcium-sensing receptor 3 122183683-122286503 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039686, HPA050335 Supported Tissue enriched 60 parathyroid gland: 1627.2 kidney: 27.0 CATSPER4 ENSG00000188782 Cation channel, sperm associated 4 1 26190561-26202968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA045257 Supported Tissue enriched 63 testis: 9.7 skin: 0.1 CATSPERB C14orf161, FLJ14298 ENSG00000133962 Catsper channel auxiliary subunit beta 14 91580696-91780707 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035134 Uncertain Uncertain Vesicles Mixed skin: 2.7 CATSPERD MGC39581, TMEM146 ENSG00000174898 Catsper channel auxiliary subunit delta 19 5720677-5778734 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024056 Supported Tissue enriched 160 testis: 15.9 epididymis: 0.0 CATSPERG C19orf15, DKFZp434A1022, FLJ46353 ENSG00000099338 Catsper channel auxiliary subunit gamma 19 38335775-38370943 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052777 Approved Nucleus
Nucleoli
Cytosol Tissue enriched 41 testis: 48.5 skin: 1.1 CAV1 CAV ENSG00000105974 Caveolin 1, caveolae protein, 22kDa 7 116524785-116561184 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003791, HPA049326 Supported Supported Golgi apparatus Tissue enhanced 0 lung: 860.5 adipose tissue: 638.7 CAV3 LGMD1C, LQT9, VIP-21, VIP21 ENSG00000182533 Caveolin 3 3 8733800-8841808 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017518, CAB018557, HPA054488 Supported Supported Vesicles
Plasma membrane Group enriched 6 heart muscle: 13.0;skeletal muscle: 63.3 esophagus: 6.0 CCDC109B FLJ20647 ENSG00000005059 Coiled-coil domain containing 109B 4 109560205-109688726 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048776 Approved Approved Nucleoplasm
Cytosol Mixed lymph node: 36.7 CCNB1 CCNB ENSG00000134057 Cyclin B1 5 69167010-69178245 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000115, CAB003804, HPA030741, HPA061448 Supported Validated Cytosol Mixed lymph node: 66.3 CCNB2 HsT17299 ENSG00000157456 Cyclin B2 15 59105078-59125045 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008873, CAB009575 Supported Validated Golgi apparatus
Cytosol Tissue enhanced 0 testis: 122.0 bone marrow: 44.8 CD151 PETA-3, RAPH, SFA-1, TSPAN24 ENSG00000177697 CD151 molecule (Raph blood group) 11 832843-839831 Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002428, HPA011906 Supported Expressed in all smooth muscle: 356.5 CD36 FAT, GP3B, GP4, GPIV, SCARB3 ENSG00000135218 CD36 molecule (thrombospondin receptor) 7 80369575-80679277 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002018, CAB025866 Supported Expressed in all adipose tissue: 1614.0 CD81 TAPA-1, TAPA1, TSPAN28 ENSG00000110651 CD81 molecule 11 2376177-2397419 CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002507, HPA007234 Supported Supported Plasma membrane Expressed in all seminal vesicle: 2246.2 CD9 BA2, MIC3, MRP-1, P24, TSPAN29 ENSG00000010278 CD9 molecule 12 6199715-6238271 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002490 Supported Supported Plasma membrane Expressed in all esophagus: 1009.8 CDK1 CDC2, CDC28A ENSG00000170312 Cyclin-dependent kinase 1 10 60778331-60794852 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003387, CAB003799 Uncertain Validated Nucleus
Cytosol Mixed lymph node: 48.1 CELSR1 ADGRC1, CDHF9, FMI2, HFMI2, ME2 ENSG00000075275 Cadherin, EGF LAG seven-pass G-type receptor 1 22 46360834-46537170 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052976, HPA060521, HPA067269 Uncertain Supported Plasma membrane Mixed fallopian tube: 15.4 CFTR ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR ENSG00000001626 Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) 7 117465784-117715971 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001951, HPA021939 Supported Tissue enhanced 0 gallbladder: 89.6;rectum: 50.1 colon: 47.0 CHRNA1 CHRNA ENSG00000138435 Cholinergic receptor, nicotinic, alpha 1 (muscle) 2 174747592-174764472 Disease related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA071554 Supported Plasma membrane Tissue enhanced 0 skeletal muscle: 7.2 prostate: 2.6 CHRNA4 BFNC, EBN, EBN1 ENSG00000101204 Cholinergic receptor, nicotinic, alpha 4 (neuronal) 20 63343223-63378401 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB034064 Uncertain Tissue enhanced 0 cerebral cortex: 6.8;parathyroid gland: 16.9 liver: 3.7 CHRNA7 ENSG00000175344 Cholinergic receptor, nicotinic, alpha 7 (neuronal) 15 32030488-32172521 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA029422, CAB033624 Supported Tissue enhanced 0 adrenal gland: 6.0;small intestine: 6.0 stomach: 3.6 CHRNB1 CHRNB ENSG00000170175 Cholinergic receptor, nicotinic, beta 1 (muscle) 17 7445061-7457707 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA005822, CAB011200 Approved Expressed in all skeletal muscle: 43.9 CLCA1 CaCC, CLCRG1 ENSG00000016490 Chloride channel accessory 1 1 86468368-86500289 Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052787, HPA059301 Supported Group enriched 8 colon: 713.1;duodenum: 906.3;rectum: 1141.9;small intestine: 1551.5 appendix: 139.7 CLCC1 MCLC ENSG00000121940 Chloride channel CLIC-like 1 1 108929508-108963457 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009087, HPA013210 Supported Validated Endoplasmic reticulum Expressed in all parathyroid gland: 38.0 CLCN2 ClC-2, CLC2, EJM6 ENSG00000114859 Chloride channel, voltage-sensitive 2 3 184346185-184361651 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009397, HPA014545, HPA024108 Approved Approved Cytosol Mixed testis: 22.0 CLCN4 ClC-4, CLC4 ENSG00000073464 Chloride channel, voltage-sensitive 4 X 10156945-10237660 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031313, HPA063637 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 49.2;epididymis: 27.6 skeletal muscle: 14.6 CLCN7 CLC-7, CLC7, OPTA2, PPP1R63 ENSG00000103249 Chloride channel, voltage-sensitive 7 16 1444934-1475580 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043019, HPA043586 Supported Supported Nucleoplasm Expressed in all parathyroid gland: 40.4 CLDN1 ILVASC, SEMP1 ENSG00000163347 Claudin 1 3 190305701-190322475 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002602, HPA048319 Supported Tissue enhanced 0 skin: 306.9;smooth muscle: 183.5 liver: 158.3 CLDN16 HOMG3, PCLN1 ENSG00000113946 Claudin 16 3 190322541-190412143 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA056020 Supported Tissue enriched 6 kidney: 51.3 thyroid gland: 8.7 CLDN17 MGC126552, MGC126554 ENSG00000156282 Claudin 17 21 30165564-30166756 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA045903 Supported Tissue enriched 5 esophagus: 6.6 tonsil: 1.3 CLDN23 CLDNL ENSG00000253958 Claudin 23 8 8701938-8704106 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA070578 Uncertain Nucleus
Plasma membrane Tissue enhanced 0 colon: 24.1;stomach: 24.9 small intestine: 16.9 CLDN3 C7orf1, CPE-R2, CPETR2, HRVP1, RVP1 ENSG00000165215 Claudin 3 7 73768997-73770270 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002702, HPA014361 Supported Supported Cell Junctions Tissue enhanced 0 colon: 89.6;small intestine: 121.9 duodenum: 56.5 CLDN4 CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8 ENSG00000189143 Claudin 4 7 73799542-73832693 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002610 Supported Supported Plasma membrane Mixed colon: 212.3 CLDN5 AWAL, BEC1, CPETRL1, TMVCF ENSG00000184113 Claudin 5 22 19523024-19527545 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB002607 Approved Tissue enhanced 0 adipose tissue: 128.2 lung: 53.8 CLDN7 CEPTRL2, CPETRL2, Hs.84359 ENSG00000181885 Claudin 7 17 7259903-7263983 Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013063, HPA014703, HPA073662 Supported Approved Vesicles
Cell Junctions Mixed small intestine: 357.1 CLDN8 ENSG00000156284 Claudin 8 21 30214006-30216073 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA060605 Approved Tissue enhanced 0 breast: 84.5;kidney: 75.5;rectum: 56.8 thyroid gland: 37.2 CLDND1 C3orf4 ENSG00000080822 Claudin domain containing 1 3 98497912-98523066 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029841 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all cerebral cortex: 400.9 CLIC1 NCC27, p64CLCP ENSG00000213719 Chloride intracellular channel 1 6 31730581-31739763 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020825, CAB040557 Supported Supported Cytosol Expressed in all rectum: 71.3 CLIC2 XAP121 ENSG00000155962 Chloride intracellular channel 2 X 155276211-155334657 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047381, HPA060101 Uncertain Approved Plasma membrane Mixed spleen: 63.7 CLIC3 ENSG00000169583 Chloride intracellular channel 3 9 136994635-136996803 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005963 Approved Supported Nuclear bodies Tissue enhanced 0 esophagus: 87.1;thyroid gland: 85.5 skin: 43.6 CLIC4 CLIC4L, DKFZP566G223, H1, huH1, P64H1 ENSG00000169504 Chloride intracellular channel 4 1 24745357-24844324 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008019, HPA060804 Supported Supported Cytosol Expressed in all smooth muscle: 393.9 CLIC5 DFNB102 ENSG00000112782 Chloride intracellular channel 5 6 45898451-46080395 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA074371 Supported Nuclear speckles
Plasma membrane Tissue enhanced 0 lung: 116.4;skeletal muscle: 119.2 heart muscle: 72.3 CLIC6 CLIC1L, CLIC5 ENSG00000159212 Chloride intracellular channel 6 21 34669389-34718227 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA055123, HPA065285 Approved Tissue enhanced 0 stomach: 76.8 cervix: 24.3 CLNS1A CLCI, ICln ENSG00000074201 Chloride channel, nucleotide-sensitive, 1A 11 77514936-77637805 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017840, HPA031707, HPA031708, HPA032045 Approved Supported Nucleus
Microtubules
Cytosol Expressed in all thyroid gland: 131.3 CLRN1 RP61, USH3, USH3A ENSG00000163646 Clarin 1 3 150926163-150972999 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA054636 Uncertain Tissue enhanced 0 adrenal gland: 6.8;duodenum: 1.6 testis: 0.8 CLRN2 ENSG00000249581 Clarin 2 4 17515165-17527104 Predicted membrane proteins, Transporters Evidence at transcript level No evidence Evidence at transcript level HPA042407 Uncertain Not detected testis: 0.3 CLRN3 MGC32871, TMEM12, USH3AL1 ENSG00000180745 Clarin 3 10 127877841-127892947 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014482 Approved Group enriched 8 colon: 71.2;duodenum: 75.4;gallbladder: 23.7;kidney: 43.9;liver: 40.2;rectum: 77.5;small intestine: 99.5 appendix: 7.5 CMKLR1 RVER1 ENSG00000174600 Chemerin chemokine-like receptor 1 12 108288044-108339341 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047865 Uncertain Tissue enhanced 0 spleen: 49.3 placenta: 40.0 CMTM1 CKLFH, CKLFH1a, CKLFSF1 ENSG00000089505 CKLF-like MARVEL transmembrane domain containing 1 16 66566393-66579137 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA013801, HPA017136 Uncertain Approved Nucleoplasm Tissue enriched 6 testis: 28.8 spleen: 4.5 CMTM7 CKLFSF7, FLJ30992 ENSG00000153551 CKLF-like MARVEL transmembrane domain containing 7 3 32391671-32483067 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA077409 Approved Plasma membrane Mixed fallopian tube: 60.9 CNGA1 CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49 ENSG00000198515 Cyclic nucleotide gated channel alpha 1 4 47935977-48016672 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA076168 Approved Vesicles
Plasma membrane Mixed liver: 14.2 CNGB1 CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45 ENSG00000070729 Cyclic nucleotide gated channel beta 1 16 57882340-57971116 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039159, HPA060355 Uncertain Approved Vesicles
Cytosol Mixed appendix: 1.6 CNIH1 CNIH, CNIL, TGAM77 ENSG00000100528 Cornichon family AMPA receptor auxiliary protein 1 14 54423560-54441431 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002544 Approved Approved Vesicles Expressed in all liver: 118.5 CNNM3 ACDP3 ENSG00000168763 Cyclin and CBS domain divalent metal cation transport mediator 3 2 96816245-96833911 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016711 Supported Approved Cytosol Expressed in all parathyroid gland: 42.9 CNNM4 ACDP4, KIAA1592 ENSG00000158158 Cyclin and CBS domain divalent metal cation transport mediator 4 2 96760902-96811891 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017732 Supported Uncertain Plasma membrane
Actin filaments Expressed in all rectum: 37.5 CNR1 CANN6, CB-R, CB1, CB1A, CB1K5, CNR ENSG00000118432 Cannabinoid receptor 1 (brain) 6 88139864-88166359 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005603, HPA042256 Approved Approved Plasma membrane
Actin filaments Tissue enhanced 0 cerebral cortex: 32.2 adipose tissue: 12.1 CNTN2 AXT, TAG-1, TAX, TAX1 ENSG00000184144 Contactin 2 (axonal) 1 205043197-205078499 Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001397, HPA012497 Approved Tissue enriched 12 cerebral cortex: 79.8 testis: 6.9 COX4I1 COX4, COX4-1 ENSG00000131143 Cytochrome c oxidase subunit IV isoform 1 16 85798633-85807044 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002485, CAB004080 Supported Supported Mitochondria Expressed in all heart muscle: 1070.8 COX5A ENSG00000178741 Cytochrome c oxidase subunit Va 15 74919791-74938168 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027526 Supported Expressed in all skeletal muscle: 548.5 COX5B ENSG00000135940 Cytochrome c oxidase subunit Vb 2 97646040-97648383 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034517 Supported Validated Mitochondria Expressed in all skeletal muscle: 447.8 COX6B2 COXVIB2, CT59, FLJ32865 ENSG00000160471 Cytochrome c oxidase subunit VIb polypeptide 2 (testis) 19 55349306-55354814 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA035014 Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 14 testis: 74.6 rectum: 5.4 COX7C ENSG00000127184 Cytochrome c oxidase subunit VIIc 5 86617904-86620962 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046647 Approved Expressed in all skeletal muscle: 822.1 COX8A COX, COX8, COX8-2, COX8L, VIII, VIII-L ENSG00000176340 Cytochrome c oxidase subunit VIIIA (ubiquitous) 11 63974607-63976543 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055942 Supported Expressed in all skeletal muscle: 512.5 COX8C COX8-3 ENSG00000187581 Cytochrome c oxidase subunit VIIIC 14 93347191-93348356 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003127 Approved Tissue enriched 52 testis: 29.6 fallopian tube: 0.5 CRAT CAT1 ENSG00000095321 Carnitine O-acetyltransferase 9 129094810-129111189 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019230, HPA020260, HPA022815 Supported Approved Nucleoplasm
Nuclear membrane Expressed in all testis: 116.2 CROT COT ENSG00000005469 Carnitine O-octanoyltransferase 7 87345681-87399795 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019052, HPA019364, HPA019365 Supported Supported Vesicles Expressed in all thyroid gland: 68.1 CSE1L CAS, CSE1, XPO2 ENSG00000124207 CSE1 chromosome segregation 1-like (yeast) 20 49046246-49096960 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002140, HPA038059, HPA038060 Supported Validated Nucleoplasm
Cytosol Expressed in all testis: 158.9 CSTB CST6, EPM1, PME, STFB ENSG00000160213 Cystatin B (stefin B) 21 43772512-43776445 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017380, CAB047320, HPA058557 Supported Supported Nucleoli
Cytosol Tissue enriched 8 esophagus: 1836.3 tonsil: 237.3 CTIF KIAA0427 ENSG00000134030 CBP80/20-dependent translation initiation factor 18 48539046-48863217 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016865, HPA024801 Uncertain Supported Cytosol Mixed cerebral cortex: 24.9 CTNS CTNS-LSB, PQLC4 ENSG00000040531 Cystinosin, lysosomal cystine transporter 17 3636468-3661542 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046947 Supported Vesicles
Intermediate filaments Expressed in all testis: 43.3 CUTC CGI-32 ENSG00000119929 CutC copper transporter 10 99702558-99756134 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038619 Approved Supported Nucleoplasm
Cytosol Expressed in all skeletal muscle: 131.6 CXCL16 CXCLG16, SR-PSOX, SRPSOX ENSG00000161921 Chemokine (C-X-C motif) ligand 16 17 4733526-4739922 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA053253, HPA066315 Approved Approved Golgi apparatus
Vesicles Mixed lung: 106.3 CYB561 CYB561A1, FRRS2 ENSG00000008283 Cytochrome b561 17 63432304-63446378 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014753 Approved Expressed in all adrenal gland: 164.3 CYBA p22-PHOX ENSG00000051523 Cytochrome b-245, alpha polypeptide 16 88643283-88651152 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009492 Supported Expressed in all spleen: 476.3 CYBB CGD, GP91-PHOX, NOX2 ENSG00000165168 Cytochrome b-245, beta polypeptide X 37780011-37813461 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051227 Supported Tissue enhanced 0 appendix: 221.1 lung: 132.4 CYSLTR1 CysLT(1), CysLT1, CYSLT1R ENSG00000173198 Cysteinyl leukotriene receptor 1 X 78271464-78327691 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA010546 Approved Mixed spleen: 15.1 DCD AIDD, DCD-1, DSEP, HCAP, PIF ENSG00000161634 Dermcidin 12 54644591-54648493 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA063967 Supported Tissue enriched 94 breast: 332.5 skeletal muscle: 3.5 DCP1A HSA275986, SMAD4IP1, SMIF ENSG00000272886 Decapping mRNA 1A 3 53283428-53347610 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013202 Approved Supported Cytoplasmic bodies Expressed in all endometrium: 19.0 DDX19A DDX19L, FLJ11126 ENSG00000168872 DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A 16 70346829-70373383 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045252, HPA066668 Approved Uncertain Nucleoplasm Expressed in all parathyroid gland: 50.2 DDX19B DBP5, DDX19 ENSG00000157349 DEAD (Asp-Glu-Ala-Asp) box polypeptide 19B 16 70289663-70335283 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037229, CAB037284, HPA046380, HPA066668 Approved Uncertain Nucleoplasm Expressed in all testis: 82.7 DDX39B BAT1, D6S81E, UAP56 ENSG00000198563 DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B 6 31530219-31542448 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB034012, HPA055334, HPA058450 Supported Validated Nuclear speckles Expressed in all epididymis: 44.0 DDX3X DBX, DDX14, DDX3, HLP2 ENSG00000215301 DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked X 41333348-41364472 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001648, HPA005631, HPA059585 Supported Approved Approved Nucleus
Cytosol Expressed in all parathyroid gland: 270.3 DEFA1 DEF1, DEFA2, HNP-1, MRS ENSG00000206047 Defensin, alpha 1 8 6977649-6980080 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB032548, HPA052517 Supported Tissue enriched 284 bone marrow: 15680.7 skin: 55.3 DEFA1B ENSG00000240247 Defensin, alpha 1B 8 6996766-7018289 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA052517 Supported Tissue enriched 514 bone marrow: 61211.3 skin: 119.2 DEFA6 DEF6, HD-6 ENSG00000164822 Defensin, alpha 6, Paneth cell-specific 8 6924693-6926076 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019462 Supported Group enriched 521 duodenum: 5909.3;small intestine: 10744.7 colon: 15.9 DERL1 DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577 ENSG00000136986 Derlin 1 8 123013164-123042423 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016562, CAB037269 Supported Validated Endoplasmic reticulum Expressed in all adipose tissue: 76.6 DIRC2 FLJ14784, RCC4 ENSG00000138463 Disrupted in renal carcinoma 2 3 122794795-122881139 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA072579 Supported Vesicles Expressed in all parathyroid gland: 15.9 DLG4 PSD-95, PSD95, SAP-90, SAP90 ENSG00000132535 Discs, large homolog 4 (Drosophila) 17 7189890-7219702 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001999, CAB002000, HPA010122 Supported Approved Vesicles Tissue enriched 6 cerebral cortex: 179.1 endometrium: 28.9 DMD BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85 ENSG00000198947 Dystrophin X 31097677-33339441 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000119, HPA002725, HPA023885 Supported Mixed seminal vesicle: 54.1 DPP6 DPPX ENSG00000130226 Dipeptidyl-peptidase 6 7 153887097-154894285 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050509 Supported Supported Tissue enhanced 0 cerebral cortex: 51.2;endometrium: 27.4 smooth muscle: 15.2 DRD2 ENSG00000149295 Dopamine receptor D2 11 113409615-113475691 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA015691 Supported Tissue enriched 5 adrenal gland: 11.3 smooth muscle: 2.2 DUOX1 LNOX1, NOXEF1, THOX1 ENSG00000137857 Dual oxidase 1 15 45129933-45165576 Enzymes, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023544 Approved Tissue enhanced 0 skin: 96.8;thyroid gland: 92.3 esophagus: 73.4 DUX4 ENSG00000260596 Double homeobox 4 4 190173774-190185942 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA058451 Approved Nucleus
Nucleoli
Cytosol Tissue enhanced 0 testis: 1.5 seminal vesicle: 0.5 DYSF FER1L1, LGMD2B ENSG00000135636 Dysferlin 2 71453722-71686768 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002510, HPA017071, HPA021945 Supported Supported Plasma membrane
Microtubule organizing center Mixed skeletal muscle: 32.8 EI24 EPG4, PIG8, TP53I8 ENSG00000149547 Etoposide induced 2.4 11 125569216-125584687 Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047165, HPA051029 Uncertain Supported Endoplasmic reticulum
Golgi apparatus
Cytosol Tissue enriched 9 parathyroid gland: 1098.6 liver: 124.7 EIF4A3 DDX48, EIF4AIII, KIAA0111 ENSG00000141543 Eukaryotic translation initiation factor 4A3 17 80135214-80147183 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021878 Supported Supported Nucleoplasm Expressed in all bone marrow: 112.3 EIF5A EIF-5A, EIF5A1, MGC104255, MGC99547 ENSG00000132507 Eukaryotic translation initiation factor 5A 17 7306999-7312463 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005042, HPA061298 Approved Validated Nucleoplasm
Cytosol Expressed in all esophagus: 437.6 EIF5A2 ENSG00000163577 Eukaryotic translation initiation factor 5A2 3 170888415-170908693 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029090 Approved Supported Vesicles Tissue enhanced 0 testis: 36.4 smooth muscle: 10.2 ENY2 DC6, FLJ20480, Sus1 ENSG00000120533 Enhancer of yellow 2 homolog (Drosophila) 8 109334324-109345953 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024648 Approved Approved Nucleoplasm
Mitochondria Expressed in all kidney: 77.0 EPB41 4.1R, EL1 ENSG00000159023 Erythrocyte membrane protein band 4.1 1 28887091-29120046 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028076, HPA028412, HPA028414 Supported Supported Plasma membrane
Cell Junctions
Cytosol Expressed in all lymph node: 51.3 ERBB4 ALS19, HER4 ENSG00000178568 Erb-b2 receptor tyrosine kinase 4 2 211375717-212538841 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB000276, HPA012016, CAB025522 Approved Tissue enhanced 0 fallopian tube: 17.6 cerebral cortex: 7.6 ERLEC1 C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB ENSG00000068912 Endoplasmic reticulum lectin 1 2 53787044-53818819 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031501, HPA031502, HPA031503 Approved Expressed in all thyroid gland: 121.4 F2RL1 GPR11, PAR2 ENSG00000164251 Coagulation factor II (thrombin) receptor-like 1 5 76818933-76835315 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB012989, HPA014091 Approved Approved Plasma membrane Mixed colon: 59.9 FABP5 E-FABP, KFABP, PA-FABP ENSG00000164687 Fatty acid binding protein 5 (psoriasis-associated) 8 81280363-81284777 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017831, CAB040577, HPA051895 Supported Supported Plasma membrane
Cytosol Expressed in all esophagus: 1671.2 FAM8A1 AHCP ENSG00000137414 Family with sequence similarity 8, member A1 6 17600355-17611719 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044698 Supported Golgi apparatus Expressed in all endometrium: 45.3 FLVCR1 AXPC1, FLVCR, MFSD7B, PCA ENSG00000162769 Feline leukemia virus subgroup C cellular receptor 1 1 212858255-212899363 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046646 Approved Approved Cell Junctions Tissue enhanced 0 small intestine: 21.9 duodenum: 10.0 FLVCR2 C14orf58, FLJ20371, MFSD7C ENSG00000119686 Feline leukemia virus subgroup C cellular receptor family, member 2 14 75578617-75663214 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037984 Supported Tissue enhanced 0 testis: 38.5 small intestine: 27.4 FOLR1 FOLR ENSG00000110195 Folate receptor 1 (adult) 11 72189558-72196301 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA077030 Approved Nuclear membrane Tissue enhanced 0 cervix, uterine: 176.8;fallopian tube: 289.8;lung: 284.9 kidney: 154.6 FXN CyaY, FA, FARR, FRDA, X25 ENSG00000165060 Frataxin 9 69035259-69100178 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022164, HPA068304 Supported Supported Mitochondria
Cytosol Expressed in all parathyroid gland: 33.5 FXYD2 ATP1G1, HOMG2, MGC12372 ENSG00000137731 FXYD domain containing ion transport regulator 2 11 117800844-117828698 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064218, HPA068838 Supported Approved Mitochondria Group enriched 6 gallbladder: 575.2;kidney: 1428.7;salivary gland: 383.4 pancreas: 134.6 FXYD5 OIT2 ENSG00000089327 FXYD domain containing ion transport regulator 5 19 35154730-35169883 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010817 Uncertain Approved Endoplasmic reticulum Expressed in all spleen: 241.4 FXYD6 ENSG00000137726 FXYD domain containing ion transport regulator 6 11 117836976-117877486 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041334, HPA042284 Approved Approved Nucleoplasm
Cytosol Expressed in all cerebral cortex: 698.7 FZD1 DKFZp564G072 ENSG00000157240 Frizzled class receptor 1 7 91264364-91271326 Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013008 Approved Supported Plasma membrane Mixed thyroid gland: 32.3 GABARAP ATG8A, MM46 ENSG00000170296 GABA(A) receptor-associated protein 17 7240014-7242770 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065883 Approved Vesicles Expressed in all epididymis: 750.2 GABBR2 GABABR2, GPR51, GPRC3B, HG20 ENSG00000136928 Gamma-aminobutyric acid (GABA) B receptor, 2 9 98288082-98709197 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013820, HPA031684 Supported Tissue enriched 19 cerebral cortex: 88.4 adrenal gland: 4.6 GABRA1 EJM5 ENSG00000022355 Gamma-aminobutyric acid (GABA) A receptor, alpha 1 5 161847191-161899981 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022502, HPA055746 Supported Tissue enriched 44 cerebral cortex: 109.1 adrenal gland: 2.4 GABRB2 ENSG00000145864 Gamma-aminobutyric acid (GABA) A receptor, beta 2 5 161288429-161549044 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001964, HPA067632 Supported Tissue enriched 11 cerebral cortex: 63.0 epididymis: 5.5 GAP43 B-50, PP46 ENSG00000172020 Growth associated protein 43 3 115623324-115721490 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004417, HPA013392, HPA015600 Supported Validated Plasma membrane Tissue enriched 37 cerebral cortex: 346.9 appendix: 9.4 GHSR ENSG00000121853 Growth hormone secretagogue receptor 3 172445133-172448456 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level CAB012451 Uncertain Not detected adrenal gland: 0.3 GIPR ENSG00000010310 Gastric inhibitory polypeptide receptor 19 45668244-45683724 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022710 Uncertain Tissue enhanced 0 stomach: 22.6 parathyroid gland: 12.2 GJA3 CX46, CZP3 ENSG00000121743 Gap junction protein, alpha 3, 46kDa 13 20138255-20161049 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA014821 Supported Tissue enhanced 0 heart muscle: 4.7;parathyroid gland: 5.8;placenta: 3.5 testis: 2.5 GJA4 CX37 ENSG00000187513 Gap junction protein, alpha 4, 37kDa 1 34792998-34795747 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA047981 Approved Tissue enhanced 0 placenta: 88.6 fallopian tube: 47.8 GJB1 CMTX, CMTX1, CX32 ENSG00000169562 Gap junction protein, beta 1, 32kDa X 71215194-71225516 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB012994 Uncertain Tissue enhanced 0 liver: 159.3 gallbladder: 59.5 GJB2 CX26, DFNA3, DFNB1, NSRD1 ENSG00000165474 Gap junction protein, beta 2, 26kDa 13 20187470-20192898 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013093, HPA014362 Uncertain Approved Mitochondria Tissue enriched 9 esophagus: 728.4 tonsil: 84.8 GJC1 CX45, GJA7 ENSG00000182963 Gap junction protein, gamma 1, 45kDa 17 44798448-44830816 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071788 Uncertain Nucleoli
Cell Junctions
Cytosol Tissue enhanced 0 endometrium: 43.9;placenta: 50.9;smooth muscle: 48.2 seminal vesicle: 27.0 GJC3 CX30.2, GJE1 ENSG00000176402 Gap junction protein, gamma 3, 30.2kDa 7 99923269-99929620 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015024 Uncertain Tissue enhanced 0 breast: 8.9;prostate: 5.6 testis: 3.2 GJD4 CX40.1, FLJ90023 ENSG00000177291 Gap junction protein, delta 4, 40.1kDa 10 35605410-35608935 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038266 Approved Mixed cerebral cortex: 1.7 GLE1 GLE1L, hGLE1, LCCS1 ENSG00000119392 GLE1 RNA export mediator 9 128504700-128542288 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041689, HPA043538, HPA061560 Supported Supported Nuclear membrane
Nucleoli Expressed in all testis: 58.6 GLRA1 STHE ENSG00000145888 Glycine receptor, alpha 1 5 151822513-151924842 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level HPA016502 Uncertain Not detected adrenal gland: 0.4 GLRA2 GLR ENSG00000101958 Glycine receptor, alpha 2 X 14529298-14731812 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB070422 Approved Group enriched 10 cerebral cortex: 6.2;colon: 1.4;rectum: 4.3 testis: 0.3 GLRB ENSG00000109738 Glycine receptor, beta 4 157076057-157172090 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052363 Approved Tissue enhanced 0 cerebral cortex: 62.2;parathyroid gland: 62.0 cervix: 14.0 GNLY D2S69E, LAG-2, LAG2, NKG5, TLA519 ENSG00000115523 Granulysin 2 85685175-85698854 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025186, HPA058021 Supported Tissue enhanced 0 bone marrow: 153.1;endometrium: 113.5;spleen: 114.5 lung: 51.2 GNRHR GRHR, LHRHR ENSG00000109163 Gonadotropin-releasing hormone receptor 4 67739328-67754360 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA013424 Supported Tissue enhanced 0 parathyroid gland: 1.2 adrenal gland: 1.0 GPR137B TM7SF1 ENSG00000077585 G protein-coupled receptor 137B 1 236142505-236221865 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA026422 Approved Mixed kidney: 70.2 GPR161 RE2 ENSG00000143147 G protein-coupled receptor 161 1 168079543-168137667 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA015576, HPA072047 Uncertain Approved Nucleus
Nucleoli Tissue enhanced 0 smooth muscle: 39.8 endometrium: 28.5 GPRC5C RAIG-3 ENSG00000170412 G protein-coupled receptor, class C, group 5, member C 17 74424851-74451653 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029776 Supported Uncertain Nucleus
Microtubule organizing center
Cytosol Mixed thyroid gland: 103.7 GRIA2 GluA2, GLUR2, GLURB ENSG00000120251 Glutamate receptor, ionotropic, AMPA 2 4 157204182-157366075 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006830, CAB007812, HPA008441, CAB012981 Supported Tissue enriched 8 cerebral cortex: 207.2 endometrium: 27.2 GRIA3 GluA3, GLUR3, GLURC, MRX94 ENSG00000125675 Glutamate receptor, ionotropic, AMPA 3 X 123184153-123490915 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058659 Uncertain Tissue enhanced 0 cerebral cortex: 56.8 adrenal gland: 11.4 GRIN1 GluN1, NMDAR1 ENSG00000176884 Glutamate receptor, ionotropic, N-methyl D-aspartate 1 9 137138390-137168762 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB006831 Approved Tissue enriched 202 cerebral cortex: 152.3 prostate: 0.7 GRM1 GPRC1A, mGlu1, MGLUR1, PPP1R85 ENSG00000152822 Glutamate receptor, metabotropic 1 6 146027646-146437598 Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015701 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 7.1 heart muscle: 1.4 GSG1L KTSR5831, MGC18079, PRO19651 ENSG00000169181 GSG1-like 16 27787535-28063509 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014479 Approved Tissue enhanced 0 cerebral cortex: 11.7;heart muscle: 8.8 fallopian tube: 2.7 HAS1 HAS ENSG00000105509 Hyaluronan synthase 1 19 51713112-51723994 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA067602 Approved Approved Nucleoplasm
Plasma membrane Tissue enhanced 0 adipose tissue: 26.9 appendix: 9.1 HEPACAM FLJ25530, GLIALCAM, hepaCAM ENSG00000165478 Hepatic and glial cell adhesion molecule 11 124919193-124936412 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017613, CAB025486 Supported Approved Vesicles Tissue enriched 6 cerebral cortex: 80.9 adipose tissue: 14.4 HIATL1 FLJ14753 ENSG00000148110 Hippocampus abundant transcript-like 1 9 94374551-94461042 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA017978 Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 251.1 HMGCR ENSG00000113161 3-hydroxy-3-methylglutaryl-CoA reductase 5 75336329-75362104 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008338, CAB016797 Approved Expressed in all cerebral cortex: 87.8 HSPA1A HSP70-1, HSPA1 ENSG00000204389 Heat shock 70kDa protein 1A 6 31815464-31817946 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB017451, CAB032815, HPA052504 Supported Uncertain Nucleoplasm
Vesicles Mixed adrenal gland: 49.9 HSPA1B HSP70-2 ENSG00000204388 Heat shock 70kDa protein 1B 6 31827735-31830255 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB008640, HPA052504 Approved Uncertain Nucleoplasm
Vesicles Tissue enhanced 0 adrenal gland: 34.3 urinary bladder: 15.0 HTN3 HIS2 ENSG00000205649 Histatin 3 4 70028413-70036538 Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB073541 Supported Uncertain Vesicles Tissue enriched 1662 salivary gland: 47809.1 ovary: 28.7 HTR1B 5-HT1B, 5-HT1DB, HTR1D2, S12 ENSG00000135312 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled 6 77462205-77463464 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA028808 Approved Uncertain Plasma membrane Tissue enhanced 0 placenta: 13.7;stomach: 5.8 cerebral cortex: 2.8 HTR2B 5-HT(2B), 5-HT2B ENSG00000135914 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled 2 231108230-231125118 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011448, HPA012867, HPA063658 Approved Approved Nucleoplasm Tissue enhanced 0 cervix, uterine: 31.1;endometrium: 30.0;smooth muscle: 23.0 adrenal gland: 19.1 HVCN1 Hv1, MGC15619, VSOP ENSG00000122986 Hydrogen voltage gated channel 1 12 110627841-110704950 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039329 Approved Mixed testis: 82.3 IFITM1 9-27, CD225, IFI17 ENSG00000185885 Interferon induced transmembrane protein 1 11 313506-315272 CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004810, CAB017615 Supported Supported Cytosol Expressed in all epididymis: 904.7 IFITM2 1-8D ENSG00000185201 Interferon induced transmembrane protein 2 11 307631-315272 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004337 Uncertain Expressed in all appendix: 722.4 IFITM3 1-8U ENSG00000142089 Interferon induced transmembrane protein 3 11 319669-327537 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004337 Uncertain Expressed in all fallopian tube: 1027.4 IPO11 RanBP11 ENSG00000086200 Importin 11 5 62403972-62628582 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA067097 Approved Validated Nucleus
Nucleoli fibrillar center Expressed in all testis: 40.5 IPO13 IMP13, KIAA0724, RANBP13 ENSG00000117408 Importin 13 1 43946939-43968022 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB070425 Uncertain Expressed in all testis: 66.5 IPO4 FLJ23338, Imp4 ENSG00000196497 Importin 4 14 24180219-24188964 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039043, HPA064572 Uncertain Approved Cytosol Tissue enhanced 0 testis: 16.9 skin: 5.3 IPO5 IMB3, KPNB3, MGC2068, Pse1, RANBP5 ENSG00000065150 Importin 5 13 97953658-98024297 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009110, HPA040983, HPA056548 Approved Supported Nucleoplasm
Cytosol Expressed in all testis: 382.6 IPO7 Imp7, RANBP7 ENSG00000205339 Importin 7 11 9384622-9448126 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019002, HPA056590 Approved Approved Validated Nucleoplasm
Cytosol Expressed in all thyroid gland: 89.6 IPO8 IMP8, RANBP8 ENSG00000133704 Importin 8 12 30628988-30695986 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018439, HPA023765 Uncertain Supported Nucleus Expressed in all parathyroid gland: 119.5 IPO9 FLJ10402, Imp9 ENSG00000198700 Importin 9 1 201829141-201884294 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059540 Approved Vesicles
Cytosol Expressed in all parathyroid gland: 30.0 ITGA1 CD49a, VLA1 ENSG00000213949 Integrin, alpha 1 5 52787896-52959210 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042555 Uncertain Approved Endoplasmic reticulum Mixed spleen: 78.9 ITGA6 CD49f ENSG00000091409 Integrin, alpha 6 2 172427354-172506282 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009009, HPA012696, HPA027582 Supported Expressed in all placenta: 114.3 ITGB1 CD29, FNRB, GPIIA, MDF2, MSK12 ENSG00000150093 Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) 10 32900319-33005792 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003434 Approved Supported Endoplasmic reticulum
Plasma membrane
Focal adhesion sites Expressed in all smooth muscle: 1058.2 ITPR1 ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29 ENSG00000150995 Inositol 1,4,5-trisphosphate receptor, type 1 3 4493348-4847840 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014765, HPA016487 Approved Approved Vesicles Tissue enhanced 0 parathyroid gland: 104.9 thyroid gland: 47.2 IZUMO1 IZUMO, MGC34799, OBF ENSG00000182264 Izumo sperm-egg fusion 1 19 48740852-48746909 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038104 Supported Tissue enriched 22 testis: 19.2 lung: 0.8 IZUMO2 C19orf41, MGC33947, SCRL ENSG00000161652 IZUMO family member 2 19 50152548-50163195 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042143 Uncertain Tissue enriched 255 testis: 55.9 thyroid gland: 0.2 IZUMO4 C19orf36 ENSG00000099840 IZUMO family member 4 19 2096429-2099593 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045099, HPA048496 Approved Uncertain Nucleoplasm
Vesicles Tissue enriched 52 testis: 341.4 ovary: 6.5 KCNA2 HK4, Kv1.2 ENSG00000177301 Potassium channel, voltage gated shaker related subfamily A, member 2 1 110593580-110631474 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001976 Supported Tissue enriched 5 cerebral cortex: 20.7 thyroid gland: 3.8 KCNA3 HLK3, HPCN3, Kv1.3, MK3 ENSG00000177272 Potassium channel, voltage gated shaker related subfamily A, member 3 1 110672465-110675033 FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016625 Approved Mixed lymph node: 10.7 KCNA5 HK2, HPCN1, Kv1.5 ENSG00000130037 Potassium channel, voltage gated shaker related subfamily A, member 5 12 5043989-5046788 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021516, CAB022562 Approved Tissue enhanced 0 heart muscle: 20.8 esophagus: 5.6 KCNAB1 AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3 ENSG00000169282 Potassium channel, voltage gated subfamily A regulatory beta subunit 1 3 156037701-156539138 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044550 Approved Tissue enhanced 0 thyroid gland: 48.3 prostate: 37.6 KCNB1 Kv2.1 ENSG00000158445 Potassium channel, voltage gated Shab related subfamily B, member 1 20 49363877-49484297 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001979, HPA042434 Supported Tissue enhanced 0 adipose tissue: 11.0;cerebral cortex: 21.0 fallopian tube: 7.5 KCNC3 Kv3.3, SCA13 ENSG00000131398 Potassium channel, voltage gated Shaw related subfamily C, member 3 19 50311937-50333515 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018041 Uncertain Tissue enhanced 0 parathyroid gland: 39.3 cerebral cortex: 19.9 KCND2 KIAA1044, Kv4.2, RK5 ENSG00000184408 Potassium channel, voltage gated Shal related subfamily D, member 2 7 120273668-120750331 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029068 Approved Tissue enhanced 0 cerebral cortex: 20.8 gallbladder: 6.9 KCND3 KSHIVB, Kv4.3, SCA19, SCA22 ENSG00000171385 Potassium channel, voltage gated Shal related subfamily D, member 3 1 111770662-111989155 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029452 Approved Mixed cerebral cortex: 26.8 KCNF1 IK8, KCNF, kH1, Kv5.1 ENSG00000162975 Potassium channel, voltage gated modifier subfamily F, member 1 2 10911937-10914225 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB004678, HPA014738 Supported Approved Golgi apparatus Tissue enriched 32 cerebral cortex: 37.6 endometrium: 1.1 KCNH1 eag, eag1, h-eag, Kv10.1 ENSG00000143473 Potassium channel, voltage gated eag related subfamily H, member 1 1 210678315-211134115 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014551, HPA019445 Supported Approved Vesicles Tissue enriched 12 cerebral cortex: 11.5 testis: 0.9 KCNH3 BEC1, elk2, Kv12.2 ENSG00000135519 Potassium channel, voltage gated eag related subfamily H, member 3 12 49539157-49558308 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051088 Uncertain Approved Nucleus
Mitochondria Group enriched 5 cerebral cortex: 24.3;fallopian tube: 7.1;parathyroid gland: 4.9 adrenal gland: 2.2 KCNIP4 CALP, KCHIP4, MGC44947 ENSG00000185774 Kv channel interacting protein 4 4 20728616-21948799 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA022862, HPA066717 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 57.4 cervix: 20.5 KCNJ1 Kir1.1, ROMK1 ENSG00000151704 Potassium channel, inwardly rectifying subfamily J, member 1 11 128836315-128867373 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA026962 Supported Tissue enriched 118 kidney: 209.0 epididymis: 1.7 KCNJ16 BIR9, Kir5.1 ENSG00000153822 Potassium channel, inwardly rectifying subfamily J, member 16 17 70053429-70135608 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA059563 Approved Uncertain Vesicles Group enriched 7 kidney: 207.9;parathyroid gland: 268.8;thyroid gland: 233.9 seminal vesicle: 31.9 KCNJ2 IRK1, Kir2.1, LQT7 ENSG00000123700 Potassium channel, inwardly rectifying subfamily J, member 2 17 70168673-70180048 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA029109 Approved Tissue enhanced 0 parathyroid gland: 46.5 fallopian tube: 11.6 KCNJ3 GIRK1, KGA, Kir3.1 ENSG00000162989 Potassium channel, inwardly rectifying subfamily J, member 3 2 154698299-154858352 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024231 Uncertain Tissue enhanced 0 cerebral cortex: 25.5;parathyroid gland: 39.5 seminal vesicle: 14.1 KCNJ5 CIR, GIRK4, KATP1, Kir3.4, LQT13 ENSG00000120457 Potassium channel, inwardly rectifying subfamily J, member 5 11 128891356-128921035 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014722, HPA017353, CAB022569 Supported Tissue enhanced 0 adrenal gland: 85.2 spleen: 19.1 KCNJ8 Kir6.1 ENSG00000121361 Potassium channel, inwardly rectifying subfamily J, member 8 12 21764955-21775581 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031066 Uncertain Mixed seminal vesicle: 31.6 KCNK15 dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5 ENSG00000124249 Potassium channel, two pore domain subfamily K, member 15 20 44745780-44752313 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA064861 Uncertain Tissue enhanced 0 fallopian tube: 8.0 testis: 2.9 KCNK17 K2p17.1, TALK-2, TALK2, TASK-4, TASK4 ENSG00000124780 Potassium channel, two pore domain subfamily K, member 17 6 39299001-39314553 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043892 Uncertain Tissue enhanced 0 lung: 5.6 placenta: 5.2 KCNK5 K2p5.1, TASK-2 ENSG00000164626 Potassium channel, two pore domain subfamily K, member 5 6 39188973-39229450 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059148 Uncertain Approved Nucleus Tissue enhanced 0 small intestine: 40.1 gallbladder: 29.6 KCNK6 K2p6.1, TWIK-2 ENSG00000099337 Potassium channel, two pore domain subfamily K, member 6 19 38319844-38332076 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB022637, HPA040184 Uncertain Approved Plasma membrane
Actin filaments
Cytosol Mixed endometrium: 22.8 KCNMB2 ENSG00000197584 Potassium channel subfamily M regulatory beta subunit 2 3 178272932-178844429 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022649 Uncertain Tissue enhanced 0 epididymis: 41.5;fallopian tube: 22.1;ovary: 19.0 adrenal gland: 7.6 KCNMB3 KCNMB2, KCNMBL ENSG00000171121 Potassium channel subfamily M regulatory beta subunit 3 3 179236691-179267002 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA015665, HPA019185 Approved Approved Nucleus
Mitochondria Mixed placenta: 5.9 KCNN2 hSK2, KCa2.2 ENSG00000080709 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2 5 114360945-114496500 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038221 Uncertain Uncertain Nucleoplasm
Cytosol Tissue enhanced 0 adrenal gland: 27.4;prostate: 18.5 liver: 15.9 KCNN4 hIKCa1, hKCa4, hSK4, IK, KCa3.1 ENSG00000104783 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 19 43766533-43781257 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053841, HPA059622 Approved Tissue enhanced 0 salivary gland: 74.3 stomach: 37.1 KCNQ1 JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1 ENSG00000053918 Potassium channel, voltage gated KQT-like subfamily Q, member 1 11 2444684-2849109 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018656, HPA048553 Supported Tissue enhanced 0 adrenal gland: 134.2;thyroid gland: 102.8 seminal vesicle: 60.3 KCNQ2 BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2 ENSG00000075043 Potassium channel, voltage gated KQT-like subfamily Q, member 2 20 63400210-63472677 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016642, HPA057112 Approved Approved Endoplasmic reticulum Tissue enriched 7 cerebral cortex: 56.3 adrenal gland: 8.2 KCNQ4 DFNA2, Kv7.4 ENSG00000117013 Potassium channel, voltage gated KQT-like subfamily Q, member 4 1 40784012-40840452 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA018305 Uncertain Mixed smooth muscle: 2.5 KCNS2 Kv9.2 ENSG00000156486 Potassium voltage-gated channel, modifier subfamily S, member 2 8 98427022-98432848 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA051417 Uncertain Tissue enhanced 0 cerebral cortex: 7.2 placenta: 2.2 KCNS3 Kv9.3 ENSG00000170745 Potassium voltage-gated channel, modifier subfamily S, member 3 2 17877847-18361616 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA014864 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Tissue enhanced 0 lung: 35.5 skeletal muscle: 29.6 KCNT1 KCa4.1, KIAA1422, SLACK, Slo2.2 ENSG00000107147 Potassium channel, sodium activated subfamily T, member 1 9 135702185-135795508 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059880 Uncertain Group enriched 5 cerebral cortex: 11.7;ovary: 3.9;skeletal muscle: 3.9;spleen: 6.7 testis: 1.2 KCNT2 KCa4.2, SLICK, SLO2.1 ENSG00000162687 Potassium channel, sodium activated subfamily T, member 2 1 196225779-196609225 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051218 Uncertain Approved Vesicles Tissue enhanced 0 ovary: 6.0 cerebral cortex: 3.5 KDELR1 ERD2, ERD2.1, HDEL ENSG00000105438 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 19 48382570-48391553 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017455 Approved Supported Golgi apparatus
Vesicles Expressed in all parathyroid gland: 259.3 KISS1R AXOR12, GPR54, HOT7T175 ENSG00000116014 KISS1 receptor 19 917287-921015 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA071913 Supported Vesicles
Plasma membrane Tissue enriched 5 cerebral cortex: 1.2 placenta: 0.2 KLB ENSG00000134962 Klotho beta 4 39406853-39451536 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021136 Uncertain Tissue enhanced 0 adipose tissue: 20.6;liver: 9.1 testis: 5.1 KPNA1 IPOA5, NPI-1, RCH2, SRP1 ENSG00000114030 Karyopherin alpha 1 (importin alpha 5) 3 122421949-122514945 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053627, HPA063426 Supported Validated Nucleus
Cytosol Expressed in all cerebral cortex: 39.5 KPNA2 IPOA1, QIP2, RCH1, SRP1alpha ENSG00000182481 Karyopherin alpha 2 (RAG cohort 1, importin alpha 1) 17 68035519-68046842 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015460, HPA041270 Supported Validated Nucleoplasm
Cytosol Expressed in all testis: 347.6 KPNA3 hSRP1, IPOA4, SRP1gamma, SRP4 ENSG00000102753 Karyopherin alpha 3 (importin alpha 4) 13 49699307-49792921 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046852 Approved Approved Nucleoplasm
Cytosol Expressed in all testis: 49.6 KPNA4 IPOA3, MGC12217, MGC26703, QIP1, SRP3 ENSG00000186432 Karyopherin alpha 4 (importin alpha 3) 3 160494995-160565588 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB034336, HPA043154, HPA045500 Supported Validated Nucleus Expressed in all skeletal muscle: 36.6 KPNA5 IPOA6, SRP6 ENSG00000196911 Karyopherin alpha 5 (importin alpha 6) 6 116681187-116741866 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026464, HPA054037 Supported Supported Cytosol Tissue enhanced 0 testis: 83.1 ovary: 23.5 KPNA6 FLJ11249, IPOA7, KPNA7, MGC17918 ENSG00000025800 Karyopherin alpha 6 (importin alpha 7) 1 32108038-32176568 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018863 Supported Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 48.5 KPNB1 IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97 ENSG00000108424 Karyopherin (importin) beta 1 17 47649476-47685505 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029878, CAB034449, HPA050302 Supported Supported Nucleoplasm
Nuclear membrane
Cytosol Expressed in all testis: 218.3 LAMP1 CD107a ENSG00000185896 Lysosomal-associated membrane protein 1 13 113297241-113323672 CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004260, HPA014750 Supported Expressed in all thyroid gland: 210.9 LAMP2 CD107b ENSG00000005893 Lysosomal-associated membrane protein 2 X 120427827-120469365 CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005272, HPA029100 Supported Expressed in all gallbladder: 223.9 LAPTM4B LC27 ENSG00000104341 Lysosomal protein transmembrane 4 beta 8 97775057-97853013 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB020782, HPA068830 Uncertain Approved Golgi apparatus Expressed in all heart muscle: 134.9 LAPTM5 ENSG00000162511 Lysosomal protein transmembrane 5 1 30732469-30757820 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051293 Approved Approved Cytosol Expressed in all bone marrow: 801.2 LBP BPIFD2 ENSG00000129988 Lipopolysaccharide binding protein 20 38346356-38377023 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001508, CAB025905 Approved Group enriched 5 adipose tissue: 68.5;liver: 264.3 appendix: 31.9 LETM1 ENSG00000168924 Leucine zipper-EF-hand containing transmembrane protein 1 4 1811479-1856247 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011029, HPA011100 Supported Validated Mitochondria Expressed in all cerebral cortex: 16.3 LHFPL5 DFNB67, dJ510O8.8, MGC33835, Tmhs ENSG00000197753 Lipoma HMGIC fusion partner-like 5 6 35805293-35833874 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA055110 Uncertain Tissue enhanced 0 epididymis: 12.0 bone marrow: 4.2 LMBRD1 bA810I22.1, C6orf209, cblF, FLJ11240 ENSG00000168216 LMBR1 domain containing 1 6 69675802-69797111 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019547 Uncertain Expressed in all parathyroid gland: 170.0 LPAR2 EDG-4, EDG4, LPA2 ENSG00000064547 Lysophosphatidic acid receptor 2 19 19623668-19628930 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019616 Approved Mixed testis: 40.7 LPAR4 GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9 ENSG00000147145 Lysophosphatidic acid receptor 4 X 78747709-78757094 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA054951, HPA055571 Uncertain Tissue enhanced 0 ovary: 4.5 cerebral cortex: 2.2 LRRC55 FLJ45686 ENSG00000183908 Leucine rich repeat containing 55 11 57181747-57191717 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014053 Uncertain Tissue enhanced 0 cerebral cortex: 6.6 lymph node: 2.4 LRRC8B KIAA0231, TA-LRRP ENSG00000197147 Leucine rich repeat containing 8 family, member B 1 89524836-89597864 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017950 Uncertain Approved Nuclear speckles Tissue enhanced 0 cerebral cortex: 38.3 testis: 30.6 LRRC8C AD158 ENSG00000171488 Leucine rich repeat containing 8 family, member C 1 89633072-89769903 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029347 Uncertain Approved Golgi apparatus Mixed smooth muscle: 22.4 LRRC8D FLJ10470, LRRC5 ENSG00000171492 Leucine rich repeat containing 8 family, member D 1 89821014-89936611 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014745 Approved Nucleoplasm
Mitochondria Expressed in all cerebral cortex: 36.0 LRRC8E FLJ23420 ENSG00000171017 Leucine rich repeat containing 8 family, member E 19 7888505-7902021 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020466 Uncertain Mixed skin: 11.2 LTB4R BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7 ENSG00000213903 Leukotriene B4 receptor 14 24311450-24318036 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003873 Approved Tissue enhanced 0 skin: 165.5 esophagus: 42.8 LYNX1 SLURP2 ENSG00000180155 Ly6/neurotoxin 1 8 142764334-142778224 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023711 Approved Tissue enhanced 0 esophagus: 346.7 skin: 140.2 LYPD6B CT116, LYPD7 ENSG00000150556 LY6/PLAUR domain containing 6B 2 149038107-149215262 Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049239 Uncertain Tissue enhanced 0 gallbladder: 58.8;skin: 56.6 testis: 42.1 MAGOH MAGOH1, MAGOHA ENSG00000162385 Mago homolog, exon junction complex core component 1 53226892-53238610 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015425, HPA043036, HPA047754 Approved Supported Nucleus Expressed in all lymph node: 83.5 MAGT1 DKFZp564K142, IAP, MRX95, OST3B ENSG00000102158 Magnesium transporter 1 X 77826364-77895593 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049851 Approved Expressed in all thyroid gland: 136.9 MARVELD2 DFNB49, FLJ30532, MRVLDC2, TRIC ENSG00000152939 MARVEL domain containing 2 5 69415112-69444330 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018119, HPA061726 Uncertain Supported Cell Junctions Tissue enhanced 0 thyroid gland: 19.7 small intestine: 8.9 MARVELD3 MRVLDC3 ENSG00000140832 MARVEL domain containing 3 16 71626161-71642114 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA043514, HPA045471 Approved Vesicles
Intermediate filaments Tissue enhanced 0 small intestine: 37.8 duodenum: 32.4 MC4R ENSG00000166603 Melanocortin 4 receptor 18 60371110-60372775 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA016719 Uncertain Group enriched 10 cerebral cortex: 3.0;fallopian tube: 5.0 epididymis: 0.4 MCM3AP GANP, KIAA0572, Map80, SAC3 ENSG00000160294 Minichromosome maintenance complex component 3 associated protein 21 46235126-46286297 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021527, HPA032103 Approved Supported Nucleus
Nuclear membrane
Cytosol Expressed in all parathyroid gland: 35.1 MCOLN1 ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1 ENSG00000090674 Mucolipin 1 19 7522626-7534009 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031763, CAB032637 Uncertain Supported Plasma membrane
Cytosol Expressed in all spleen: 49.0 MCOLN2 FLJ36691, TRP-ML2, TRPML2 ENSG00000153898 Mucolipin 2 1 84925583-84997113 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level HPA019114, HPA048999 Uncertain Supported Intermediate filaments Mixed rectum: 17.6 MCOLN3 FLJ11006, TRP-ML3, TRPML3 ENSG00000055732 Mucolipin 3 1 85018082-85048499 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018106, HPA062137 Approved Approved Nucleoli
Cytosol Tissue enhanced 0 adrenal gland: 57.9;parathyroid gland: 42.1 epididymis: 17.3 MFN2 CMT2A2, CPRP1, KIAA0214, MARF ENSG00000116688 Mitofusin 2 1 11980181-12013514 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030554 Uncertain Expressed in all heart muscle: 197.9 MFSD2A FLJ14490, MFSD2 ENSG00000168389 Major facilitator superfamily domain containing 2A 1 39955112-39969968 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043107 Uncertain Approved Plasma membrane
Cytosol
Cytoplasmic bodies Tissue enhanced 0 epididymis: 114.6;seminal vesicle: 109.6 testis: 63.3 MFSD6L FLJ35773 ENSG00000185156 Major facilitator superfamily domain containing 6-like 17 8797162-8799349 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA023164 Uncertain Tissue enhanced 0 testis: 29.7 parathyroid gland: 8.3 MFSD8 CLN7, MGC33302 ENSG00000164073 Major facilitator superfamily domain containing 8 4 127917805-127965995 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044802 Approved Supported Nucleoplasm
Vesicles Expressed in all parathyroid gland: 12.2 MICU1 CALC, CBARA1, EFHA3, FLJ12684 ENSG00000107745 Mitochondrial calcium uptake 1 10 72367327-72626191 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037479, HPA037480 Uncertain Supported Mitochondria Expressed in all kidney: 107.0 MICU2 EFHA1 ENSG00000165487 Mitochondrial calcium uptake 2 13 21492691-21604214 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045511, HPA058790 Approved Approved Nucleus
Mitochondria Expressed in all kidney: 77.9 MLC1 KIAA0027, LVM, MLC, VL ENSG00000100427 Megalencephalic leukoencephalopathy with subcortical cysts 1 22 50059391-50085902 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003040, HPA067533 Supported Tissue enriched 8 cerebral cortex: 181.4 bone marrow: 23.1 MMD MMA, PAQR11 ENSG00000108960 Monocyte to macrophage differentiation-associated 17 55392613-55421992 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA026978 Approved Vesicles Tissue enhanced 0 adipose tissue: 141.1 cerebral cortex: 73.3 MPC1 BRP44L, CGI-129, dJ68L15.3 ENSG00000060762 Mitochondrial pyruvate carrier 1 6 166364919-166383013 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045119, HPA055790 Supported Validated Mitochondria Expressed in all heart muscle: 409.2 MPC2 BRP44, DKFZP564B167 ENSG00000143158 Mitochondrial pyruvate carrier 2 1 167916729-167937040 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056091 Uncertain Expressed in all testis: 353.7 MPEG1 MPG1 ENSG00000197629 Macrophage expressed 1 11 59208510-59212951 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA046801 Approved Tissue enhanced 0 spleen: 287.6 appendix: 156.3 MRGPRF GPR140, GPR168, MGC21621, mrgF ENSG00000172935 MAS-related GPR, member F 11 69004395-69013409 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA028811 Approved Supported Nuclear membrane
Plasma membrane Mixed smooth muscle: 77.8 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supported Group enriched 15 appendix: 249.3;lymph node: 780.6;spleen: 476.2;tonsil: 821.5 urinary bladder: 39.8 MS4A10 CD20L7, MS4A9 ENSG00000172689 Membrane-spanning 4-domains, subfamily A, member 10 11 60785348-60801305 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014778 Uncertain Group enriched 93 duodenum: 76.3;small intestine: 97.7 parathyroid gland: 0.9 MT-CO1 COI, COX1, MTCO1 ENSG00000198804 Mitochondrially encoded cytochrome c oxidase I MT 5904-7445 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016241, HPA069328 Supported Supported Mitochondria Expressed in all heart muscle: 79793.3 MT-CO2 CO2, COX2, MTCO2 ENSG00000198712 Mitochondrially encoded cytochrome c oxidase II MT 7586-8269 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016243, HPA051505, HPA054758 Supported Expressed in all heart muscle: 42147.3 MT-CO3 CO3, COIII, COX3, MTCO3 ENSG00000198938 Mitochondrially encoded cytochrome c oxidase III MT 9207-9990 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042788 Approved Approved Nucleoplasm Expressed in all heart muscle: 56545.8 MTCH1 CGI-64, PSAP, SLC25A49 ENSG00000137409 Mitochondrial carrier 1 6 36968141-36986298 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015971 Approved Expressed in all thyroid gland: 568.7 MTCH2 SLC25A50 ENSG00000109919 Mitochondrial carrier 2 11 47617315-47642623 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038390 Approved Supported Mitochondria Expressed in all testis: 137.7 MVP LRP, VAULT1 ENSG00000013364 Major vault protein 16 29820394-29848039 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002321, CAB002752, CAB022717, HPA064740 Supported Validated Cytosol Expressed in all small intestine: 169.1 MX2 MXB ENSG00000183486 MX dynamin-like GTPase 2 21 41361943-41409390 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030235 Uncertain Mixed spleen: 46.7 MYADM ENSG00000179820 Myeloid-associated differentiation marker 19 53866223-53876437 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056301 Approved Nuclear speckles Expressed in all smooth muscle: 257.6 MYO1C myr2 ENSG00000197879 Myosin IC 17 1464098-1492812 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001768, HPA005924, CAB037023 Supported Validated Nuclear bodies
Plasma membrane Expressed in all adipose tissue: 191.9 NALCN bA430M15.1, CanIon, VGCNL1 ENSG00000102452 Sodium leak channel, non selective 13 101053776-101416492 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031889, HPA031890, HPA031958 Approved Tissue enhanced 0 cerebral cortex: 28.2 adrenal gland: 6.0 NCBP1 CBP80, NCBP, Sto1 ENSG00000136937 Nuclear cap binding protein subunit 1, 80kDa 9 97633626-97673748 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042411, HPA049031 Supported Supported Nucleoplasm
Cytosol Expressed in all testis: 32.3 NCBP2 Cbc2, CBP20, NIP1 ENSG00000114503 Nuclear cap binding protein subunit 2, 20kDa 3 196935402-196942597 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044850, HPA062483 Supported Validated Nucleoplasm Expressed in all cerebral cortex: 79.5 NDC1 FLJ10407, NET3, TMEM48 ENSG00000058804 NDC1 transmembrane nucleoporin 1 53765460-53838860 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069751, HPA070882 Approved Supported Nuclear membrane
Plasma membrane
Actin filaments Mixed lymph node: 16.6 NEDD4 KIAA0093, MGC176705, NEDD4-1, RPF1 ENSG00000069869 Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase 15 55826922-55993746 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001991, HPA039883, CAB072833 Approved Approved Cytosol Mixed placenta: 22.3 NEK6 SID6-1512 ENSG00000119408 NIMA-related kinase 6 9 124257606-124353307 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB045993, HPA056828 Approved Supported Nucleoplasm
Microtubule organizing center
Cytosol Expressed in all appendix: 45.6 NEK7 ENSG00000151414 NIMA-related kinase 7 1 198156963-198322420 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015520, HPA018193 Approved Supported Nucleoplasm Expressed in all heart muscle: 88.6 NEK9 DKFZp434D0935, MGC16714, Nek8, NERCC ENSG00000119638 NIMA-related kinase 9 14 75079353-75127344 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001405 Approved Approved Mitochondria Expressed in all parathyroid gland: 30.1 NETO1 BCTL1, BTCL1 ENSG00000166342 Neuropilin (NRP) and tolloid (TLL)-like 1 18 72742314-72868146 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA064630 Approved Golgi apparatus Tissue enriched 15 cerebral cortex: 64.1 spleen: 4.1 NETO2 FLJ10430, NEOT2 ENSG00000171208 Neuropilin (NRP) and tolloid (TLL)-like 2 16 47077703-47143997 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013180 Uncertain Approved Golgi apparatus Tissue enhanced 0 spleen: 32.0 cerebral cortex: 21.0 NIPA1 MGC35570, SPG6 ENSG00000170113 Non imprinted in Prader-Willi/Angelman syndrome 1 15 22773063-22829791 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023269 Uncertain Tissue enhanced 0 cerebral cortex: 38.3 parathyroid gland: 16.6 NIPA2 ENSG00000140157 Non imprinted in Prader-Willi/Angelman syndrome 2 15 22838641-22868384 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA067160, HPA071342 Approved Approved Golgi apparatus Expressed in all appendix: 45.7 NIPAL3 DJ462O23.2, NPAL3 ENSG00000001461 NIPA-like domain containing 3 1 24415794-24472976 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039978 Approved Approved Nucleoplasm Expressed in all prostate: 94.7 NIPAL4 ICHYN ENSG00000172548 NIPA-like domain containing 4 5 157460019-157474717 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038259 Approved Tissue enhanced 0 skin: 42.0 esophagus: 10.2 NMUR1 FM-3, GPC-R, GPR66, NMU1R ENSG00000171596 Neuromedin U receptor 1 2 231523160-231530495 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA027895 Uncertain Mixed adipose tissue: 5.5 NOX3 GP91-3 ENSG00000074771 NADPH oxidase 3 6 155395370-155455903 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA073837 Uncertain Vesicles Not detected adrenal gland: 0.1 NOX4 KOX, KOX-1 ENSG00000086991 NADPH oxidase 4 11 89324356-89498187 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015475 Uncertain Approved Nucleus Tissue enriched 12 kidney: 133.6 parathyroid gland: 10.7 NPAP1 C15orf2 ENSG00000185823 Nuclear pore associated protein 1 15 24675868-24683393 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA018828, HPA019562 Uncertain Tissue enriched 11 testis: 5.3 skin: 0.4 NPC1 ENSG00000141458 Niemann-Pick disease, type C1 18 23506184-23586898 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026618, CAB070132 Approved Expressed in all parathyroid gland: 110.9 NPC2 EDDM1, HE1, NP-C2 ENSG00000119655 Niemann-Pick disease, type C2 14 74476192-74494177 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000835 Supported Tissue enriched 19 epididymis: 16057.0 lung: 850.5 NPIPA1 morpheus, NPIP ENSG00000183426 Nuclear pore complex interacting protein family, member A1 16 14750813-14952060 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA053611 Supported Approved Nucleoplasm Mixed ovary: 68.2 NPLOC4 FLJ20657, KIAA1499, NPL4 ENSG00000182446 NPL4 homolog, ubiquitin recognition factor 17 81556887-81648465 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021560, HPA023295 Supported Supported Nucleoplasm
Cytosol Expressed in all testis: 67.9 NPPC CNP ENSG00000163273 Natriuretic peptide C 2 231921820-231926403 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA035362 Uncertain Tissue enhanced 0 prostate: 5.7 appendix: 3.0 NRSN1 p24, VMP ENSG00000152954 Neurensin 1 6 24126122-24154900 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA061006 Approved Approved Nucleus
Vesicles Tissue enriched 14 cerebral cortex: 96.7 adrenal gland: 6.7 NRSN2 C20orf98, dJ1103G7.6 ENSG00000125841 Neurensin 2 20 346782-359660 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015967 Approved Approved Nucleoplasm
Vesicles
Cytosol Tissue enhanced 0 cerebral cortex: 126.5 parathyroid gland: 68.4 NSF SKD2 ENSG00000073969 N-ethylmaleimide-sensitive factor 17 46590669-46757464 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003154, CAB009324, CAB013645, HPA071089 Approved Supported Cytosol Tissue enriched 5 cerebral cortex: 134.7 parathyroid gland: 25.1 NTSR1 NTR ENSG00000101188 Neurotensin receptor 1 (high affinity) 20 62708837-62762771 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050299 Supported Plasma membrane Not detected cerebral cortex: 0.5 NUP107 NUP84 ENSG00000111581 Nucleoporin 107kDa 12 68686734-68745809 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024141, HPA031679 Uncertain Supported Nucleoplasm
Centrosome Expressed in all testis: 38.0 NUP133 FLJ10814 ENSG00000069248 Nucleoporin 133kDa 1 229440260-229508341 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059767 Approved Supported Nuclear membrane Expressed in all parathyroid gland: 32.5 NUP153 HNUP153 ENSG00000124789 Nucleoporin 153kDa 6 17615035-17706834 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027896, HPA027897, HPA027898 Supported Validated Nuclear membrane Expressed in all testis: 53.3 NUP155 KIAA0791, N155 ENSG00000113569 Nucleoporin 155kDa 5 37288137-37371181 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037775 Uncertain Validated Nuclear membrane Tissue enriched 9 testis: 126.2 parathyroid gland: 14.1 NUP188 KIAA0169 ENSG00000095319 Nucleoporin 188kDa 9 128947699-129007096 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061750, HPA063942 Approved Supported Nucleus Expressed in all testis: 104.4 NUP205 C7orf14, KIAA0225 ENSG00000155561 Nucleoporin 205kDa 7 135557919-135648757 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024574 Uncertain Expressed in all parathyroid gland: 29.7 NUP210 FLJ22389, GP210, KIAA0906, POM210 ENSG00000132182 Nucleoporin 210kDa 3 13316235-13420309 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA066888 Approved Expressed in all lymph node: 49.2 NUP214 CAIN, CAN, D9S46E, N214 ENSG00000126883 Nucleoporin 214kDa 9 131125561-131234670 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048789 Supported Nucleus
Vesicles
Focal adhesion sites Expressed in all testis: 122.9 NUP35 MP44 ENSG00000163002 Nucleoporin 35kDa 2 183117513-183161680 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018401, HPA018410, HPA018441 Supported Supported Nucleoplasm
Nuclear membrane
Plasma membrane Expressed in all testis: 44.7 NUP37 FLJ22618, MGC5585 ENSG00000075188 Nucleoporin 37kDa 12 102073103-102120124 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056300, HPA073708 Supported Supported Nucleoplasm Expressed in all lymph node: 32.6 NUP43 bA350J20.1, FLJ13287 ENSG00000120253 Nucleoporin 43kDa 6 149724315-149749665 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027126, HPA027291, HPA028500 Approved Expressed in all thyroid gland: 18.6 NUP50 NPAP60L ENSG00000093000 Nucleoporin 50kDa 22 45163841-45188015 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047162, HPA048328 Supported Validated Nucleoplasm
Nuclear membrane Expressed in all testis: 54.5 NUP54 ENSG00000138750 Nucleoporin 54kDa 4 76114659-76148515 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035929, HPA058122 Approved Approved Nucleoplasm Expressed in all testis: 38.9 NUP58 KIAA0410, NUP45, NUPL1 ENSG00000139496 Nucleoporin 58kDa 13 25301524-25349800 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039360 Approved Approved Plasma membrane
Mitochondria
Cytosol Expressed in all testis: 86.6 NUP62 DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI ENSG00000213024 Nucleoporin 62kDa 19 49906825-49929763 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005435, CAB020724 Supported Supported Nuclear membrane
Vesicles Expressed in all testis: 76.8 NUP85 FLJ12549, NUP75 ENSG00000125450 Nucleoporin 85kDa 17 75205659-75235758 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061910, HPA062595 Supported Supported Nucleus
Cytosol Expressed in all testis: 34.1 NUP88 MGC8530 ENSG00000108559 Nucleoporin 88kDa 17 5360963-5420160 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002209, HPA021816 Approved Supported Nucleoplasm Expressed in all testis: 94.1 NUP93 KIAA0095 ENSG00000102900 Nucleoporin 93kDa 16 56730105-56850286 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017937 Uncertain Expressed in all testis: 74.3 NUPL2 CG1, hCG1, H_RG271G13.9, NLP_1 ENSG00000136243 Nucleoporin like 2 7 23181827-23201011 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049036, HPA057251 Validated Nucleus Expressed in all testis: 32.6 NXF1 DKFZp667O0311, Mex67, TAP ENSG00000162231 Nuclear RNA export factor 1 11 62792123-62806302 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016327, HPA061593 Supported Supported Nucleoplasm Expressed in all parathyroid gland: 144.9 OCLN PPP1R115 ENSG00000197822 Occludin 5 69492292-69558104 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005933, CAB013075, CAB068212, CAB068213, CAB068214 Supported Supported Plasma membrane
Cell Junctions Tissue enhanced 0 thyroid gland: 78.3 lung: 39.9 OPA1 FLJ12460, KIAA0567, MGM1, NPG, NTG ENSG00000198836 Optic atrophy 1 (autosomal dominant) 3 193593144-193697823 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036926, HPA036927 Supported Supported Nucleoplasm
Mitochondria Expressed in all cerebral cortex: 56.4 OPN4 melanopsin, MOP ENSG00000122375 Opsin 4 10 86654557-86666848 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA039147 Approved Tissue enhanced 0 cerebral cortex: 2.2;parathyroid gland: 1.4 skeletal muscle: 0.9 ORAI1 CRACM1, FLJ14466, TMEM142A ENSG00000276045 ORAI calcium release-activated calcium modulator 1 12 121626550-121642677 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016583, HPA061823 Approved Supported Cytosol Expressed in all parathyroid gland: 48.9 ORAI3 MGC13024, TMEM142C ENSG00000175938 ORAI calcium release-activated calcium modulator 3 16 30949066-30956461 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015022 Uncertain Approved Nucleoplasm
Cytosol Expressed in all prostate: 26.7 OS9 ERLEC2, OS-9 ENSG00000135506 Osteosarcoma amplified 9, endoplasmic reticulum lectin 12 57693955-57721557 Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011518, HPA013694 Supported Expressed in all parathyroid gland: 290.9 OSBPL5 KIAA1534, ORP5 ENSG00000021762 Oxysterol binding protein-like 5 11 3087116-3166739 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038335, HPA038712, HPA058727 Approved Validated Vesicles Mixed spleen: 20.1 OSBPL8 MST120, MSTP120, ORP8, OSBP10 ENSG00000091039 Oxysterol binding protein-like 8 12 76351797-76559809 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001309 Uncertain Approved Vesicles
Cytosol Expressed in all cerebral cortex: 39.6 OSCP1 C1orf102, NOR1 ENSG00000116885 Organic solute carrier partner 1 1 36415827-36450451 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028436, HPA052655 Uncertain Approved Nucleus
Nucleoli
Plasma membrane Expressed in all testis: 126.0 OXA1L MGC133129, OXA1 ENSG00000155463 Oxidase (cytochrome c) assembly 1-like 14 22766522-22773041 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003531 Approved Supported Mitochondria Expressed in all parathyroid gland: 139.8 P2RX3 P2X3 ENSG00000109991 Purinergic receptor P2X, ligand gated ion channel, 3 11 57338374-57370600 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA057776 Uncertain Tissue enhanced 0 heart muscle: 2.0;testis: 6.1 liver: 0.9 P2RX4 P2X4 ENSG00000135124 Purinergic receptor P2X, ligand gated ion channel, 4 12 121209857-121234106 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039494 Approved Approved Actin filaments
Cytosol Mixed placenta: 33.5 P2RX7 MGC20089, P2X7 ENSG00000089041 Purinergic receptor P2X, ligand gated ion channel, 7 12 121132819-121188032 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034968, HPA042013, HPA044141 Approved Mixed cerebral cortex: 21.1 PANX1 MRS1, PX1, UNQ2529 ENSG00000110218 Pannexin 1 11 94128928-94181972 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016930 Uncertain Validated Plasma membrane Expressed in all testis: 19.4 PANX2 hPANX2, PX2 ENSG00000073150 Pannexin 2 22 50170731-50180294 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA004624, HPA039117 Approved Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 8.7 seminal vesicle: 2.1 PARL PRO2207, PSARL, PSARL1, RHBDS1 ENSG00000175193 Presenilin associated, rhomboid-like 3 183829385-183884933 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019545 Approved Supported Mitochondria Expressed in all epididymis: 71.5 PDCD6 ALG-2, PEF1B ENSG00000249915 Programmed cell death 6 5 271621-353856 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047221 Approved Cytosol Expressed in all epididymis: 120.0 PDYN ADCA, PENKB, SCA23 ENSG00000101327 Prodynorphin 20 1978757-1994285 Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049841, HPA053342 Approved Tissue enriched 11 cerebral cortex: 63.5 testis: 5.5 PENK ENSG00000181195 Proenkephalin 8 56436674-56446734 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013138, CAB016390 Supported Group enriched 8 adrenal gland: 568.1;testis: 207.8 prostate: 47.7 PEX1 ZWS, ZWS1 ENSG00000127980 Peroxisomal biogenesis factor 1 7 92487020-92528531 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020235 Approved Supported Peroxisomes Expressed in all parathyroid gland: 22.2 PEX10 RNF69 ENSG00000157911 Peroxisomal biogenesis factor 10 1 2403964-2413797 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049458, HPA049755 Approved Approved Nucleoplasm Expressed in all cerebral cortex: 19.3 PEX12 ENSG00000108733 Peroxisomal biogenesis factor 12 17 35574795-35578863 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069386 Supported Mixed parathyroid gland: 17.0 PEX13 ENSG00000162928 Peroxisomal biogenesis factor 13 2 61017225-61051990 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032141, HPA032142, CAB032689 Supported Supported Vesicles Expressed in all testis: 27.4 PEX14 ENSG00000142655 Peroxisomal biogenesis factor 14 1 10472288-10630758 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046104, HPA049231 Supported Supported Nucleoli fibrillar center
Peroxisomes Expressed in all seminal vesicle: 32.3 PEX16 ENSG00000121680 Peroxisomal biogenesis factor 16 11 45909669-45918812 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043286 Approved Expressed in all cerebral cortex: 27.5 PEX19 D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1 ENSG00000162735 Peroxisomal biogenesis factor 19 1 160276812-160286348 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044837, HPA051966 Supported Validated Peroxisomes Expressed in all adipose tissue: 85.8 PEX2 PAF-1, PMP35, PXMP3, RNF72, ZWS3 ENSG00000164751 Peroxisomal biogenesis factor 2 8 76980258-77001044 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010983, HPA011410, HPA027729 Approved Supported Vesicles Expressed in all seminal vesicle: 111.4 PEX26 FLJ20695 ENSG00000215193 Peroxisomal biogenesis factor 26 22 18077920-18131138 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB070429 Approved Expressed in all small intestine: 34.8 PEX3 ENSG00000034693 Peroxisomal biogenesis factor 3 6 143450807-143490010 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042830, HPA058006 Supported Supported Nucleoplasm
Peroxisomes Expressed in all adrenal gland: 54.6 PEX6 PAF-2, PXAAA1 ENSG00000124587 Peroxisomal biogenesis factor 6 6 42963870-42979220 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA025924, HPA074179 Supported Approved Nucleoplasm
Vesicles Expressed in all fallopian tube: 36.4 PEX7 PTS2R, RD ENSG00000112357 Peroxisomal biogenesis factor 7 6 136822564-136913937 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049202 Uncertain Expressed in all parathyroid gland: 24.8 PGAP2 CWH43-N, FRAG1, MRT21 ENSG00000148985 Post-GPI attachment to proteins 2 11 3797724-3826371 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA063099 Approved Approved Microtubules Expressed in all epididymis: 258.9 PHAX FLJ13193, RNUXA ENSG00000164902 Phosphorylated adaptor for RNA export 5 126600268-126627252 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059630, HPA070326 Supported Validated Nucleoplasm Expressed in all cerebral cortex: 17.9 PIEZO1 FAM38A, KIAA0233 ENSG00000103335 Piezo-type mechanosensitive ion channel component 1 16 88715343-88785211 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047185 Uncertain Mixed adipose tissue: 42.0 PIEZO2 C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771 ENSG00000154864 Piezo-type mechanosensitive ion channel component 2 18 10666483-11148762 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015986, HPA031974, HPA031975, HPA040616 Approved Approved Vesicles Mixed lung: 12.8 PIRT ENSG00000233670 Phosphoinositide-interacting regulator of transient receptor potential channels 17 10822475-10838445 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042337 Uncertain Uncertain Plasma membrane
Cytosol Tissue enhanced 0 adrenal gland: 3.1;cerebral cortex: 2.7;rectum: 2.7 colon: 2.1 PKD1 PBP, Pc-1, TRPP1 ENSG00000008710 Polycystic kidney disease 1 (autosomal dominant) 16 2088710-2135898 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB046448 Approved Mixed cerebral cortex: 21.6 PKD1L1 PRO19563 ENSG00000158683 Polycystic kidney disease 1 like 1 7 47774652-47948491 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020422, HPA022424 Uncertain Tissue enhanced 0 testis: 2.4 adipose tissue: 1.8 PKD2 Pc-2, PC2, PKD4, TRPP2 ENSG00000118762 Polycystic kidney disease 2 (autosomal dominant) 4 88007668-88077777 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004544, HPA015794 Approved Validated Endoplasmic reticulum Expressed in all endometrium: 100.4 PKD2L1 PCL, PKD2L, PKDL, TRPP3 ENSG00000107593 Polycystic kidney disease 2-like 1 10 100288154-100330486 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022621 Uncertain Tissue enhanced 0 spleen: 10.0 lung: 3.4 PLN CMD1P, PLB ENSG00000198523 Phospholamban 6 118548298-118560730 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005597, HPA026900 Supported Tissue enriched 6 heart muscle: 1486.3 smooth muscle: 266.8 PLP1 GPM6C, PLP, SPG2 ENSG00000123560 Proteolipid protein 1 X 103773718-103792619 Cancer-related genes, Disease related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004128 Supported Tissue enriched 30 cerebral cortex: 3225.1 parathyroid gland: 106.1 PLP2 A4, A4-LSB, MGC126187 ENSG00000102007 Proteolipid protein 2 (colonic epithelium-enriched) X 49171926-49175239 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042415 Approved Expressed in all skin: 480.7 PLSCR1 MMTRA1B ENSG00000188313 Phospholipid scramblase 1 3 146515180-146544864 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA068923, CAB070421 Approved Approved Nucleus
Golgi apparatus
Plasma membrane Expressed in all appendix: 117.3 PLTP BPIFE ENSG00000100979 Phospholipid transfer protein 20 45898621-45912155 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032873 Approved Expressed in all placenta: 630.8 PNN memA ENSG00000100941 Pinin, desmosome associated protein 14 39175183-39183218 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001378 Supported Validated Nuclear speckles Expressed in all epididymis: 141.4 POM121 DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A ENSG00000196313 POM121 transmembrane nucleoporin 7 72879365-72951440 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003710, HPA043809, HPA049817 Approved Validated Nucleoplasm
Nuclear membrane Expressed in all cerebral cortex: 30.2 PON1 ESA, PON ENSG00000005421 Paraoxonase 1 7 95297676-95324707 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001610 Uncertain Tissue enriched 69 liver: 234.0 adrenal gland: 3.3 PQLC2 FLJ20320 ENSG00000040487 PQ loop repeat containing 2 1 19312326-19329300 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA057810 Approved Validated Vesicles Expressed in all testis: 16.3 PRPH2 CACD2, rd2, RDS, RP7, TSPAN22 ENSG00000112619 Peripherin 2 (retinal degeneration, slow) 6 42696600-42722574 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029458 Supported Mixed parathyroid gland: 8.5 PSAP GLBA, SAP1 ENSG00000197746 Prosaposin 10 71816298-71851375 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004426, CAB004647 Supported Supported Vesicles Expressed in all cerebral cortex: 1917.1 PSEN1 AD3, FAD, PS1, S182 ENSG00000080815 Presenilin 1 14 73136418-73223691 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006844, HPA030760, HPA067496 Approved Approved Nucleus
Golgi apparatus
Cell Junctions Expressed in all cerebral cortex: 66.1 PSEN2 AD3L, AD4, PS2, STM2 ENSG00000143801 Presenilin 2 1 226870184-226896105 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013634, HPA038005 Supported Nucleus Expressed in all parathyroid gland: 29.1 PTAFR ENSG00000169403 Platelet-activating factor receptor 1 28147166-28193936 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027543 Approved Supported Nucleoplasm
Vesicles
Plasma membrane Tissue enhanced 0 appendix: 42.1 bone marrow: 26.2 PTH1R PTHR, PTHR1 ENSG00000160801 Parathyroid hormone 1 receptor 3 46877746-46903799 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA007978 Approved Tissue enhanced 0 kidney: 158.5 adrenal gland: 36.8 PXMP4 PMP24 ENSG00000101417 Peroxisomal membrane protein 4, 24kDa 20 33702754-33720319 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050077 Approved Approved Nucleoli fibrillar center
Peroxisomes Expressed in all parathyroid gland: 29.8 RAE1 Mnrp41 ENSG00000101146 Ribonucleic acid export 1 20 57351010-57379211 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048795 Supported Nucleus
Nucleoli fibrillar center Tissue enriched 6 testis: 182.6 bone marrow: 31.4 RALBP1 RIP, RIP1, RLIP76 ENSG00000017797 RalA binding protein 1 18 9475009-9538116 Predicted intracellular proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB046010, HPA046651 Approved Approved Nuclear membrane
Vesicles
Cytosol Expressed in all seminal vesicle: 69.8 RAN ARA24, Gsp1, TC4 ENSG00000132341 RAN, member RAS oncogene family 12 130871879-130877678 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA063353 Uncertain Nucleus Expressed in all testis: 557.0 RANBP17 ENSG00000204764 RAN binding protein 17 5 170861870-171300015 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029568, HPA029569 Uncertain Approved Nuclear membrane
Nuclear bodies
Cytosol Tissue enhanced 0 testis: 5.0 thyroid gland: 1.7 RANBP2 ADANE, ANE1, NUP358 ENSG00000153201 RAN binding protein 2 2 108719481-108785811 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564 Supported Validated Nuclear membrane
Vesicles Expressed in all parathyroid gland: 73.6 RANGAP1 Fug1, KIAA1835, SD ENSG00000100401 Ran GTPase activating protein 1 22 41245611-41286251 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004293, HPA050110, HPA062034 Supported Validated Nuclear membrane
Vesicles
Cytosol Expressed in all testis: 205.5 RBM8A BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP ENSG00000265241 RNA binding motif protein 8A 1 145917714-145927678 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018403 Supported Validated Nuclear speckles Expressed in all esophagus: 162.1 RBP2 CRABP-II, CRBP2, CRBPII, RBPC2 ENSG00000114113 Retinol binding protein 2, cellular 3 139452884-139480747 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035866 Supported Approved Golgi apparatus Group enriched 207 duodenum: 2824.3;small intestine: 2085.7 lung: 11.8 REG3A HIP, PAP, PAP1, PBCGF, REG-III, REG3 ENSG00000172016 Regenerating islet-derived 3 alpha 2 79157003-79159753 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047894, HPA048334, HPA060705 Supported Approved Cytosol Group enriched 57 duodenum: 5795.6;small intestine: 8246.6 stomach: 122.9 RER1 ENSG00000157916 Retention in endoplasmic reticulum sorting receptor 1 1 2391775-2405444 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037240, HPA051400 Supported Validated Golgi apparatus Expressed in all testis: 183.8 RFT1 CDG1N ENSG00000163933 RFT1 homolog 3 53088483-53130462 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060327 Approved Vesicles Expressed in all testis: 25.8 RHAG CD241, RH50A, SLC42A1 ENSG00000112077 Rh-associated glycoprotein 6 49605158-49636839 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055331 Approved Tissue enriched 24 bone marrow: 73.8 placenta: 3.0 RHBDD1 DKFZp547E052 ENSG00000144468 Rhomboid domain containing 1 2 226835581-226999215 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013972, HPA057125 Approved Supported Endoplasmic reticulum Expressed in all testis: 32.2 RHBG SLC42A2 ENSG00000132677 Rh family, B glycoprotein (gene/pseudogene) 1 156369212-156385219 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA042726, HPA048489 Approved Approved Nucleoplasm Tissue enhanced 0 kidney: 3.5;ovary: 2.0 liver: 0.6 RHCG C15orf6, PDRC2, RHGK, SLC42A3 ENSG00000140519 Rh family, C glycoprotein 15 89471398-89496613 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041874, HPA043317 Supported Tissue enriched 7 esophagus: 2912.7 tonsil: 436.1 RHO CSNBAD1, OPN2, RP4 ENSG00000163914 Rhodopsin 3 129528640-129535169 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013440, CAB022486 Supported Not detected cerebral cortex: 0.3 RNPS1 ENSG00000205937 RNA binding protein S1, serine-rich domain 16 2253116-2268412 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044014 Approved Supported Nucleoplasm Expressed in all cerebral cortex: 144.2 ROMO1 bA353C18.2, C20orf52, MTGMP ENSG00000125995 Reactive oxygen species modulator 1 20 35699272-35700984 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012782 Uncertain Expressed in all adrenal gland: 121.3 RYR1 CCO, MHS, MHS1, PPP1R137, RYR ENSG00000196218 Ryanodine receptor 1 (skeletal) 19 38433699-38587564 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056416 Supported Approved Golgi apparatus
Vesicles
Cytosol Tissue enriched 30 skeletal muscle: 572.4 esophagus: 18.7 RYR2 ARVC2, ARVD2, VTSIP ENSG00000198626 Ryanodine receptor 2 (cardiac) 1 237042205-237833988 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020028 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 9 heart muscle: 68.2 cerebral cortex: 8.0 S1PR1 CD363, D1S3362, edg-1, EDG1 ENSG00000170989 Sphingosine-1-phosphate receptor 1 1 101236888-101241518 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010104, HPA075568 Supported Supported Vesicles Expressed in all adipose tissue: 86.5 SAMM50 CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W ENSG00000100347 SAMM50 sorting and assembly machinery component 22 43955421-44010531 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034537 Supported Validated Mitochondria Expressed in all parathyroid gland: 237.7 SAP18 2HOR0202, MGC27131, SAP18p ENSG00000150459 Sin3A-associated protein, 18kDa 13 21140514-21149084 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011352, CAB012273 Supported Supported Nucleoplasm
Nuclear bodies
Cytosol Expressed in all testis: 256.3 SCARB1 CD36L1, CLA-1, CLA1, SR-BI, SRB1 ENSG00000073060 Scavenger receptor class B, member 1 12 124776856-124882668 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA066285, CAB070124 Supported Approved Vesicles Group enriched 7 adrenal gland: 762.1;placenta: 284.3 liver: 71.6 SCN11A NaN, Nav1.9, SCN12A, SNS-2 ENSG00000168356 Sodium channel, voltage gated, type XI alpha subunit 3 38845769-38950561 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA036746, HPA036747 Uncertain Tissue enhanced 0 placenta: 3.7;spleen: 5.4 testis: 2.1 SCN1A FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI ENSG00000144285 Sodium channel, voltage gated, type I alpha subunit 2 165989160-166128047 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA078664 Approved Nucleoplasm
Nuclear bodies
Plasma membrane Tissue enhanced 0 cerebral cortex: 12.0;fallopian tube: 4.4;lung: 3.2 testis: 2.2 SCN2A HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2 ENSG00000136531 Sodium channel, voltage gated, type II alpha subunit 2 165239402-165392310 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022567 Supported Tissue enriched 22 cerebral cortex: 58.5 kidney: 2.7 SCN4A HYKPP, HYPP, Nav1.4, SkM1 ENSG00000007314 Sodium channel, voltage gated, type IV alpha subunit 17 63938554-63972918 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053992 Approved Nucleoplasm
Microtubule organizing center Group enriched 9 adipose tissue: 12.3;skeletal muscle: 47.2 thyroid gland: 3.3 SCN4B LQT10 ENSG00000177098 Sodium channel, voltage gated, type IV beta subunit 11 118133377-118152888 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017293 Approved Tissue enhanced 0 adipose tissue: 25.0 thyroid gland: 17.0 SCN8A CerIII, MED, NaCh6, Nav1.6, PN4 ENSG00000196876 Sodium channel, voltage gated, type VIII alpha subunit 12 51590266-51812864 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022169 Supported Vesicles
Cell Junctions Tissue enriched 6 cerebral cortex: 22.1 testis: 3.5 SCN9A ETHA, Nav1.7, NE-NA, NENA, PN1 ENSG00000169432 Sodium channel, voltage gated, type IX alpha subunit 2 166195185-166375993 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013679, HPA061843 Uncertain Approved Plasma membrane
Actin filaments
Focal adhesion sites Tissue enhanced 0 testis: 9.1 placenta: 5.9 SCNN1A ENaCalpha, SCNN1 ENSG00000111319 Sodium channel, non voltage gated 1 alpha subunit 12 6346843-6377730 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA012743 Supported Mixed cervix: 94.4 SCNN1B ENaCbeta ENSG00000168447 Sodium channel, non voltage gated 1 beta subunit 16 23278231-23381299 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015612 Uncertain Tissue enhanced 0 cervix, uterine: 71.5 esophagus: 45.0 SCNN1D dNaCh, ENaCdelta ENSG00000162572 Sodium channel, non voltage gated 1 delta subunit 1 1280436-1292029 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB009540, HPA026884 Approved Supported Plasma membrane
Actin filaments Tissue enhanced 0 testis: 13.8 cerebral cortex: 7.3 SCNN1G ENaCgamma, SCNEG ENSG00000166828 Sodium channel, non voltage gated 1 gamma subunit 16 23182715-23216883 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA071194 Approved Nucleoplasm
Nucleoli
Plasma membrane Tissue enhanced 0 cervix, uterine: 24.5;kidney: 46.4 thyroid gland: 9.5 SCTR ENSG00000080293 Secretin receptor 2 119439843-119525301 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007269 Uncertain Tissue enhanced 0 duodenum: 27.4;lung: 13.0;pancreas: 14.3 stomach: 4.2 SDC1 CD138, SDC, SYND1, syndecan ENSG00000115884 Syndecan 1 2 20200797-20225433 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002424, HPA006185 Approved Approved Focal adhesion sites Tissue enhanced 0 esophagus: 251.7;skin: 288.6 liver: 144.9 SDC4 amphiglycan, ryudocan, SYND4 ENSG00000124145 Syndecan 4 20 45325288-45348424 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005716, CAB013240 Supported Approved Golgi apparatus
Plasma membrane Expressed in all lung: 250.5 SEC13 D3S1231E, npp-20, SEC13L1, SEC13R ENSG00000157020 SEC13 homolog, nuclear pore and COPII coat complex component 3 10293131-10321178 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035292, HPA057943 Approved Supported Nucleoplasm
Vesicles Expressed in all cervix: 119.1 SEC31A ABP125, ABP130, KIAA0905, SEC31L1 ENSG00000138674 SEC31 homolog A, COPII coat complex component 4 82818661-82901166 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005457 Approved Supported Vesicles
Cytosol Expressed in all thyroid gland: 279.9 SEC61A1 ENSG00000058262 Sec61 translocon alpha 1 subunit 3 128051641-128071683 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022076 Supported Endoplasmic reticulum Expressed in all cervix: 217.0 SEC61B ENSG00000106803 Sec61 translocon beta subunit 9 99222064-99230615 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049407 Approved Validated Endoplasmic reticulum Expressed in all epididymis: 333.0 SEC61G SSS1 ENSG00000132432 Sec61 translocon gamma subunit 7 54752250-54759974 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053196 Uncertain Expressed in all epididymis: 401.2 SEC63 DNAJC23, ERdj2, PRO2507, SEC63L ENSG00000025796 SEC63 homolog, protein translocation regulator 6 107867756-107958189 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053295, HPA060535 Supported Supported Endoplasmic reticulum Expressed in all thyroid gland: 87.1 SEH1L SEC13L, Seh1, SEH1A, SEH1B ENSG00000085415 SEH1-like nucleoporin 18 12947133-12987536 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039964 Uncertain Expressed in all cerebral cortex: 34.0 SENP2 AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2 ENSG00000163904 SUMO1/sentrin/SMT3 specific peptidase 2 3 185582496-185633551 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029247, HPA029248 Approved Supported Cytosol Expressed in all testis: 26.8 SFXN4 ENSG00000183605 Sideroflexin 4 10 119140767-119165667 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018028, HPA020872 Approved Supported Vesicles Expressed in all thyroid gland: 47.1 SIDT1 FLJ20174, SID-1 ENSG00000072858 SID1 transmembrane family, member 1 3 113532296-113629578 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035862 Approved Mixed rectum: 10.7 SIDT2 CGI-40 ENSG00000149577 SID1 transmembrane family, member 2 11 117178733-117197445 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052352 Approved Expressed in all prostate: 59.7 SIGMAR1 OPRS1, SR-BP1 ENSG00000147955 Sigma non-opioid intracellular receptor 1 9 34634722-34637809 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013470, HPA018002, HPA024071 Approved Expressed in all liver: 67.8 SLC10A1 NTCP ENSG00000100652 Solute carrier family 10 (sodium/bile acid cotransporter), member 1 14 69775417-69797289 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042727 Approved Tissue enriched 392 liver: 212.1 gallbladder: 0.5 SLC10A2 ASBT, ISBT ENSG00000125255 Solute carrier family 10 (sodium/bile acid cotransporter), member 2 13 103043998-103066846 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA004795 Approved Group enriched 32 duodenum: 21.6;kidney: 15.3;small intestine: 52.2 gallbladder: 0.9 SLC10A3 DXS253E, P3 ENSG00000126903 Solute carrier family 10, member 3 X 154487306-154490690 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA021656 Approved Approved Intermediate filaments Expressed in all gallbladder: 33.2 SLC10A4 MGC29802 ENSG00000145248 Solute carrier family 10, member 4 4 48483343-48489196 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028835 Uncertain Supported Tissue enhanced 0 adrenal gland: 6.2;cerebral cortex: 4.0 cervix: 1.5 SLC10A5 ENSG00000253598 Solute carrier family 10, member 5 8 81693607-81696174 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA025966 Uncertain Approved Plasma membrane Mixed liver: 3.0 SLC10A7 C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043 ENSG00000120519 Solute carrier family 10, member 7 4 146253975-146521964 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039996, HPA057906 Uncertain Approved Nucleoli Mixed epididymis: 16.0 SLC11A1 LSH, NRAMP, NRAMP1 ENSG00000018280 Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 2 218382029-218396894 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029590 Uncertain Tissue enhanced 0 appendix: 9.3;lung: 13.2 spleen: 4.8 SLC11A2 DCT1, DMT1, NRAMP2 ENSG00000110911 Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 12 50979401-51028566 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032139, HPA032140 Uncertain Supported Mitochondria Expressed in all thyroid gland: 74.8 SLC12A1 NKCC2 ENSG00000074803 Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 15 48191664-48304078 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014967, HPA018107 Supported Tissue enriched 456 kidney: 773.2 testis: 1.6 SLC12A2 BSC, BSC2, NKCC1, PPP1R141 ENSG00000064651 Solute carrier family 12 (sodium/potassium/chloride transporter), member 2 5 128083766-128189688 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020130, HPA063697 Approved Approved Vesicles
Plasma membrane Expressed in all rectum: 66.4 SLC12A3 NCCT ENSG00000070915 Solute carrier family 12 (sodium/chloride transporter), member 3 16 56865207-56915850 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028748 Supported Tissue enriched 107 kidney: 109.3 lymph node: 1.0 SLC12A4 KCC1 ENSG00000124067 Solute carrier family 12 (potassium/chloride transporter), member 4 16 67943474-67969601 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041138 Approved Approved Endosomes Expressed in all parathyroid gland: 62.5 SLC12A5 KCC2, KIAA1176 ENSG00000124140 Solute carrier family 12 (potassium/chloride transporter), member 5 20 46021690-46060152 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA072058 Supported Tissue enriched 8 cerebral cortex: 94.5 adrenal gland: 12.0 SLC12A6 ACCPN, KCC3 ENSG00000140199 Solute carrier family 12 (potassium/chloride transporter), member 6 15 34229996-34338060 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034563 Uncertain Approved Vesicles
Cytosol Mixed testis: 46.2 SLC12A7 DKFZP434F076, KCC4 ENSG00000113504 Solute carrier family 12 (potassium/chloride transporter), member 7 5 1050376-1112035 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041652 Approved Uncertain Cytosol Mixed duodenum: 25.0 SLC12A8 CCC9 ENSG00000221955 Solute carrier family 12, member 8 3 125082636-125212864 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA031123 Uncertain Supported Nucleoplasm Tissue enhanced 0 thyroid gland: 39.4 gallbladder: 16.3 SLC13A1 NAS1, NaSi-1 ENSG00000081800 Solute carrier family 13 (sodium/sulfate symporter), member 1 7 123113531-123199986 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA053615, HPA062714 Approved Tissue enriched 6 kidney: 84.4 small intestine: 14.3 SLC13A2 NaDC-1 ENSG00000007216 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 17 28473293-28497781 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014963 Supported Tissue enhanced 0 duodenum: 70.6;small intestine: 55.4 kidney: 19.6 SLC13A3 NADC3, SDCT2 ENSG00000158296 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 20 46557823-46684467 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014353, HPA014736 Supported Tissue enriched 7 kidney: 428.6 placenta: 60.6 SLC13A4 SUT-1, SUT1 ENSG00000164707 Solute carrier family 13 (sodium/sulfate symporter), member 4 7 135681237-135729258 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA048582 Approved Tissue enriched 10 placenta: 76.2 testis: 7.3 SLC13A5 NACT ENSG00000141485 Solute carrier family 13 (sodium-dependent citrate transporter), member 5 17 6684713-6713567 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044343, HPA057088 Approved Uncertain Nucleoplasm Tissue enriched 9 liver: 118.1 salivary gland: 12.8 SLC14A1 HsT1341, JK, RACH1, RACH2 ENSG00000141469 Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) 18 45724127-45752520 Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058353, HPA059570 Supported Supported Vesicles Group enriched 5 prostate: 132.1;urinary bladder: 51.9 cerebral cortex: 18.2 SLC15A1 HPECT1, HPEPT1, PEPT1 ENSG00000088386 Solute carrier family 15 (oligopeptide transporter), member 1 13 98683801-98752654 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA002827 Uncertain Approved Nucleoplasm
Cytosol Group enriched 5 duodenum: 157.7;gallbladder: 68.0;small intestine: 230.1 skin: 27.9 SLC15A3 hPTR3, PHT2 ENSG00000110446 Solute carrier family 15 (oligopeptide transporter), member 3 11 60937083-60952530 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA047880, HPA057642 Approved Supported Vesicles Expressed in all lung: 102.3 SLC15A4 PHT1, PTR4 ENSG00000139370 Solute carrier family 15 (oligopeptide transporter), member 4 12 128793191-128823983 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA016713 Approved Expressed in all lymph node: 27.7 SLC15A5 ENSG00000188991 Solute carrier family 15, member 5 12 16188485-16277685 Predicted membrane proteins, Transporters No evidence No evidence No evidence HPA041638 Uncertain Not detected testis: 0.3 SLC16A1 MCT, MCT1 ENSG00000155380 Solute carrier family 16 (monocarboxylate transporter), member 1 1 112911847-112957013 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003324, CAB017489, HPA071055 Supported Validated Plasma membrane
Cell Junctions Mixed testis: 32.0 SLC16A10 MCT10, TAT1 ENSG00000112394 Solute carrier family 16 (aromatic amino acid transporter), member 10 6 111087503-111231194 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016860 Approved Approved Vesicles
Cell Junctions Tissue enhanced 0 placenta: 38.2 skin: 22.5 SLC16A13 MCT13 ENSG00000174327 Solute carrier family 16, member 13 17 7036075-7040121 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA065245 Supported Golgi apparatus Mixed liver: 15.4 SLC16A14 FLJ30794, MCT14 ENSG00000163053 Solute carrier family 16, member 14 2 230034974-230068999 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA040518 Uncertain Approved Cytosol Mixed parathyroid gland: 14.6 SLC16A2 AHDS, DXS128, MCT7, MCT8, MRX22, XPCT ENSG00000147100 Solute carrier family 16, member 2 (thyroid hormone transporter) X 74421461-74533917 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA072719 Approved Plasma membrane Mixed liver: 41.9 SLC16A3 MCT3, MCT4 ENSG00000141526 Solute carrier family 16 (monocarboxylate transporter), member 3 17 82228397-82261129 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017490, HPA021451 Approved Supported Nuclear membrane
Plasma membrane Expressed in all skeletal muscle: 74.4 SLC16A6 MCT6, MCT7 ENSG00000108932 Solute carrier family 16, member 6 17 68267026-68291267 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054459, HPA066328 Uncertain Approved Vesicles Tissue enhanced 0 epididymis: 39.8 esophagus: 12.1 SLC16A7 MCT2 ENSG00000118596 Solute carrier family 16 (monocarboxylate transporter), member 7 12 59596067-59789855 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005911 Approved Approved Nucleoplasm
Plasma membrane Mixed adipose tissue: 24.8 SLC16A8 MCT3, REMP ENSG00000100156 Solute carrier family 16 (monocarboxylate transporter), member 8 22 38078134-38084093 Plasma proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA075017 Approved Intermediate filaments
Focal adhesion sites Mixed prostate: 5.7 SLC16A9 C10orf36, FLJ43803, MCT9 ENSG00000165449 Solute carrier family 16, member 9 10 59650761-59736002 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA049286 Approved Approved Nucleus
Cell Junctions Tissue enhanced 0 adrenal gland: 199.5;kidney: 199.2 spleen: 57.0 SLC17A1 NAPI-1, NPT1 ENSG00000124568 Solute carrier family 17 (organic anion transporter), member 1 6 25782897-25832059 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA050513 Approved Golgi apparatus Tissue enriched 7 kidney: 173.1 liver: 25.2 SLC17A2 NPT3 ENSG00000112337 Solute carrier family 17, member 2 6 25912754-25930726 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA038270 Uncertain Tissue enriched 85 liver: 40.9 testis: 0.4 SLC17A3 NPT4 ENSG00000124564 Solute carrier family 17 (organic anion transporter), member 3 6 25833066-25882286 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016569 Uncertain Tissue enriched 9 kidney: 167.2 liver: 18.5 SLC17A4 KIAA2138 ENSG00000146039 Solute carrier family 17, member 4 6 25754699-25781191 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055564 Approved Group enriched 6 colon: 20.8;duodenum: 29.4;gallbladder: 25.5;liver: 22.4;rectum: 29.4;small intestine: 35.7 pancreas: 4.2 SLC17A6 DNPI, VGLUT2 ENSG00000091664 Solute carrier family 17 (vesicular glutamate transporter), member 6 11 22338097-22379503 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037130, HPA039226 Supported Supported Tissue enriched 65 cerebral cortex: 6.5 epididymis: 0.0 SLC17A7 BNPI, VGLUT1 ENSG00000104888 Solute carrier family 17 (vesicular glutamate transporter), member 7 19 49429401-49442360 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037183, HPA050458, HPA063679 Supported Tissue enriched 178 cerebral cortex: 586.2 adipose tissue: 3.2 SLC17A9 C20orf59, FLJ23412, VNUT ENSG00000101194 Solute carrier family 17 (vesicular nucleotide transporter), member 9 20 62952647-62969585 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA047470, HPA056499 Uncertain Approved Nucleoplasm Mixed stomach: 8.7 SLC18A1 CGAT, VAT1, VMAT1 ENSG00000036565 Solute carrier family 18 (vesicular monoamine transporter), member 1 8 20144855-20183206 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA006877, HPA063797 Supported Tissue enriched 10 adrenal gland: 32.8 rectum: 3.1 SLC18A3 VACHT ENSG00000187714 Solute carrier family 18 (vesicular acetylcholine transporter), member 3 10 49610301-49612720 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB037102 Uncertain Not detected placenta: 0.6 SLC18B1 C6orf192, dJ55C23.6 ENSG00000146409 Solute carrier family 18, subfamily B, member 1 6 132769370-132798553 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029747, HPA049659 Approved Supported Golgi apparatus
Cytosol Expressed in all cerebral cortex: 37.6 SLC19A1 FOLT ENSG00000173638 Solute carrier family 19 (folate transporter), member 1 21 45493572-45544411 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024802 Approved Approved Plasma membrane Mixed duodenum: 22.6 SLC19A2 THTR1, TRMA ENSG00000117479 Solute carrier family 19 (thiamine transporter), member 2 1 169463909-169486003 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006119, HPA016599 Uncertain Approved Cytosol Expressed in all gallbladder: 49.3 SLC19A3 THTR2 ENSG00000135917 Solute carrier family 19 (thiamine transporter), member 3 2 227685210-227718012 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038898 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 adipose tissue: 50.1;placenta: 34.5 duodenum: 12.7 SLC1A1 EAAC1, EAAT3 ENSG00000106688 Solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 9 4490444-4587469 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015466, HPA020086 Approved Tissue enhanced 0 small intestine: 72.7 epididymis: 53.8 SLC1A2 EAAT2, GLT-1 ENSG00000110436 Solute carrier family 1 (glial high affinity glutamate transporter), member 2 11 35251206-35420063 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002574, HPA009172 Supported Tissue enriched 30 cerebral cortex: 367.1 liver: 12.2 SLC1A3 EA6, EAAT1, GLAST ENSG00000079215 Solute carrier family 1 (glial high affinity glutamate transporter), member 3 5 36606355-36688334 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002573, HPA037467, HPA037468 Supported Approved Nucleoli
Mitochondria Tissue enriched 16 cerebral cortex: 519.6 adipose tissue: 31.7 SLC1A4 ASCT1, SATT ENSG00000115902 Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 2 64988477-65023865 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034963, HPA034964 Approved Validated Microtubule organizing center
Centrosome Expressed in all cerebral cortex: 79.3 SLC1A5 AAAT, ASCT2, M7V1, RDRC ENSG00000105281 Solute carrier family 1 (neutral amino acid transporter), member 5 19 46774883-46788594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035239, HPA035240 Supported Validated Plasma membrane Expressed in all epididymis: 117.4 SLC1A6 EAAT4 ENSG00000105143 Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 19 14950034-15022990 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041505, HPA044066 Supported Uncertain Intermediate filaments Group enriched 6 cerebral cortex: 16.2;skin: 8.9;testis: 36.8 epididymis: 3.7 SLC20A1 Glvr-1, GLVR1, PiT-1 ENSG00000144136 Solute carrier family 20 (phosphate transporter), member 1 2 112645857-112663827 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019279, HPA035834 Approved Approved Vesicles Expressed in all colon: 51.9 SLC20A2 Glvr-2, GLVR2, MLVAR, PiT-2 ENSG00000168575 Solute carrier family 20 (phosphate transporter), member 2 8 42416475-42541926 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026540 Approved Expressed in all thyroid gland: 137.7 SLC22A1 OCT1 ENSG00000175003 Solute carrier family 22 (organic cation transporter), member 1 6 160121789-160158718 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029846 Approved Tissue enriched 252 liver: 286.8 gallbladder: 1.1 SLC22A11 OAT4 ENSG00000168065 Solute carrier family 22 (organic anion/urate transporter), member 11 11 64555626-64572875 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026076 Approved Group enriched 134 epididymis: 10.0;kidney: 25.9;placenta: 44.5 seminal vesicle: 0.2 SLC22A12 OAT4L, RST, URAT1 ENSG00000197891 Solute carrier family 22 (organic anion/urate transporter), member 12 11 64590641-64602353 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024575 Supported Tissue enriched 195 kidney: 104.6 adipose tissue: 0.5 SLC22A13 OAT10, OCTL1, OCTL3, ORCTL3 ENSG00000172940 Solute carrier family 22 (organic anion/urate transporter), member 13 3 38265812-38278315 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA035603, HPA035962 Supported Tissue enriched 39 kidney: 10.6 testis: 0.2 SLC22A15 FLIPT1 ENSG00000163393 Solute carrier family 22, member 15 1 115976498-116070054 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019785 Approved Approved Vesicles Tissue enhanced 0 bone marrow: 20.5 skin: 11.1 SLC22A17 BOCT, BOIT, NGALR ENSG00000092096 Solute carrier family 22, member 17 14 23346306-23352912 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA002728 Uncertain Tissue enriched 6 cerebral cortex: 229.2 prostate: 38.6 SLC22A18 BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5 ENSG00000110628 Solute carrier family 22, member 18 11 2899721-2925246 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067812, HPA071461 Approved Tissue enhanced 0 duodenum: 44.5;small intestine: 32.4 colon: 10.5 SLC22A2 OCT2 ENSG00000112499 Solute carrier family 22 (organic cation transporter), member 2 6 160171061-160277638 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008567, CAB068236, CAB068237 Supported Tissue enriched 83 kidney: 149.2 seminal vesicle: 1.7 SLC22A23 C6orf85, FLJ22174 ENSG00000137266 Solute carrier family 22, member 23 6 3268962-3457022 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014697 Approved Approved Nucleoplasm
Vesicles
Cytosol Expressed in all stomach: 28.2 SLC22A24 MGC34821, NET46 ENSG00000197658 Solute carrier family 22, member 24 11 63079940-63144221 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045015 Uncertain Tissue enriched 46 kidney: 4.6 adipose tissue: 0.0 SLC22A25 HIMTP, MGC120420, UST6 ENSG00000196600 Solute carrier family 22, member 25 11 63163776-63229652 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039390 Uncertain Tissue enriched 57 liver: 5.7 epididymis: 0.0 SLC22A3 EMT, OCT3 ENSG00000146477 Solute carrier family 22 (organic cation transporter), member 3 6 160348268-160452581 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029750 Approved Approved Nucleoplasm
Vesicles
Cytosol Mixed seminal vesicle: 70.0 SLC22A4 MGC34546, OCTN1 ENSG00000197208 Solute carrier family 22 (organic cation/zwitterion transporter), member 4 5 132294443-132344206 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB015468, HPA036973 Approved Uncertain Nucleoplasm
Cytosol Tissue enhanced 0 fallopian tube: 18.6 bone marrow: 13.2 SLC22A5 CDSP, OCTN2, SCD ENSG00000197375 Solute carrier family 22 (organic cation/carnitine transporter), member 5 5 132369752-132395614 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA063062 Approved Mitochondria Mixed parathyroid gland: 31.4 SLC22A7 NLT, OAT2 ENSG00000137204 Solute carrier family 22 (organic anion transporter), member 7 6 43295694-43305538 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030220 Approved Group enriched 63 kidney: 50.1;liver: 167.4 testis: 1.7 SLC22A8 OAT3 ENSG00000149452 Solute carrier family 22 (organic anion transporter), member 8 11 62989154-63015839 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044174 Supported Tissue enriched 391 kidney: 337.6 cerebral cortex: 0.8 SLC23A1 SLC23A2, SVCT1, YSPL3 ENSG00000170482 Solute carrier family 23 (ascorbic acid transporter), member 1 5 139367196-139384553 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047612 Supported Group enriched 5 duodenum: 27.5;fallopian tube: 85.7;kidney: 41.7;small intestine: 73.4 liver: 10.7 SLC23A2 KIAA0238, SLC23A1, SVCT2, YSPL2 ENSG00000089057 Solute carrier family 23 (ascorbic acid transporter), member 2 20 4852356-5010293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052825, HPA059314 Approved Supported Golgi apparatus
Vesicles Expressed in all adrenal gland: 98.6 SLC23A3 FLJ31168, SVCT3, Yspl1 ENSG00000213901 Solute carrier family 23, member 3 2 219161465-219170095 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA019059 Approved Nucleus
Cell Junctions Tissue enhanced 0 kidney: 52.7;small intestine: 23.3 duodenum: 9.0 SLC24A1 CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX ENSG00000074621 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 15 65611366-65660995 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039370 Supported Approved Microtubules Mixed fallopian tube: 8.7 SLC24A3 ENSG00000185052 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 20 19212646-19722937 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA043400, HPA045497 Uncertain Mixed endometrium: 47.4 SLC25A10 DIC ENSG00000183048 Solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 17 81712236-81721016 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023048 Supported Supported Nucleoplasm
Mitochondria Mixed kidney: 35.3 SLC25A11 OGC, SLC20A4 ENSG00000108528 Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 17 4937130-4940251 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021167 Approved Expressed in all heart muscle: 148.2 SLC25A12 Aralar ENSG00000115840 Solute carrier family 25 (aspartate/glutamate carrier), member 12 2 171784370-171999859 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035333, HPA035334 Supported Mixed skeletal muscle: 55.3 SLC25A13 ARALAR2, CITRIN, CTLN2 ENSG00000004864 Solute carrier family 25 (aspartate/glutamate carrier), member 13 7 96120220-96322147 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018997 Approved Supported Mitochondria Expressed in all liver: 77.3 SLC25A14 BMCP1, UCP5 ENSG00000102078 Solute carrier family 25 (mitochondrial carrier, brain), member 14 X 130339888-130373361 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA060316 Approved Mitochondria Mixed cerebral cortex: 20.5 SLC25A15 D13S327, HHH, ORC1, ORNT1 ENSG00000102743 Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 13 40789412-40810111 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042146 Approved Expressed in all liver: 49.6 SLC25A16 D10S105E, GDA, HGT.1, ML7 ENSG00000122912 Solute carrier family 25 (mitochondrial carrier), member 16 10 68477999-68527474 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036243, HPA044580 Uncertain Approved Mitochondria Mixed prostate: 13.7 SLC25A17 PMP34 ENSG00000100372 Solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 22 40769630-40819399 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052708, HPA060972 Approved Supported Peroxisomes Expressed in all ovary: 24.0 SLC25A2 ORNT2 ENSG00000120329 Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2 5 141302629-141304045 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA042146 Uncertain Tissue enriched 116 testis: 11.6 epididymis: 0.0 SLC25A20 CAC, CACT ENSG00000178537 Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 3 48856931-48898993 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016862, HPA029863 Approved Supported Mitochondria
Cytosol Expressed in all liver: 70.8 SLC25A21 ODC, ODC1 ENSG00000183032 Solute carrier family 25 (mitochondrial oxoadipate carrier), member 21 14 36677921-37172866 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000662 Uncertain Mixed testis: 7.6 SLC25A22 EIEE3, FLJ13044, GC1, NET44 ENSG00000177542 Solute carrier family 25 (mitochondrial carrier: glutamate), member 22 11 790475-798333 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014662 Approved Validated Nucleoplasm
Mitochondria Tissue enriched 6 cerebral cortex: 89.9 testis: 15.2 SLC25A23 APC2, FLJ30339, MGC2615 ENSG00000125648 Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 19 6436079-6465203 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009675, HPA050883 Approved Supported Mitochondria Mixed cerebral cortex: 141.8 SLC25A24 APC1, DKFZp586G0123 ENSG00000085491 Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 1 108134036-108200849 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028519, HPA063636 Supported Validated Mitochondria Expressed in all cervix: 44.3 SLC25A26 ENSG00000144741 Solute carrier family 25 (S-adenosylmethionine carrier), member 26 3 66133610-66388116 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA026887 Supported Supported Mitochondria Expressed in all thyroid gland: 17.4 SLC25A27 FLJ33552, UCP4 ENSG00000153291 Solute carrier family 25, member 27 6 46652915-46678193 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA069732 Supported Mitochondria Mixed epididymis: 83.8 SLC25A29 C14orf69, FLJ38975 ENSG00000197119 Solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 14 100291111-100306547 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030781 Uncertain Expressed in all thyroid gland: 158.5 SLC25A3 PHC ENSG00000075415 Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 12 98593591-98606379 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045709 Supported Mitochondria Expressed in all parathyroid gland: 583.9 SLC25A30 ENSG00000174032 Solute carrier family 25, member 30 13 45393316-45418455 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045260 Approved Nucleoplasm Expressed in all kidney: 43.2 SLC25A31 ANT4, DKFZP434N1235 ENSG00000151475 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 4 127730378-127774299 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA015064, HPA016841, HPA046835, HPA071684 Uncertain Validated Mitochondria Tissue enriched 849 testis: 84.9 epididymis: 0.0 SLC25A32 MFTC ENSG00000164933 Solute carrier family 25 (mitochondrial folate carrier), member 32 8 103398635-103415189 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024763, HPA047402 Uncertain Supported Mitochondria Expressed in all lymph node: 21.3 SLC25A33 BMSC-MCP, MGC4399, PNC1 ENSG00000171612 Solute carrier family 25 (pyrimidine nucleotide carrier), member 33 1 9539482-9585179 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049982 Uncertain Mixed testis: 22.0 SLC25A34 DKFZp781A10161 ENSG00000162461 Solute carrier family 25, member 34 1 15736405-15741396 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA069806 Supported Mitochondria Tissue enhanced 0 duodenum: 14.9;small intestine: 15.5 skeletal muscle: 8.2 SLC25A35 FLJ40217 ENSG00000125434 Solute carrier family 25, member 35 17 8287763-8295343 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051720 Uncertain Approved Vesicles
Mitochondria Mixed testis: 19.6 SLC25A36 FLJ10618, PNC2 ENSG00000114120 Solute carrier family 25 (pyrimidine nucleotide carrier), member 36 3 140941830-140979933 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027036 Approved Approved Nucleus
Mitochondria
Cytosol Expressed in all parathyroid gland: 68.3 SLC25A37 MFRN, MFRN1, MSCP ENSG00000147454 Solute carrier family 25 (mitochondrial iron transporter), member 37 8 23528805-23575463 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045680 Uncertain Expressed in all bone marrow: 80.2 SLC25A38 FLJ20551 ENSG00000144659 Solute carrier family 25, member 38 3 39383348-39397351 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041027 Approved Expressed in all thyroid gland: 65.8 SLC25A39 CGI-69, FLJ22407 ENSG00000013306 Solute carrier family 25, member 39 17 44319625-44324870 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA026785 Approved Expressed in all bone marrow: 181.5 SLC25A4 ANT1, PEO2, PEO3, T1 ENSG00000151729 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 4 185143241-185150382 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046835, HPA071684 Approved Supported Mitochondria Tissue enhanced 0 heart muscle: 119.0;skeletal muscle: 66.2 cerebral cortex: 38.2 SLC25A40 MCFP ENSG00000075303 Solute carrier family 25, member 40 7 87833568-87876357 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055197 Uncertain Mixed prostate: 13.6 SLC25A41 APC4, FLJ40442, MGC34725 ENSG00000181240 Solute carrier family 25, member 41 19 6426037-6433779 Predicted intracellular proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043591 Uncertain Tissue enhanced 0 cerebral cortex: 1.0;testis: 1.9 esophagus: 0.4 SLC25A42 MGC26694 ENSG00000181035 Solute carrier family 25, member 42 19 19063999-19112888 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA049449 Approved Supported Mitochondria Expressed in all kidney: 28.7 SLC25A43 ENSG00000077713 Solute carrier family 25, member 43 X 119399060-119454478 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035188 Uncertain Approved Nucleus Mixed esophagus: 20.6 SLC25A44 FLJ90431, KIAA0446 ENSG00000160785 Solute carrier family 25, member 44 1 156193932-156212796 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA065411 Approved Nucleus
Mitochondria Expressed in all cerebral cortex: 43.1 SLC25A45 ENSG00000162241 Solute carrier family 25, member 45 11 65375192-65383701 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA050821 Uncertain Approved Nucleoplasm
Cytosol Expressed in all spleen: 12.6 SLC25A46 ENSG00000164209 Solute carrier family 25, member 46 5 110738136-110765161 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039601, HPA071582 Approved Supported Mitochondria Expressed in all testis: 37.3 SLC25A48 FLJ44862, HDMCP ENSG00000145832 Solute carrier family 25, member 48 5 135834649-135888637 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014674 Uncertain Approved Intermediate filaments
Actin filaments Tissue enhanced 0 cerebral cortex: 17.7;kidney: 7.3 skeletal muscle: 2.7 SLC25A5 2F1, ANT2, T2, T3 ENSG00000005022 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 X 119468400-119471319 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046835, HPA071684 Approved Supported Mitochondria Expressed in all duodenum: 791.0 SLC25A51 CG7943, MCART1, MGC14836 ENSG00000122696 Solute carrier family 25, member 51 9 37879400-37904353 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046388, HPA058261 Uncertain Approved Mitochondria Expressed in all parathyroid gland: 16.4 SLC25A6 ANT3, ANT3Y, MGC17525 ENSG00000169100 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 X 1386152-1392724 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046835, HPA071684 Approved Supported Mitochondria Expressed in all duodenum: 294.5 SLC26A1 EDM4, SAT-1 ENSG00000145217 Solute carrier family 26 (anion exchanger), member 1 4 979073-993440 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041654 Uncertain Approved Microtubules Mixed kidney: 6.1 SLC26A10 ENSG00000135502 Solute carrier family 26, member 10 12 57619527-57626151 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044719 Uncertain Not detected endometrium: 0.5 SLC26A11 ENSG00000181045 Solute carrier family 26 (anion exchanger), member 11 17 80219699-80253500 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA029893 Approved Supported Nucleoplasm
Golgi apparatus
Vesicles Expressed in all adrenal gland: 34.5 SLC26A2 DTD, DTDST ENSG00000155850 Solute carrier family 26 (anion exchanger), member 2 5 149960737-149993455 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041957, HPA058090 Supported Approved Vesicles Tissue enhanced 0 colon: 215.9;rectum: 209.8 parathyroid gland: 81.4 SLC26A3 CLD, DRA ENSG00000091138 Solute carrier family 26 (anion exchanger), member 3 7 107765467-107803225 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036055 Approved Tissue enhanced 0 colon: 1092.5;duodenum: 594.0;rectum: 974.8 seminal vesicle: 183.9 SLC26A4 DFNB4, PDS ENSG00000091137 Solute carrier family 26 (anion exchanger), member 4 7 107660635-107717809 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042860 Approved Tissue enriched 28 thyroid gland: 422.9 cerebral cortex: 15.2 SLC26A6 DKFZp586E1422 ENSG00000225697 Solute carrier family 26 (anion exchanger), member 6 3 48625723-48635493 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048363 Approved Uncertain Cytosol Expressed in all rectum: 24.3 SLC26A8 ENSG00000112053 Solute carrier family 26 (anion exchanger), member 8 6 35943514-36024868 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038080, HPA038081 Uncertain Tissue enriched 27 testis: 75.6 bone marrow: 2.8 SLC26A9 ENSG00000174502 Solute carrier family 26 (anion exchanger), member 9 1 205913048-205943460 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051485 Approved Approved Nucleus
Cell Junctions Tissue enhanced 0 salivary gland: 31.7;stomach: 30.4 lung: 11.4 SLC27A2 ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS ENSG00000140284 Solute carrier family 27 (fatty acid transporter), member 2 15 50182196-50236395 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026089 Supported Group enriched 5 epididymis: 79.2;kidney: 160.9;liver: 145.2 placenta: 24.5 SLC27A3 ACSVL3, FATP3, MGC4365 ENSG00000143554 Solute carrier family 27 (fatty acid transporter), member 3 1 153774354-153780157 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA006935, HPA067508 Uncertain Supported Endoplasmic reticulum Tissue enhanced 0 epididymis: 43.7 lung: 20.9 SLC27A4 ACSVL4, FATP4 ENSG00000167114 Solute carrier family 27 (fatty acid transporter), member 4 9 128340646-128361470 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007293, CAB009771 Approved Supported Vesicles Expressed in all duodenum: 74.1 SLC27A5 ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2 ENSG00000083807 Solute carrier family 27 (fatty acid transporter), member 5 19 58479512-58512413 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007292, CAB056160, CAB068239 Supported Tissue enriched 23 liver: 335.8 fallopian tube: 14.4 SLC27A6 ACSVL2, FACVL2, FATP6, VLCS-H1 ENSG00000113396 Solute carrier family 27 (fatty acid transporter), member 6 5 128538013-129033642 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA008987 Approved Approved Nuclear bodies Tissue enhanced 0 adrenal gland: 32.7;fallopian tube: 33.7 testis: 24.1 SLC28A1 CNT1 ENSG00000156222 Solute carrier family 28 (concentrative nucleoside transporter), member 1 15 84884654-84945796 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019551 Supported Group enriched 26 duodenum: 39.0;kidney: 49.1;liver: 35.4;small intestine: 54.7 placenta: 1.6 SLC28A2 CNT2, HCNT2, HsT17153, SPNT1 ENSG00000137860 Solute carrier family 28 (concentrative nucleoside transporter), member 2 15 45252230-45277845 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA046068, HPA055623 Supported Tissue enhanced 0 duodenum: 66.8;rectum: 37.9;small intestine: 100.1 stomach: 21.4 SLC28A3 CNT3 ENSG00000197506 Solute carrier family 28 (concentrative nucleoside transporter), member 3 9 84275457-84340683 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA023311, HPA024729 Approved Tissue enhanced 0 breast: 10.7;gallbladder: 11.7;skin: 9.8 bone marrow: 6.2 SLC29A1 ENT1 ENSG00000112759 Solute carrier family 29 (equilibrative nucleoside transporter), member 1 6 44219505-44234151 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012384 Approved Expressed in all adrenal gland: 125.1 SLC29A2 DER12, ENT2, HNP36 ENSG00000174669 Solute carrier family 29 (equilibrative nucleoside transporter), member 2 11 66362521-66372214 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018168 Approved Uncertain Nucleoplasm Tissue enhanced 0 skeletal muscle: 36.4 parathyroid gland: 21.8 SLC29A3 ENT3, FLJ11160 ENSG00000198246 Solute carrier family 29 (equilibrative nucleoside transporter), member 3 10 71319258-71363385 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046085, HPA054976, HPA057905 Approved Supported Golgi apparatus
Vesicles Mixed placenta: 18.7 SLC29A4 ENT4, FLJ34923 ENSG00000164638 Solute carrier family 29 (equilibrative nucleoside transporter), member 4 7 5274369-5306870 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA052829 Supported Microtubules
Cytokinetic bridge Tissue enhanced 0 adipose tissue: 44.2 cerebral cortex: 12.0 SLC2A1 CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR ENSG00000117394 Solute carrier family 2 (facilitated glucose transporter), member 1 1 42925375-42959173 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002759, HPA031345, HPA058494 Supported Supported Validated Plasma membrane Tissue enhanced 0 placenta: 133.9 skin: 31.3 SLC2A10 GLUT10 ENSG00000197496 Solute carrier family 2 (facilitated glucose transporter), member 10 20 46709487-46736347 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041015, HPA055673 Approved Supported Cytosol Mixed prostate: 46.7 SLC2A11 GLUT10, GLUT11 ENSG00000133460 Solute carrier family 2 (facilitated glucose transporter), member 11 22 23856703-23886309 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042960, HPA071184 Uncertain Uncertain Nucleus
Cell Junctions Mixed parathyroid gland: 10.7 SLC2A12 GLUT12, GLUT8 ENSG00000146411 Solute carrier family 2 (facilitated glucose transporter), member 12 6 133988697-134052636 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA031593, HPA031594 Approved Validated Plasma membrane
Cell Junctions Tissue enhanced 0 prostate: 38.8 endometrium: 15.7 SLC2A13 HMIT ENSG00000151229 Solute carrier family 2 (facilitated glucose transporter), member 13 12 39755021-40106089 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006584 Approved Approved Nuclear membrane Tissue enhanced 0 cerebral cortex: 49.5;parathyroid gland: 73.3 cervix: 20.3 SLC2A14 GLUT14, SLC2A3P3 ENSG00000173262 Solute carrier family 2 (facilitated glucose transporter), member 14 12 7812512-7891148 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA006539 Approved Approved Plasma membrane Tissue enriched 9 testis: 151.1 breast: 17.2 SLC2A2 GLUT2 ENSG00000163581 Solute carrier family 2 (facilitated glucose transporter), member 2 3 170996348-171026750 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010444, HPA028997, HPA028998 Supported Approved Nucleoplasm Tissue enriched 6 liver: 432.5 duodenum: 67.5 SLC2A3 GLUT3 ENSG00000059804 Solute carrier family 2 (facilitated glucose transporter), member 3 12 7919230-7936275 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002763, HPA006539 Approved Approved Plasma membrane Tissue enhanced 0 bone marrow: 271.6 placenta: 137.6 SLC2A4 GLUT4 ENSG00000181856 Solute carrier family 2 (facilitated glucose transporter), member 4 17 7281667-7288257 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016544 Supported Tissue enhanced 0 heart muscle: 30.1;skeletal muscle: 45.0 adipose tissue: 21.9 SLC2A4RG GEF, HDBP1, Si-1-2, Si-1-2-19 ENSG00000125520 SLC2A4 regulator 20 63739861-63743505 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA063050 Supported Nuclear speckles Expressed in all adipose tissue: 53.6 SLC2A6 GLUT6, GLUT9, HSA011372 ENSG00000160326 Solute carrier family 2 (facilitated glucose transporter), member 6 9 133471095-133479137 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042272, CAB046014 Uncertain Mixed appendix: 6.3 SLC2A7 GLUT7 ENSG00000197241 Solute carrier family 2 (facilitated glucose transporter), member 7 1 9003300-9026345 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039931 Uncertain Group enriched 9 duodenum: 3.1;small intestine: 3.1 epididymis: 0.3 SLC2A8 GLUT8, GLUTX1 ENSG00000136856 Solute carrier family 2 (facilitated glucose transporter), member 8 9 127397138-127408424 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011935 Uncertain Approved Vesicles Expressed in all testis: 50.1 SLC2A9 Glut9, GLUTX, URATv1 ENSG00000109667 Solute carrier family 2 (facilitated glucose transporter), member 9 4 9771153-10054936 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA066229 Approved Tissue enhanced 0 kidney: 30.9;seminal vesicle: 29.4 duodenum: 11.1 SLC30A1 ZNT1, ZRC1 ENSG00000170385 Solute carrier family 30 (zinc transporter), member 1 1 211571568-211578742 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015275, HPA049000 Uncertain Supported Vesicles
Plasma membrane Mixed liver: 47.3 SLC30A10 DKFZp547M236, ZnT-10, ZNT8, ZRC1 ENSG00000196660 Solute carrier family 30, member 10 1 219685427-219958647 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017989 Uncertain Tissue enhanced 0 duodenum: 2.2;liver: 2.3 testis: 1.1 SLC30A2 ZNT2 ENSG00000158014 Solute carrier family 30 (zinc transporter), member 2 1 26037252-26046133 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA017979 Approved Vesicles Tissue enhanced 0 kidney: 21.9;thyroid gland: 42.3 pancreas: 16.5 SLC30A3 ZNT3 ENSG00000115194 Solute carrier family 30 (zinc transporter), member 3 2 27253684-27275817 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060505, HPA067637 Approved Approved Nucleus
Nucleoli
Vesicles
Cytosol Group enriched 14 cerebral cortex: 36.7;epididymis: 65.2;testis: 43.6 heart muscle: 3.4 SLC30A4 ZNT4 ENSG00000104154 Solute carrier family 30 (zinc transporter), member 4 15 45479611-45522807 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018178 Uncertain Tissue enriched 5 prostate: 64.1 testis: 11.8 SLC30A5 FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1 ENSG00000145740 Solute carrier family 30 (zinc transporter), member 5 5 69093646-69131069 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035373 Approved Supported Nucleus
Golgi apparatus Expressed in all thyroid gland: 61.6 SLC30A6 FLJ31101, ZNT6 ENSG00000152683 Solute carrier family 30 (zinc transporter), member 6 2 32165841-32224379 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055032, HPA057328 Uncertain Validated Golgi apparatus Expressed in all thyroid gland: 19.7 SLC30A7 ZNT7, ZnTL2 ENSG00000162695 Solute carrier family 30 (zinc transporter), member 7 1 100896076-100981753 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA018034 Uncertain Supported Golgi apparatus Mixed parathyroid gland: 20.6 SLC30A9 C4orf1, GAC63, HUEL, ZNT9 ENSG00000014824 Solute carrier family 30 (zinc transporter), member 9 4 41990472-42090457 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004014 Approved Expressed in all parathyroid gland: 35.7 SLC31A1 COPT1, CTR1, hCTR1 ENSG00000136868 Solute carrier family 31 (copper transporter), member 1 9 113221562-113264492 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013810 Approved Expressed in all liver: 56.5 SLC31A2 COPT2, CTR2, hCTR2 ENSG00000136867 Solute carrier family 31 (copper transporter), member 2 9 113150942-113164137 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014861 Approved Approved Nuclear speckles
Plasma membrane
Intermediate filaments Expressed in all salivary gland: 170.9 SLC32A1 bA122O1.1, VGAT, VIAAT ENSG00000101438 Solute carrier family 32 (GABA vesicular transporter), member 1 20 38724462-38729372 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037156, HPA058859, HPA059985 Supported Tissue enriched 34 cerebral cortex: 15.9 testis: 0.4 SLC33A1 ACATN, AT-1, AT1, SPG42 ENSG00000169359 Solute carrier family 33 (acetyl-CoA transporter), member 1 3 155821024-155854429 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042430 Uncertain Expressed in all thyroid gland: 67.1 SLC34A1 NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2 ENSG00000131183 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 1 5 177379235-177398848 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA051255 Approved Tissue enriched 164 kidney: 161.0 liver: 0.9 SLC34A2 NAPI-3B ENSG00000157765 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 2 4 25655301-25678748 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037989 Supported Tissue enriched 10 lung: 1127.5 fallopian tube: 111.7 SLC34A3 FLJ38680, NPTIIc ENSG00000198569 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 3 9 137230757-137236554 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023776 Supported Group enriched 14 kidney: 11.8;small intestine: 9.2 testis: 0.7 SLC35A2 UGALT, UGAT, UGT, UGT1, UGT2, UGTL ENSG00000102100 Solute carrier family 35 (UDP-galactose transporter), member A2 X 48903180-48911958 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036087 Approved Supported Golgi apparatus Expressed in all fallopian tube: 44.1 SLC35A3 ENSG00000117620 Solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 1 99969789-100026979 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015253 Uncertain Expressed in all rectum: 47.2 SLC35A4 ENSG00000176087 Solute carrier family 35, member A4 5 140564456-140569103 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA062210 Approved Nucleoplasm Expressed in all parathyroid gland: 110.8 SLC35A5 FLJ20730 ENSG00000138459 Solute carrier family 35, member A5 3 112561709-112585577 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035519, HPA057964 Uncertain Approved Golgi apparatus Expressed in all thyroid gland: 43.7 SLC35B1 UGTREL1 ENSG00000121073 Solute carrier family 35, member B1 17 49700943-49709014 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048655, HPA057418 Approved Approved Nucleus
Endoplasmic reticulum
Vesicles Expressed in all thyroid gland: 52.0 SLC35B2 UGTrel4 ENSG00000157593 Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B2 6 44254096-44257890 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029638 Approved Approved Vesicles Expressed in all parathyroid gland: 58.0 SLC35B3 C6orf196, CGI-19, dJ453H5.1, PAPST2 ENSG00000124786 Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 6 8413068-8435483 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054661, HPA057801 Approved Expressed in all epididymis: 62.2 SLC35C1 FLJ11320, FUCT1 ENSG00000181830 Solute carrier family 35 (GDP-fucose transporter), member C1 11 45804072-45813015 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064001 Supported Supported Golgi apparatus Expressed in all esophagus: 29.5 SLC35C2 bA394O2.1, C20orf5, CGI-15, OVCOV1 ENSG00000080189 Solute carrier family 35 (GDP-fucose transporter), member C2 20 46345980-46364458 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA027011 Approved Supported Nucleoplasm
Golgi apparatus Expressed in all fallopian tube: 36.6 SLC35D2 SQV7L, UGTrel8 ENSG00000130958 Solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 9 96320706-96383710 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA064047 Approved Validated Golgi apparatus Expressed in all small intestine: 73.8 SLC35D3 FRCL1 ENSG00000182747 Solute carrier family 35, member D3 6 136922264-136925639 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030431, HPA067497 Uncertain Approved Microtubule organizing center Tissue enhanced 0 adrenal gland: 1.2 lung: 0.6 SLC35E1 FLJ14251 ENSG00000127526 Solute carrier family 35, member E1 19 16549831-16572382 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016570, HPA062214 Approved Validated Golgi apparatus Expressed in all parathyroid gland: 29.2 SLC35E2B ENSG00000189339 Solute carrier family 35, member E2B 1 1659529-1692728 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045641, HPA062711 Uncertain Uncertain Nucleus Expressed in all smooth muscle: 47.0 SLC35E3 BLOV1 ENSG00000175782 Solute carrier family 35, member E3 12 68746106-68793964 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049403 Uncertain Mixed skin: 6.1 SLC35E4 ENSG00000100036 Solute carrier family 35, member E4 22 30635652-30669016 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049558 Approved Approved Cytosol Tissue enhanced 0 testis: 17.6 cerebral cortex: 5.1 SLC35F1 C6orf169, dJ230I3.1 ENSG00000196376 Solute carrier family 35, member F1 6 117907526-118317676 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019576 Approved Approved Nucleoplasm
Microtubule organizing center
Cytosol Tissue enriched 12 cerebral cortex: 45.6 epididymis: 3.7 SLC35F2 FLJ13018 ENSG00000110660 Solute carrier family 35, member F2 11 107790991-107928293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048185, HPA050695 Uncertain Approved Mitochondria Mixed prostate: 33.0 SLC35F3 FLJ37712 ENSG00000183780 Solute carrier family 35, member F3 1 233904933-234324516 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051327, HPA061582 Uncertain Approved Nucleoli
Golgi apparatus Tissue enhanced 0 cerebral cortex: 10.2 breast: 3.0 SLC35F4 C14orf36, FLJ37712 ENSG00000151812 Solute carrier family 35, member F4 14 57563922-57982194 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043853 Uncertain Approved Nucleoli fibrillar center Tissue enhanced 0 prostate: 1.9;seminal vesicle: 4.9;testis: 1.8 thyroid gland: 1.0 SLC35F5 FLJ22004 ENSG00000115084 Solute carrier family 35, member F5 2 113705011-113756823 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034828, HPA049229 Uncertain Uncertain Plasma membrane Expressed in all thyroid gland: 65.7 SLC35F6 ANT2BP, C2orf18, FLJ20555, TANGO9 ENSG00000213699 Solute carrier family 35, member F6 2 26764284-26781231 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034655 Approved Approved Nucleoplasm
Vesicles
Cytosol Expressed in all thyroid gland: 26.2 SLC35G2 DKFZp564K2464, MGC3295, TMEM22 ENSG00000168917 Solute carrier family 35, member G2 3 136818647-136855892 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052054, HPA064728 Approved Approved Cytosol Mixed testis: 21.2 SLC36A1 LYAAT-1, PAT1, TRAMD3 ENSG00000123643 Solute carrier family 36 (proton/amino acid symporter), member 1 5 151437046-151492381 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035937 Approved Tissue enhanced 0 parathyroid gland: 64.1 duodenum: 45.5 SLC36A2 PAT2, TRAMD1, tramdorin ENSG00000186335 Solute carrier family 36 (proton/amino acid symporter), member 2 5 151314978-151347590 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044002, HPA062229 Supported Group enriched 26 kidney: 67.2;skeletal muscle: 28.1 testis: 1.8 SLC36A4 FLJ38932, PAT4 ENSG00000180773 Solute carrier family 36 (proton/amino acid symporter), member 4 11 93144171-93197964 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017887 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Mixed thyroid gland: 14.7 SLC37A1 ENSG00000160190 Solute carrier family 37 (glucose-6-phosphate transporter), member 1 21 42496008-42581440 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030418, CAB034154 Approved Approved Nucleus Mixed duodenum: 46.9 SLC37A2 FLJ00171 ENSG00000134955 Solute carrier family 37 (glucose-6-phosphate transporter), member 2 11 125063067-125090312 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014948 Uncertain Mixed adrenal gland: 24.8 SLC37A3 DKFZp761N0624 ENSG00000157800 Solute carrier family 37, member 3 7 140293693-140404433 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA014713, HPA061841 Supported Cytosol Expressed in all endometrium: 72.5 SLC38A1 ATA1, NAT2, SAT1 ENSG00000111371 Solute carrier family 38, member 1 12 46183063-46270017 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039460, HPA052272 Uncertain Supported Expressed in all parathyroid gland: 153.2 SLC38A10 MGC15523, PP1744 ENSG00000157637 Solute carrier family 38, member 10 17 81245000-81295547 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021374, HPA023161, HPA024631 Supported Validated Golgi apparatus Expressed in all thyroid gland: 44.6 SLC38A11 AVT2, FLJ39822 ENSG00000169507 Solute carrier family 38, member 11 2 164896186-164955525 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043432 Uncertain Tissue enhanced 0 epididymis: 47.1;gallbladder: 28.3 seminal vesicle: 23.3 SLC38A3 G17, SN1 ENSG00000188338 Solute carrier family 38, member 3 3 50205246-50221486 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031871 Approved Microtubules
Cytosol Tissue enriched 7 liver: 173.5 cerebral cortex: 25.6 SLC38A5 JM24, SN2 ENSG00000017483 Solute carrier family 38, member 5 X 48458537-48470256 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047411 Approved Approved Vesicles
Plasma membrane
Cytosol Mixed pancreas: 50.0 SLC38A6 NAT-1 ENSG00000139974 Solute carrier family 38, member 6 14 60981114-61083733 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018508 Approved Approved Plasma membrane
Cell Junctions
Microtubules Mixed parathyroid gland: 24.3 SLC38A7 FLJ10815 ENSG00000103042 Solute carrier family 38, member 7 16 58665109-58685104 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041777 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Mixed testis: 34.8 SLC38A9 FLJ90709 ENSG00000177058 Solute carrier family 38, member 9 5 55625845-55773194 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043785 Uncertain Approved Nucleoplasm
Vesicles Expressed in all placenta: 79.8 SLC39A1 ZIP1, ZIRTL ENSG00000143570 Solute carrier family 39 (zinc transporter), member 1 1 153959099-153968184 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016506 Uncertain Cytosol Expressed in all placenta: 133.4 SLC39A10 DKFZp564L2123, FLJ90515, KIAA1265 ENSG00000196950 Solute carrier family 39 (zinc transporter), member 10 2 195575977-195737702 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036512, HPA036513, HPA066087 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 78.0;thyroid gland: 79.0 prostate: 27.6 SLC39A11 C17orf26 ENSG00000133195 Solute carrier family 39, member 11 17 72645949-73092712 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA021455 Approved Nucleoplasm Expressed in all thyroid gland: 60.0 SLC39A13 FLJ25785 ENSG00000165915 Solute carrier family 39 (zinc transporter), member 13 11 47407132-47416501 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA043971 Approved Uncertain Cytosol Expressed in all placenta: 58.0 SLC39A3 ZIP3 ENSG00000141873 Solute carrier family 39 (zinc transporter), member 3 19 2732204-2740152 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042139, HPA058526 Uncertain Approved Vesicles Expressed in all testis: 109.9 SLC39A5 ENSG00000139540 Solute carrier family 39 (zinc transporter), member 5 12 56230049-56237846 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018423 Approved Nucleoplasm
Vesicles
Cytosol Group enriched 12 colon: 74.5;duodenum: 247.0;kidney: 114.6;liver: 85.7;pancreas: 53.1;rectum: 49.7;small intestine: 245.4 gallbladder: 10.0 SLC39A6 LIV-1 ENSG00000141424 Solute carrier family 39 (zinc transporter), member 6 18 36108532-36129385 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042377 Approved Expressed in all prostate: 209.0 SLC39A7 D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7 ENSG00000112473 Solute carrier family 39 (zinc transporter), member 7 6 33200445-33204439 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053999 Approved Supported Endoplasmic reticulum Expressed in all parathyroid gland: 40.2 SLC39A8 BIGM103 ENSG00000138821 Solute carrier family 39 (zinc transporter), member 8 4 102251041-102431258 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA038832, HPA038833 Approved Tissue enhanced 0 lung: 257.1 cervix: 128.6 SLC39A9 FLJ11274 ENSG00000029364 Solute carrier family 39, member 9 14 69398015-69462388 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA007921, HPA075390 Approved Approved Endoplasmic reticulum Expressed in all parathyroid gland: 44.1 SLC3A1 ATR1, CSNU1, D2H, NBAT, RBAT ENSG00000138079 Solute carrier family 3 (amino acid transporter heavy chain), member 1 2 44275458-44321494 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038360 Supported Tissue enhanced 0 kidney: 649.8 small intestine: 151.9 SLC3A2 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE ENSG00000168003 Solute carrier family 3 (amino acid transporter heavy chain), member 2 11 62856102-62888875 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010455, HPA017980 Supported Supported Nucleus
Plasma membrane
Cytosol Expressed in all parathyroid gland: 424.3 SLC40A1 FPN1, HFE4, IREG1, MTP1, SLC11A3 ENSG00000138449 Solute carrier family 40 (iron-regulated transporter), member 1 2 189560579-189583758 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065634 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Expressed in all spleen: 496.0 SLC41A1 MgtE ENSG00000133065 Solute carrier family 41 (magnesium transporter), member 1 1 205789093-205813748 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014721, HPA015138 Uncertain Approved Mitochondria Tissue enhanced 0 heart muscle: 72.6 testis: 37.3 SLC41A2 DKFZP434K0427 ENSG00000136052 Solute carrier family 41 (magnesium transporter), member 2 12 104802553-104958744 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038658 Approved Mixed liver: 59.8 SLC41A3 FLJ20473 ENSG00000114544 Solute carrier family 41, member 3 3 126006355-126101561 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045847 Approved Supported Plasma membrane Expressed in all testis: 79.0 SLC43A1 PB39, POV1, R00504 ENSG00000149150 Solute carrier family 43 (amino acid system L transporter), member 1 11 57484534-57515786 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018813, HPA018826 Supported Approved Golgi apparatus
Vesicles
Plasma membrane Expressed in all liver: 50.0 SLC43A2 MGC34680 ENSG00000167703 Solute carrier family 43 (amino acid system L transporter), member 2 17 1569267-1628886 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021564 Approved Tissue enhanced 0 placenta: 31.6 appendix: 17.4 SLC43A3 DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1 ENSG00000134802 Solute carrier family 43, member 3 11 57406954-57427580 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030551 Approved Expressed in all thyroid gland: 121.6 SLC44A1 CD92, CDW92, CHTL1, CTL1 ENSG00000070214 Solute carrier family 44 (choline transporter), member 1 9 105244622-105439171 CD markers, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064714 Supported Nucleoplasm
Mitochondria Expressed in all cerebral cortex: 107.8 SLC44A2 CTL2 ENSG00000129353 Solute carrier family 44 (choline transporter), member 2 19 10602457-10644559 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003228, HPA070799 Approved Approved Vesicles
Cell Junctions Expressed in all placenta: 224.3 SLC44A3 CTL3, MGC45474 ENSG00000143036 Solute carrier family 44, member 3 1 94820342-94895246 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047433 Approved Mixed rectum: 39.1 SLC44A4 C6orf29, CTL4, FLJ14491, NG22, TPPT ENSG00000204385 Solute carrier family 44, member 4 6 31863192-31879046 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046977, HPA054176 Approved Tissue enhanced 0 duodenum: 36.0 prostate: 30.1 SLC44A5 CTL5, MGC34032 ENSG00000137968 Solute carrier family 44, member 5 1 75202131-75611116 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA047455, HPA051011 Uncertain Approved Cytosol Tissue enhanced 0 skin: 12.6 testis: 8.0 SLC45A3 IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein ENSG00000158715 Solute carrier family 45, member 3 1 205657851-205680459 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019073, HPA019075 Supported Approved Nucleoplasm
Vesicles Tissue enriched 25 prostate: 430.6 stomach: 16.9 SLC45A4 KIAA1126 ENSG00000022567 Solute carrier family 45, member 4 8 141207166-141308305 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023154 Uncertain Approved Plasma membrane Mixed testis: 21.1 SLC46A1 HCP1, MGC9564, PCFT ENSG00000076351 Solute carrier family 46 (folate transporter), member 1 17 28394756-28407197 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011614 Approved Supported Plasma membrane
Cytosol Expressed in all duodenum: 97.7 SLC46A2 Ly110, TSCOT ENSG00000119457 Solute carrier family 46, member 2 9 112878920-112890913 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA020098 Approved Group enriched 6 cervix, uterine: 23.0;endometrium: 5.5;epididymis: 5.4;lung: 15.2;skin: 11.3 seminal vesicle: 2.0 SLC46A3 DKFZp686A1775, FLJ42613 ENSG00000139508 Solute carrier family 46, member 3 13 28700064-28718970 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039930 Uncertain Approved Plasma membrane
Actin filaments
Cytosol Expressed in all small intestine: 89.4 SLC47A1 FLJ10847, MATE1 ENSG00000142494 Solute carrier family 47 (multidrug and toxin extrusion), member 1 17 19495385-19579034 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021987 Supported Tissue enhanced 0 adrenal gland: 139.0;kidney: 105.0 liver: 55.2 SLC48A1 FLJ20489, hHRG-1, HRG1 ENSG00000211584 Solute carrier family 48 (heme transporter), member 1 12 47753916-47782753 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA073994 Supported Vesicles Expressed in all thyroid gland: 79.4 SLC4A1 AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR ENSG00000004939 Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) 17 44248385-44268141 Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015584, CAB034438, HPA063911 Supported Tissue enriched 8 bone marrow: 238.4 kidney: 29.9 SLC4A10 NBCn2, NCBE ENSG00000144290 Solute carrier family 4, sodium bicarbonate transporter, member 10 2 161424332-161985282 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA034755 Supported Tissue enriched 22 cerebral cortex: 57.7 adrenal gland: 2.6 SLC4A11 BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1 ENSG00000088836 Solute carrier family 4, sodium borate transporter, member 11 20 3227417-3239190 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018120, HPA058377 Uncertain Uncertain Nucleoplasm
Vesicles Tissue enhanced 0 salivary gland: 19.3;thyroid gland: 27.6 cervix: 14.3 SLC4A1AP HLC3, kanadaptin ENSG00000163798 Solute carrier family 4 (anion exchanger), member 1, adaptor protein 2 27663471-27694976 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036679 Approved Supported Nucleoplasm
Vesicles Expressed in all testis: 61.8 SLC4A2 AE2, BND3L, EPB3L1, HKB3, NBND3 ENSG00000164889 Solute carrier family 4 (anion exchanger), member 2 7 151057210-151076527 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019339 Supported Approved Nuclear speckles
Plasma membrane
Cytosol Expressed in all parathyroid gland: 87.8 SLC4A3 AE3, SLC2C ENSG00000114923 Solute carrier family 4 (anion exchanger), member 3 2 219627327-219641980 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA063498 Approved Nucleoplasm Group enriched 6 cerebral cortex: 30.1;heart muscle: 125.7;ovary: 47.6 testis: 10.9 SLC4A4 hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5 ENSG00000080493 Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 4 71187286-71572087 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022493, HPA035628, HPA035629 Supported Tissue enhanced 0 kidney: 124.6 cerebral cortex: 57.5 SLC4A7 NBC3, SBC2, SLC4A6 ENSG00000033867 Solute carrier family 4, sodium bicarbonate cotransporter, member 7 3 27372721-27484420 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022494, HPA035857 Supported Supported Plasma membrane
Focal adhesion sites Tissue enhanced 0 duodenum: 59.2 breast: 23.6 SLC4A9 AE4 ENSG00000113073 Solute carrier family 4, sodium bicarbonate cotransporter, member 9 5 140360202-140375143 Plasma proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051307 Uncertain Tissue enriched 17 kidney: 12.1 testis: 0.6 SLC50A1 HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1 ENSG00000169241 Solute carrier family 50 (sugar efflux transporter), member 1 1 155135344-155138857 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018095 Approved Expressed in all epididymis: 133.2 SLC51A OSTalpha ENSG00000163959 Solute carrier family 51, alpha subunit 3 196211487-196243178 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039123 Approved Tissue enhanced 0 duodenum: 30.1;liver: 35.2;small intestine: 72.7 colon: 10.2 SLC51B OSTbeta ENSG00000186198 Solute carrier family 51, beta subunit 15 65045370-65053396 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA008398, HPA008533 Supported Approved Vesicles
Mitochondria Tissue enhanced 0 duodenum: 87.8;small intestine: 120.6 cervix: 63.7 SLC52A1 FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1 ENSG00000132517 Solute carrier family 52 (riboflavin transporter), member 1 17 5032600-5052009 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011449 Uncertain Group enriched 10 duodenum: 37.1;placenta: 26.0;skin: 13.3;small intestine: 26.8 parathyroid gland: 2.6 SLC52A2 D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2 ENSG00000185803 Solute carrier family 52 (riboflavin transporter), member 2 8 144354135-144361272 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA063036 Approved Expressed in all placenta: 24.0 SLC52A3 bA371L19.1, C20orf54, hRFT2, RFVT3 ENSG00000101276 Solute carrier family 52 (riboflavin transporter), member 3 20 760080-776015 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049391 Approved Tissue enhanced 0 testis: 62.2 small intestine: 18.5 SLC5A1 D22S675, NAGT, SGLT1 ENSG00000100170 Solute carrier family 5 (sodium/glucose cotransporter), member 1 22 32043032-32113029 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015467, HPA051805, HPA055106 Supported Approved Nucleoplasm
Vesicles Group enriched 10 duodenum: 518.9;small intestine: 320.2 gallbladder: 40.3 SLC5A10 SGLT5 ENSG00000154025 Solute carrier family 5 (sodium/sugar cotransporter), member 10 17 18950345-19022595 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052014 Uncertain Tissue enriched 25 kidney: 43.7 bone marrow: 1.7 SLC5A12 MGC52019, SMCT2 ENSG00000148942 Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 11 26667019-26723427 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA060904 Supported Tissue enhanced 0 epididymis: 57.8;kidney: 172.6 small intestine: 34.0 SLC5A2 SGLT2 ENSG00000140675 Solute carrier family 5 (sodium/glucose cotransporter), member 2 16 31483002-31490860 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041603 Supported Tissue enriched 9 kidney: 25.3 testis: 2.8 SLC5A3 SMIT, SMIT1 ENSG00000198743 Solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 21 34073570-34106260 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA029791 Approved Plasma membrane
Cytosol Tissue enhanced 0 thyroid gland: 42.0 kidney: 32.9 SLC5A5 NIS ENSG00000105641 Solute carrier family 5 (sodium/iodide cotransporter), member 5 19 17871973-17895174 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB022364, HPA049055 Supported Tissue enhanced 0 salivary gland: 28.5;stomach: 56.7;thyroid gland: 20.6 cervix: 8.3 SLC5A6 SMVT ENSG00000138074 Solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 2 27199587-27212958 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036958 Approved Approved Cell Junctions Expressed in all epididymis: 82.1 SLC5A7 CHT1, hCHT ENSG00000115665 Solute carrier family 5 (sodium/choline cotransporter), member 7 2 107986523-108013994 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046105 Approved Nuclear bodies
Cell Junctions
Intermediate filaments Mixed thyroid gland: 2.0 SLC5A9 SGLT4 ENSG00000117834 Solute carrier family 5 (sodium/sugar cotransporter), member 9 1 48222685-48248644 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050263 Approved Actin filaments
Cytosol Group enriched 10 duodenum: 43.8;small intestine: 46.4 lung: 4.5 SLC6A1 GABATHG, GABATR, GAT1 ENSG00000157103 Solute carrier family 6 (neurotransmitter transporter), member 1 3 10992724-11039247 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013341, CAB022293 Supported Uncertain Mitochondria Group enriched 5 cerebral cortex: 119.7;liver: 50.3 parathyroid gland: 15.7 SLC6A11 GAT3 ENSG00000132164 Solute carrier family 6 (neurotransmitter transporter), member 11 3 10816200-10940733 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA037981 Supported Supported Tissue enhanced 0 cerebral cortex: 18.2;skin: 6.7 esophagus: 5.5 SLC6A12 BGT-1 ENSG00000111181 Solute carrier family 6 (neurotransmitter transporter), member 12 12 190077-214570 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034973, HPA057917 Approved Approved Golgi apparatus Tissue enhanced 0 kidney: 29.4;liver: 43.6 cerebral cortex: 14.8 SLC6A13 GAT2 ENSG00000010379 Solute carrier family 6 (neurotransmitter transporter), member 13 12 220621-262873 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036449, HPA052726 Approved Approved Mitochondria Tissue enriched 14 kidney: 152.9 fallopian tube: 11.2 SLC6A14 ENSG00000268104 Solute carrier family 6 (amino acid transporter), member 14 X 116436622-116461458 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003193 Uncertain Approved Vesicles Tissue enhanced 0 cervix, uterine: 11.0;lung: 23.9 breast: 9.2 SLC6A15 FLJ10316, hv7-3, NTT73, SBAT1, V7-3 ENSG00000072041 Solute carrier family 6 (neutral amino acid transporter), member 15 12 84859488-84913615 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008609 Uncertain Approved Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 23.1 placenta: 5.5 SLC6A16 NTT5 ENSG00000063127 Solute carrier family 6, member 16 19 49289638-49325225 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA076812 Approved Golgi apparatus Tissue enriched 18 testis: 161.8 lymph node: 9.0 SLC6A17 ENSG00000197106 Solute carrier family 6 (neutral amino acid transporter), member 17 1 110150486-110202202 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007663, HPA008044 Approved Approved Nucleus
Golgi apparatus Tissue enriched 10 cerebral cortex: 75.6 adrenal gland: 7.9 SLC6A18 FLJ31236, Xtrp2 ENSG00000164363 Solute carrier family 6 (neutral amino acid transporter), member 18 5 1225355-1246189 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA011885 Supported Tissue enriched 83 kidney: 8.2 epididymis: 0.0 SLC6A19 ENSG00000174358 Solute carrier family 6 (neutral amino acid transporter), member 19 5 1201595-1225117 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037415, HPA043207 Supported Group enriched 21 duodenum: 143.3;kidney: 91.3;small intestine: 160.0 rectum: 6.3 SLC6A2 NAT1, NET, NET1, SLC6A5 ENSG00000103546 Solute carrier family 6 (neurotransmitter transporter), member 2 16 55655604-55706192 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004057, CAB078195 Supported Supported Approved Mitochondria
Cytosol Tissue enhanced 0 adrenal gland: 29.4;placenta: 18.2;skin: 15.7 testis: 11.4 SLC6A20 XT3, Xtrp3 ENSG00000163817 Solute carrier family 6 (proline IMINO transporter), member 20 3 45755450-45796535 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029873 Approved Tissue enhanced 0 duodenum: 25.1;small intestine: 19.7 gallbladder: 10.9 SLC6A3 DAT, DAT1 ENSG00000142319 Solute carrier family 6 (neurotransmitter transporter), member 3 5 1392790-1445430 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level HPA013602, CAB016249, CAB078172 Uncertain Supported Approved Vesicles Not detected thyroid gland: 0.3 SLC6A4 5-HTT, HTT, OCD1, SERT1 ENSG00000108576 Solute carrier family 6 (neurotransmitter transporter), member 4 17 30194319-30236002 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054723, HPA074728 Supported Supported Golgi apparatus
Vesicles Group enriched 10 duodenum: 10.7;lung: 44.2;placenta: 26.3;small intestine: 46.2 esophagus: 3.1 SLC6A6 TAUT ENSG00000131389 Solute carrier family 6 (neurotransmitter transporter), member 6 3 14402576-14489349 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015028, HPA016488 Supported Approved Cell Junctions
Cytosol Mixed ovary: 50.7 SLC6A7 PROT ENSG00000011083 Solute carrier family 6 (neurotransmitter transporter), member 7 5 150189957-150222788 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA028907 Uncertain Tissue enhanced 0 cerebral cortex: 17.0;rectum: 4.3 colon: 2.9 SLC6A9 GLYT1 ENSG00000196517 Solute carrier family 6 (neurotransmitter transporter, glycine), member 9 1 43991500-44031467 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA013977 Uncertain Approved Nucleus
Golgi apparatus Tissue enhanced 0 skin: 49.8 adrenal gland: 31.0 SLC7A1 ATRC1, CAT-1, ERR, HCAT1, REC1L ENSG00000139514 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 13 29509410-29595688 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039721 Approved Mixed esophagus: 42.0 SLC7A10 asc-1 ENSG00000130876 Solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 19 33208664-33225850 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041884, HPA057036 Uncertain Uncertain Nucleus
Nucleoli Group enriched 23 adipose tissue: 31.5;cerebral cortex: 6.6 breast: 0.8 SLC7A11 xCT ENSG00000151012 Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 4 138164097-138242349 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064215 Approved Vesicles Tissue enhanced 0 cerebral cortex: 22.5 epididymis: 8.2 SLC7A14 KIAA1613, PPP1R142 ENSG00000013293 Solute carrier family 7, member 14 3 170459584-170586074 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045929 Approved Tissue enriched 8 cerebral cortex: 26.8 adrenal gland: 3.1 SLC7A2 ATRC2, CAT-2, HCAT2 ENSG00000003989 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 8 17497088-17570573 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009277 Supported Plasma membrane
Cell Junctions Tissue enhanced 0 parathyroid gland: 373.7 liver: 92.6 SLC7A3 ATRC3, CAT-3, FLJ14541 ENSG00000165349 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 X 70925582-70931125 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003629 Approved Tissue enhanced 0 endometrium: 7.8;prostate: 9.6;seminal vesicle: 7.4 smooth muscle: 4.0 SLC7A4 CAT-4, HCAT3, VH ENSG00000099960 Solute carrier family 7, member 4 22 21028718-21032840 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA031023 Approved Tissue enhanced 0 testis: 22.5 esophagus: 6.0 SLC7A5 CD98, D16S469E, E16, LAT1, MPE16 ENSG00000103257 Solute carrier family 7 (amino acid transporter light chain, L system), member 5 16 87830023-87869488 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052673, HPA056077 Approved Supported Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 90.5;testis: 84.4 bone marrow: 66.3 SLC7A6 KIAA0245, LAT-2, LAT3, y+LAT-2 ENSG00000103064 Solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 16 68264516-68301823 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050713 Uncertain Approved Vesicles
Plasma membrane Mixed adipose tissue: 35.1 SLC7A7 LPI, y+LAT-1 ENSG00000155465 Solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 14 22773222-22829820 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036227 Approved Tissue enhanced 0 kidney: 279.7 parathyroid gland: 159.0 SLC7A8 LAT2, LPI-PC1 ENSG00000092068 Solute carrier family 7 (amino acid transporter light chain, L system), member 8 14 23125295-23183674 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB046015, HPA051950, HPA060672 Supported Tissue enriched 8 parathyroid gland: 1066.4 kidney: 131.5 SLC7A9 CSNU3 ENSG00000021488 Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 19 32830509-32869766 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042591 Supported Group enriched 10 duodenum: 81.2;kidney: 69.6;small intestine: 125.7 liver: 8.9 SLC8A1 NCX1 ENSG00000183023 Solute carrier family 8 (sodium/calcium exchanger), member 1 2 40097270-40611053 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022694, HPA070007 Uncertain Supported Nucleoplasm
Plasma membrane Tissue enhanced 0 heart muscle: 79.5 seminal vesicle: 38.2 SLC8A2 KIAA1087, NCX2 ENSG00000118160 Solute carrier family 8 (sodium/calcium exchanger), member 2 19 47428017-47472168 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA050818, HPA054671 Supported Tissue enriched 11 cerebral cortex: 68.4 endometrium: 6.2 SLC8B1 FLJ22233, NCKX6, NCLX, SLC24A6 ENSG00000089060 Solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 12 113298759-113359493 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA040668 Approved Expressed in all adrenal gland: 48.6 SLC9A1 APNH, NHE1, PPP1R143 ENSG00000090020 Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 1 27098815-27166981 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022371, HPA048532, HPA052891 Supported Supported Plasma membrane Expressed in all stomach: 66.4 SLC9A2 NHE2 ENSG00000115616 Solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 2 102619707-102711318 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA035121, HPA035122 Approved Approved Cell Junctions Tissue enhanced 0 colon: 20.9;rectum: 23.7;stomach: 25.8 testis: 10.6 SLC9A3 NHE3 ENSG00000066230 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 5 473310-524332 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036493, HPA036669 Supported Supported Plasma membrane Tissue enhanced 0 colon: 82.6;small intestine: 74.1 gallbladder: 66.3 SLC9A3R1 EBP50, NHERF ENSG00000109062 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 17 74748652-74769353 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001962, HPA009672, HPA027247 Supported Approved Vesicles
Plasma membrane
Microtubule organizing center Expressed in all small intestine: 308.5 SLC9A3R2 E3KARP, NHERF-2, SIP-1, TKA-1 ENSG00000065054 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 16 2025356-2039026 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001672 Approved Supported Plasma membrane Mixed lung: 161.9 SLC9A4 NHE4 ENSG00000180251 Solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 2 102473303-102533972 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036096 Approved Approved Nucleoplasm
Plasma membrane Tissue enriched 5 stomach: 51.1 kidney: 9.5 SLC9A5 NHE5 ENSG00000135740 Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 16 67237683-67272190 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA041004, HPA041329 Uncertain Approved Nucleoplasm
Cytosol Tissue enhanced 0 spleen: 7.8 cerebral cortex: 2.5 SLC9A6 KIAA0267, NHE6 ENSG00000198689 Solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 X 135985424-136047269 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059445, HPA059590 Approved Supported Vesicles Tissue enhanced 0 cerebral cortex: 76.1 parathyroid gland: 17.3 SLC9A7 NHE7 ENSG00000065923 Solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 X 46599252-46759172 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048938, HPA075385 Approved Supported Vesicles Mixed cerebral cortex: 14.4 SLC9A8 KIAA0939, NHE8 ENSG00000197818 Solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8 20 49812713-49892242 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB033682 Approved Expressed in all bone marrow: 13.2 SLC9A9 FLJ35613, NHE9 ENSG00000181804 Solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 3 143265222-143848531 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058234 Approved Mixed placenta: 22.1 SLC9B1 NHA1, NHEDC1 ENSG00000164037 Solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 4 102885048-103019739 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA035435, HPA058971, HPA065520 Uncertain Approved Mitochondria Tissue enriched 25 testis: 73.9 epididymis: 2.9 SLC9B2 FLJ23984, NHA2, NHEDC2 ENSG00000164038 Solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 4 103019868-103085829 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047008 Uncertain Approved Nucleoplasm
Cell Junctions Tissue enhanced 0 cerebral cortex: 32.6 liver: 20.5 SLCO1A2 OATP, OATP-A, OATP1A2, SLC21A3 ENSG00000084453 Solute carrier organic anion transporter family, member 1A2 12 21264600-21419594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA071152 Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 28.8 salivary gland: 6.6 SLCO1B1 LST-1, OATP-C, OATP1B1, SLC21A6 ENSG00000134538 Solute carrier organic anion transporter family, member 1B1 12 21131202-21239246 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050892 Supported Tissue enriched 249 liver: 307.4 breast: 1.2 SLCO1B3 OATP1B3, OATP8, SLC21A8 ENSG00000111700 Solute carrier organic anion transporter family, member 1B3 12 20810702-20916911 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004943, HPA050892 Supported Supported Plasma membrane Tissue enriched 7 liver: 138.5 cervix: 19.4 SLCO2A1 MATR1, OATP2A1, PGT, SLC21A2 ENSG00000174640 Solute carrier organic anion transporter family, member 2A1 3 133932696-134052184 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013742 Supported Tissue enhanced 0 seminal vesicle: 113.4 thyroid gland: 71.0 SLCO2B1 OATP-B, OATP2B1, SLC21A9 ENSG00000137491 Solute carrier organic anion transporter family, member 2B1 11 75100563-75206549 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020659 Uncertain Expressed in all liver: 123.0 SLCO4A1 OATP-E, OATP4A1, SLC21A12 ENSG00000101187 Solute carrier organic anion transporter family, member 4A1 20 62642445-62685785 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030669, HPA030670 Uncertain Approved Cell Junctions Mixed esophagus: 10.6 SLCO5A1 OATP-J, OATP5A1, OATPRP4, SLC21A15 ENSG00000137571 Solute carrier organic anion transporter family, member 5A1 8 69667047-69835064 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA025062 Uncertain Tissue enhanced 0 prostate: 3.6 skeletal muscle: 2.6 SLCO6A1 CT48, MGC26949, OATP6A1, OATPY ENSG00000205359 Solute carrier organic anion transporter family, member 6A1 5 102371782-102499016 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA054126 Supported Tissue enriched 136 testis: 53.7 placenta: 0.3 SLN MGC12301, MGC125854, MGC125855 ENSG00000170290 Sarcolipin 11 107707378-107719693 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011628 Approved Microtubules Tissue enriched 11 skeletal muscle: 2802.5 heart muscle: 263.2 SMDT1 C22orf32, DDDD, dJ186O1.1, EMRE ENSG00000183172 Single-pass membrane protein with aspartate-rich tail 1 22 42079691-42084284 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032117, HPA060340 Uncertain Supported Nucleus
Mitochondria Expressed in all thyroid gland: 7.8 SNAP23 HsT17016, SNAP23A, SNAP23B ENSG00000092531 Synaptosomal-associated protein, 23kDa 15 42491233-42545356 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001214, CAB037083, CAB037317 Approved Supported Plasma membrane Expressed in all spleen: 88.1 SNAP25 bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25 ENSG00000132639 Synaptosomal-associated protein, 25kDa 20 10218830-10307418 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000360, HPA001830 Supported Supported Tissue enriched 31 cerebral cortex: 1764.2 adrenal gland: 57.4 SNAPIN BLOC1S7, BORCS3, SNAPAP ENSG00000143553 SNAP-associated protein 1 153658654-153661830 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046974 Approved Approved Nucleoli
Golgi apparatus Expressed in all fallopian tube: 41.8 SNCA alpha-synuclein, NACP, PARK1, PARK4, PD1 ENSG00000145335 Synuclein, alpha (non A4 component of amyloid precursor) 4 89724099-89838315 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005459, CAB010877 Supported Group enriched 5 bone marrow: 161.2;cerebral cortex: 460.5 endometrium: 56.7 SNX27 KIAA0488, MGC20471, MY014 ENSG00000143376 Sorting nexin family member 27 1 151612065-151699091 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045816 Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 18.8 SNX31 MGC39715 ENSG00000174226 Sorting nexin 31 8 100572882-100663415 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024284, HPA053466 Uncertain Approved Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced 0 urinary bladder: 33.8 esophagus: 7.3 SON BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP ENSG00000159140 SON DNA binding protein 21 33542618-33577481 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023535, HPA031755, HPA031756 Supported Validated Nuclear speckles Expressed in all parathyroid gland: 220.0 SPNS1 HSpin1, LAT, nrs, PP2030, SPIN1, SPINL ENSG00000169682 Spinster homolog 1 (Drosophila) 16 28974221-28984548 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041995, HPA042988 Supported Approved Nucleoli fibrillar center
Golgi apparatus
Vesicles
Cytosol Expressed in all parathyroid gland: 36.3 SPNS2 ENSG00000183018 Spinster homolog 2 (Drosophila) 17 4498838-4539035 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA068717 Uncertain Tissue enhanced 0 esophagus: 46.5 kidney: 29.9 SPPL2A IMP3, PSL2 ENSG00000138600 Signal peptide peptidase like 2A 15 50702266-50765808 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036062, HPA067304 Supported Supported Vesicles Expressed in all parathyroid gland: 285.5 SRP14 ALURBP, MGC14326 ENSG00000140319 Signal recognition particle 14kDa (homologous Alu RNA binding protein) 15 40035739-40039188 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053738, HPA065118 Approved Nucleus
Nucleoli Expressed in all thyroid gland: 372.6 SRP19 ENSG00000153037 Signal recognition particle 19kDa 5 112861222-112869788 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029272 Approved Expressed in all thyroid gland: 64.7 SRP54 ENSG00000100883 Signal recognition particle 54kDa 14 34981957-35029567 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048977, HPA062044 Approved Supported Nucleoli
Cytosol Expressed in all testis: 89.5 SRP68 ENSG00000167881 Signal recognition particle 68kDa 17 76038775-76072653 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023303, HPA055617 Approved Validated Focal adhesion sites
Cytosol Expressed in all thyroid gland: 71.7 SRP72 ENSG00000174780 Signal recognition particle 72kDa 4 56466915-56503680 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034621 Approved Expressed in all thyroid gland: 88.8 SRRM1 MGC39488, POP101, SRM160 ENSG00000133226 Serine/arginine repetitive matrix 1 1 24631716-24673267 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049941, HPA058612 Supported Validated Nuclear speckles Expressed in all epididymis: 96.3 STAC STAC1 ENSG00000144681 SH3 and cysteine rich domain 3 36380344-36548007 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA035143 Uncertain Uncertain Nucleoplasm
Plasma membrane Tissue enhanced 0 parathyroid gland: 23.0;prostate: 20.0 lung: 15.8 STARD3 es64, MLN64 ENSG00000131748 StAR-related lipid transfer (START) domain containing 3 17 39637065-39663484 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB017021 Uncertain Expressed in all testis: 33.3 STATH STR ENSG00000126549 Statherin 4 69995930-70002570 Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044569 Supported Tissue enriched 1726 salivary gland: 45012.6 ovary: 26.0 STEAP1 PRSS24, STEAP ENSG00000164647 Six transmembrane epithelial antigen of the prostate 1 7 90154375-90164829 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030985 Uncertain Tissue enhanced 0 prostate: 124.2 appendix: 41.5 STEAP2 IPCA-1, PCANAP1, STAMP1, STMP ENSG00000157214 STEAP family member 2, metalloreductase 7 90167590-90238137 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029115, HPA055603 Uncertain Supported Vesicles Tissue enriched 11 prostate: 205.1 parathyroid gland: 18.5 STEAP4 FLJ23153, STAMP2, TIARP, TNFAIP9 ENSG00000127954 STEAP family member 4 7 88270892-88306891 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA075871 Supported Golgi apparatus Expressed in all adipose tissue: 129.9 STIM1 D11S4896E, GOK ENSG00000167323 Stromal interaction molecule 1 11 3854527-4093210 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011088, HPA012123, CAB037128, CAB037288 Supported Validated Endoplasmic reticulum Expressed in all parathyroid gland: 86.3 STIM2 ENSG00000109689 Stromal interaction molecule 2 4 26857678-27025381 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036933, CAB037196, HPA057511 Supported Approved Vesicles Expressed in all gallbladder: 44.5 STOM BND7, EPB7, EPB72 ENSG00000148175 Stomatin 9 121338988-121370304 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010961, HPA011419 Approved Validated Cytosol Expressed in all adipose tissue: 461.2 STRA6 FLJ12541 ENSG00000137868 Stimulated by retinoic acid 6 15 74179466-74212267 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040839 Approved Approved Nucleus
Cytosol Tissue enhanced 0 cervix, uterine: 37.3;placenta: 20.4 endometrium: 13.5 STT3A ITM1, MGC9042, STT3-A, TMC ENSG00000134910 STT3A, subunit of the oligosaccharyltransferase complex (catalytic) 11 125591712-125625215 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030735 Approved Uncertain Nucleoplasm
Vesicles
Cytosol Tissue enriched 6 parathyroid gland: 1111.5 epididymis: 173.1 STX1A HPC-1, p35-1, STX1 ENSG00000106089 Syntaxin 1A (brain) 7 73699206-73719672 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008372, HPA069176 Supported Tissue enriched 15 cerebral cortex: 167.1 gallbladder: 10.8 STX4 p35-2, STX4A ENSG00000103496 Syntaxin 4 16 31032889-31042975 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001330 Approved Validated Plasma membrane Expressed in all parathyroid gland: 63.4 SUN1 FLJ12407, KIAA0810, UNC84A ENSG00000164828 Sad1 and UNC84 domain containing 1 7 816615-896435 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008346, HPA008461 Supported Validated Nuclear membrane Expressed in all endometrium: 120.0 SYP MRX96 ENSG00000102003 Synaptophysin X 49187804-49200259 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000076, HPA002858, CAB055505 Supported Tissue enriched 11 cerebral cortex: 573.3 adrenal gland: 51.4 SYT1 P65, SVP65, SYT ENSG00000067715 Synaptotagmin I 12 78863993-79452008 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008394, HPA064788 Supported Tissue enriched 13 cerebral cortex: 477.9 smooth muscle: 36.4 TAP1 ABCB2, D6S114E, PSF1, RING4 ENSG00000168394 Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) 6 32845209-32853978 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009516, HPA072354 Approved Supported Endoplasmic reticulum
Microtubule organizing center Mixed appendix: 20.6 TAP2 ABCB3, D6S217E, PSF2, RING11 ENSG00000204267 Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) 6 32821833-32838780 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001312 Approved Approved Nuclear speckles
Endoplasmic reticulum Mixed urinary bladder: 15.7 TAS1R1 GPR70, T1R1, TR1 ENSG00000173662 Taste receptor, type 1, member 1 1 6555181-6579757 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034579, HPA034580 Approved Tissue enriched 7 testis: 4.2 skin: 0.5 TM4SF4 il-TMP ENSG00000169903 Transmembrane 4 L six family member 4 3 149473974-149503281 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046430 Supported Approved Plasma membrane
Cytosol Group enriched 34 duodenum: 595.8;gallbladder: 1326.5;liver: 343.7;small intestine: 515.2 stomach: 20.3 TM9SF2 P76 ENSG00000125304 Transmembrane 9 superfamily member 2 13 99501417-99564006 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005657 Supported Expressed in all thyroid gland: 201.3 TM9SF4 dJ836N17.2, KIAA0255 ENSG00000101337 Transmembrane 9 superfamily protein member 4 20 32109506-32167258 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064099 Approved Approved Mitochondria Expressed in all parathyroid gland: 91.3 TMBIM4 CGI-119, GAAP, LFG4, S1R, ZPRO ENSG00000155957 Transmembrane BAX inhibitor motif containing 4 12 66135846-66170072 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA077642 Supported Golgi apparatus Expressed in all thyroid gland: 164.8 TMBIM6 BAXI1, BI-1, TEGT ENSG00000139644 Transmembrane BAX inhibitor motif containing 6 12 49707725-49764934 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017378 Approved Expressed in all kidney: 1179.3 TMC6 EVER1, EVIN1, LAK-4P ENSG00000141524 Transmembrane channel-like 6 17 78110458-78132407 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051430 Uncertain Expressed in all spleen: 84.5 TMC8 EVER2, EVIN2 ENSG00000167895 Transmembrane channel-like 8 17 78130770-78142968 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047387, HPA054429 Uncertain Uncertain Golgi apparatus Tissue enhanced 0 lymph node: 120.4;spleen: 107.5 appendix: 75.5 TMED1 Il1rl1l, IL1RL1LG, MGC1270, p24g1, p24gamma1, ST2L ENSG00000099203 Transmembrane p24 trafficking protein 1 19 10832438-10836318 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018507, HPA078574 Uncertain Supported Vesicles Expressed in all thyroid gland: 47.6 TMED2 P24A, p24b1, p24beta1, RNP24 ENSG00000086598 Transmembrane p24 trafficking protein 2 12 123584531-123598577 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014060 Approved Supported Vesicles Expressed in all thyroid gland: 327.0 TMED3 C15orf22, p24B, p24g4, p24gamma4 ENSG00000166557 Transmembrane p24 trafficking protein 3 15 79311062-79427432 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049314, HPA076949 Approved Supported Golgi apparatus Mixed salivary gland: 164.3 TMEM104 FLJ00021, FLJ20255 ENSG00000109066 Transmembrane protein 104 17 74776483-74839779 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044330 Approved Approved Nucleoplasm
Golgi apparatus Expressed in all parathyroid gland: 14.7 TMEM109 MGC5508 ENSG00000110108 Transmembrane protein 109 11 60913874-60923443 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011785 Approved Approved Nuclear membrane
Cytosol Expressed in all endometrium: 94.2 TMEM110 MGC52022 ENSG00000213533 Transmembrane protein 110 3 52836219-52897596 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA051855 Uncertain Approved Cytosol Expressed in all fallopian tube: 20.8 TMEM139 FLJ90586 ENSG00000178826 Transmembrane protein 139 7 143279957-143288048 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA036982, HPA036983 Approved Approved Plasma membrane
Focal adhesion sites Tissue enhanced 0 duodenum: 34.9;kidney: 34.4 small intestine: 21.2 TMEM163 DKFZP566N034, SV31 ENSG00000152128 Transmembrane protein 163 2 134455759-134719000 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA007224 Uncertain Mixed lung: 21.5 TMEM165 GDT1, TMPT27, TPARL ENSG00000134851 Transmembrane protein 165 4 55395957-55453397 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038299 Supported Supported Golgi apparatus
Vesicles Expressed in all placenta: 86.4 TMEM175 MGC4618 ENSG00000127419 Transmembrane protein 175 4 932387-958656 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057160 Approved Approved Nucleus
Nuclear membrane Expressed in all cerebral cortex: 20.8 TMEM178A MGC33926, TMEM178 ENSG00000152154 Transmembrane protein 178A 2 39664982-39717963 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052128, HPA058560 Uncertain Approved Nucleus
Vesicles Tissue enhanced 0 cerebral cortex: 55.6 kidney: 19.1 TMEM180 bA18I14.8, C10orf77, FLJ22529 ENSG00000138111 Transmembrane protein 180 10 102461395-102477045 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA018031 Uncertain Approved Golgi apparatus
Cytosol Mixed skin: 8.8 TMEM184B C22orf5, DKFZP586A1024, FM08, HS5O6A ENSG00000198792 Transmembrane protein 184B 22 38219291-38273034 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024076 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Expressed in all cerebral cortex: 57.5 TMEM192 FLJ38482 ENSG00000170088 Transmembrane protein 192 4 165070608-165208549 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014717, HPA024110 Supported Validated Nucleoplasm
Endosomes
Lysosomes Expressed in all kidney: 50.6 TMEM205 MBC3205, UNQ501 ENSG00000105518 Transmembrane protein 205 19 11342776-11346518 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041504 Approved Approved Nucleoplasm
Nuclear membrane
Endoplasmic reticulum Expressed in all parathyroid gland: 253.1 TMEM208 HSPC171 ENSG00000168701 Transmembrane protein 208 16 67227103-67229278 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041868, HPA041949 Supported Expressed in all parathyroid gland: 88.4 TMEM234 C1orf91, dJ622L5.7, FLJ90779, RP4-622L5 ENSG00000160055 Transmembrane protein 234 1 32214472-32222359 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015049 Uncertain Approved Vesicles Mixed epididymis: 12.8 TMEM27 NX17 ENSG00000147003 Transmembrane protein 27 X 15627318-15665031 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048543 Approved Approved Endoplasmic reticulum
Vesicles Tissue enriched 16 kidney: 418.5 parathyroid gland: 26.1 TMEM30A C6orf67, CDC50A, FLJ10856 ENSG00000112697 Transmembrane protein 30A 6 75252924-75284968 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014561 Approved Supported Mitochondria Expressed in all cerebral cortex: 167.9 TMEM30B CDC50B ENSG00000182107 Transmembrane protein 30B 14 61277370-61281840 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043162 Uncertain Mixed parathyroid gland: 80.6 TMEM57 FLJ10747 ENSG00000204178 Transmembrane protein 57 1 25430858-25500209 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019680 Approved Cytosol Expressed in all testis: 36.0 TMEM63B C6orf110, dJ421H19.2, DKFZp434P0531 ENSG00000137216 Transmembrane protein 63B 6 44126914-44155519 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029249, HPA029250, HPA029251 Uncertain Validated Plasma membrane
Actin filaments Expressed in all lung: 59.2 TMEM63C C14orf171, CSC1, DKFZp434P0111, hsCSC1 ENSG00000165548 Transmembrane protein 63C 14 77116568-77259495 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030657 Uncertain Approved Centrosome Tissue enhanced 0 adrenal gland: 12.9;cerebral cortex: 18.6;testis: 13.8 epididymis: 5.5 TMEM64 DKFZp762C1112 ENSG00000180694 Transmembrane protein 64 8 90621995-90791632 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB034221 Uncertain Expressed in all epididymis: 173.0 TMEM67 JBTS6, MGC26979, MKS3, NPHP11 ENSG00000164953 Transmembrane protein 67 8 93754844-93819234 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039940 Uncertain Tissue enhanced 0 fallopian tube: 21.9 testis: 12.8 TMIE DFNB6 ENSG00000181585 Transmembrane inner ear 3 46701333-46710886 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038298 Uncertain Uncertain Vesicles
Cytosol Tissue enhanced 0 adrenal gland: 7.5;cerebral cortex: 5.3 testis: 1.7 TMUB1 C7orf21, SB144 ENSG00000164897 Transmembrane and ubiquitin-like domain containing 1 7 151081080-151083546 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029429 Approved Supported Nucleoplasm
Cytosol Expressed in all small intestine: 53.3 TNFAIP2 B94, EXOC3L3 ENSG00000185215 Tumor necrosis factor, alpha-induced protein 2 14 103123442-103137439 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB004598, HPA030624 Supported Approved Nucleus
Nuclear membrane
Golgi apparatus
Cytosol Expressed in all urinary bladder: 211.4 TNKS PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1 ENSG00000173273 Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 8 9555914-9782346 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA025690 Approved Approved Nucleoplasm
Nuclear membrane Expressed in all testis: 52.7 TNPO1 IPO2, KPNB2, MIP, MIP1, TRN ENSG00000083312 Transportin 1 5 72816312-72916733 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016325 Approved Supported Nucleoplasm
Cytosol
Cytoplasmic bodies Expressed in all parathyroid gland: 108.4 TNPO2 FLJ12155, IPO3, KPNB2B, TRN2 ENSG00000105576 Transportin 2 19 12699194-12724011 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB046446, HPA071498 Approved Approved Nucleus
Nucleoli Expressed in all cerebral cortex: 91.2 TOMM40 C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40 ENSG00000130204 Translocase of outer mitochondrial membrane 40 homolog (yeast) 19 44890569-44903689 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036231, HPA036232 Supported Validated Mitochondria
Cytosol Expressed in all appendix: 35.2 TP53 LFS1, p53 ENSG00000141510 Tumor protein p53 17 7661779-7687550 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002973, CAB039238, CAB039239, HPA051244, CAB072876 Supported Validated Nucleoplasm Expressed in all fallopian tube: 50.3 TPCN1 FLJ20612, KIAA1169, TPC1 ENSG00000186815 Two pore segment channel 1 12 113221050-113298585 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039757 Approved Expressed in all thyroid gland: 53.3 TPCN2 TPC2 ENSG00000162341 Two pore segment channel 2 11 69048897-69090604 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016561, HPA027080 Supported Approved Nucleoli Mixed endometrium: 11.7 TPR ENSG00000047410 Translocated promoter region, nuclear basket protein 1 186311652-186375693 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019661, HPA019663, HPA024336 Supported Validated Nuclear membrane Expressed in all testis: 78.8 TRIAP1 HSPC132, MDM35, P53CSV, WF-1 ENSG00000170855 TP53 regulated inhibitor of apoptosis 1 12 120443961-120446412 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053640 Approved Approved Nucleoplasm
Mitochondria Expressed in all placenta: 40.0 TRIM72 MG53 ENSG00000177238 Tripartite motif containing 72, E3 ubiquitin protein ligase 16 31214021-31231537 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023122, HPA054909 Supported Approved Nucleus
Nucleoli Tissue enriched 21 skeletal muscle: 52.5 prostate: 2.4 TRPA1 ANKTM1 ENSG00000104321 Transient receptor potential cation channel, subfamily A, member 1 8 72019917-72075617 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026630 Uncertain Tissue enhanced 0 urinary bladder: 30.5 gallbladder: 11.4 TRPC1 HTRP-1 ENSG00000144935 Transient receptor potential cation channel, subfamily C, member 1 3 142724074-142807888 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009387, HPA021130 Supported Approved Vesicles Mixed endometrium: 18.5 TRPC3 ENSG00000138741 Transient receptor potential cation channel, subfamily C, member 3 4 121879027-121951754 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA037969 Uncertain Tissue enhanced 0 smooth muscle: 4.1 cerebral cortex: 2.1 TRPC6 FSGS2, TRP6 ENSG00000137672 Transient receptor potential cation channel, subfamily C, member 6 11 101451564-101872562 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045098, HPA062164 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 placenta: 29.8 lung: 20.0 TRPM2 EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7 ENSG00000142185 Transient receptor potential cation channel, subfamily M, member 2 21 44350163-44443081 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030976, HPA035260 Approved Approved Nuclear membrane Mixed bone marrow: 18.9 TRPM4 FLJ20041 ENSG00000130529 Transient receptor potential cation channel, subfamily M, member 4 19 49157741-49211836 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041169 Supported Supported Nucleoplasm
Plasma membrane Mixed colon: 27.5 TRPM5 LTRPC5, MTR1 ENSG00000070985 Transient receptor potential cation channel, subfamily M, member 5 11 2404515-2423045 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042115, HPA043315 Approved Group enriched 5 colon: 1.0;duodenum: 3.0;epididymis: 2.2;seminal vesicle: 2.5;small intestine: 2.9 thyroid gland: 0.4 TRPM7 CHAK1, LTRPC7, TRP-PLIK ENSG00000092439 Transient receptor potential cation channel, subfamily M, member 7 15 50552473-50686815 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035523, HPA052173 Uncertain Approved Nucleoplasm Tissue enriched 7 parathyroid gland: 212.8 thyroid gland: 29.0 TRPV2 VRL, VRL-1, VRL1 ENSG00000187688 Transient receptor potential cation channel, subfamily V, member 2 17 16415542-16437003 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044993 Uncertain Supported Plasma membrane Mixed lung: 44.1 TRPV5 CaT2, ECAC1 ENSG00000127412 Transient receptor potential cation channel, subfamily V, member 5 7 142908101-142933808 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA063175 Approved Not detected kidney: 0.5 TRPV6 CaT1, ECAC2 ENSG00000165125 Transient receptor potential cation channel, subfamily V, member 6 7 142871203-142885762 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA062864 Approved Tissue enhanced 0 prostate: 38.7;salivary gland: 29.3 placenta: 17.4 TSPAN33 MGC50844, Penumbra ENSG00000158457 Tetraspanin 33 7 129144892-129169697 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA020357 Approved Approved Microtubules Expressed in all kidney: 126.4 TSPAN7 A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2 ENSG00000156298 Tetraspanin 7 X 38561370-38688920 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003140, CAB062566, CAB068245 Supported Tissue enriched 6 cerebral cortex: 576.3 adrenal gland: 99.7 TSPO BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS ENSG00000100300 Translocator protein (18kDa) 22 43151514-43163242 Cancer-related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011232, HPA046260 Uncertain Approved Vesicles
Mitochondria
Cytosol Expressed in all bone marrow: 301.2 TTYH1 ENSG00000167614 Tweety family member 1 19 54415219-54436900 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA023617, HPA050655 Approved Tissue enriched 27 cerebral cortex: 57.9 testis: 2.1 TUSC3 MGC13453, MRT7, N33, OST3A ENSG00000104723 Tumor suppressor candidate 3 8 15417215-15766649 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049851, HPA049974 Approved Mixed epididymis: 140.7 UBE2D2 UBC4, UbcH5B ENSG00000131508 Ubiquitin-conjugating enzyme E2D 2 5 139526431-139628433 Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003920 Approved Approved Plasma membrane
Cytosol Expressed in all testis: 237.4 UBE2I UBC9 ENSG00000103275 Ubiquitin-conjugating enzyme E2I 16 1308880-1327018 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003909, CAB009021 Approved Validated Cytosol Expressed in all ovary: 116.8 UBQLN4 A1U, C1orf6, UBIN ENSG00000160803 Ubiquilin 4 1 156035301-156053794 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061797 Approved Supported Nucleus Expressed in all cerebral cortex: 41.2 UCP2 BMIQ4, SLC25A8 ENSG00000175567 Uncoupling protein 2 (mitochondrial, proton carrier) 11 73974667-73983307 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB025583 Approved Expressed in all lymph node: 391.2 UCP3 SLC25A9 ENSG00000175564 Uncoupling protein 3 (mitochondrial, proton carrier) 11 74000281-74009435 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB010771, HPA072225 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 19 skeletal muscle: 71.2 testis: 3.8 UFD1L UFD1 ENSG00000070010 Ubiquitin fusion degradation 1 like (yeast) 22 19449910-19479215 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030287, HPA030288, HPA073425 Approved Validated Endoplasmic reticulum Expressed in all testis: 64.5 UGCG GCS ENSG00000148154 UDP-glucose ceramide glucosyltransferase 9 111896766-111935369 Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024124 Approved Expressed in all adrenal gland: 84.4 VAMP1 SYB1, VAMP-1 ENSG00000139190 Vesicle-associated membrane protein 1 (synaptobrevin 1) 12 6462237-6470987 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002779, CAB016119 Approved Mixed cerebral cortex: 43.6 VAMP2 SYB2, VAMP-2 ENSG00000220205 Vesicle-associated membrane protein 2 (synaptobrevin 2) 17 8159149-8163546 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB078785 Supported Expressed in all cerebral cortex: 485.0 VAMP8 EDB ENSG00000118640 Vesicle-associated membrane protein 8 2 85561562-85582031 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006882, CAB037132, CAB037147 Supported Expressed in all lung: 328.4 VAPB ALS8, VAP-B, VAP-C ENSG00000124164 VAMP (vesicle-associated membrane protein)-associated protein B and C 20 58389122-58451101 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013144, CAB013722 Supported Validated Endoplasmic reticulum Expressed in all cerebral cortex: 42.5 VCP IBMPFD, p97 ENSG00000165280 Valosin containing protein 9 35056064-35073249 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005593, HPA012728, HPA012814 Supported Validated Nucleoplasm
Cytosol Expressed in all parathyroid gland: 92.6 VDAC2 ENSG00000165637 Voltage-dependent anion channel 2 10 75210154-75231448 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043475 Supported Validated Mitochondria Expressed in all esophagus: 266.4 VIPR1 HVR1, RDC1, VPAC1, VPAC1R ENSG00000114812 Vasoactive intestinal peptide receptor 1 3 42489299-42537573 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA026777 Approved Tissue enhanced 0 lung: 60.0 duodenum: 35.4 VN1R1 V1RL1, VNR19I1, ZVNH1, ZVNR1 ENSG00000178201 Vomeronasal 1 receptor 1 19 57454790-57457142 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062209 Uncertain Nucleus
Vesicles Mixed epididymis: 2.8 WFS1 DFNA14, DFNA38, DFNA6, DIDMOAD, WFS ENSG00000109501 Wolfram syndrome 1 (wolframin) 4 6269849-6303265 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029128 Approved Mixed ovary: 61.4 WLS C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls ENSG00000116729 Wntless Wnt ligand secretion mediator 1 68098473-68233120 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069520 Approved Supported Endoplasmic reticulum Expressed in all epididymis: 160.7 WRB CHD5, GET1 ENSG00000182093 Tryptophan rich basic protein 21 39380244-39428528 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018527 Approved Expressed in all fallopian tube: 107.8 XK Kx, NA, NAC, X1k, XKR1 ENSG00000047597 X-linked Kx blood group X 37685759-37732130 Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019036 Approved Approved Nucleoplasm
Vesicles
Mitochondria Mixed rectum: 12.3 XKR3 MGC57211, XTES ENSG00000172967 XK, Kell blood group complex subunit-related family, member 3 22 16783412-16821699 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003379, HPA035081 Uncertain Tissue enriched 80 testis: 14.3 cerebral cortex: 0.1 XKR4 KIAA1889 ENSG00000206579 XK, Kell blood group complex subunit-related family, member 4 8 55102389-55542054 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA025072, HPA028083 Uncertain Tissue enriched 6 cerebral cortex: 4.7 seminal vesicle: 0.8 XKR8 FLJ10307 ENSG00000158156 XK, Kell blood group complex subunit-related family, member 8 1 27959462-27968096 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA049984, HPA053529 Uncertain Approved Golgi apparatus Expressed in all placenta: 13.6 XKR9 ENSG00000221947 XK, Kell blood group complex subunit-related family, member 9 8 70669365-70790371 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044430 Uncertain Approved Mitochondria Tissue enhanced 0 testis: 14.1 small intestine: 6.2 XPO1 CRM1, emb ENSG00000082898 Exportin 1 2 61477849-61538626 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010184, HPA042933 Supported Validated Nucleoplasm
Nuclear membrane
Vesicles
Cytosol Expressed in all testis: 138.5 XPO4 FLJ13046, KIAA1721 ENSG00000132953 Exportin 4 13 20777329-20903048 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053768 Supported Nucleoplasm
Cytosol Mixed skeletal muscle: 15.7 XPO5 KIAA1291 ENSG00000124571 Exportin 5 6 43522330-43576075 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB012357, HPA018402, HPA023959, HPA029909, HPA029910 Supported Validated Nucleoplasm Expressed in all testis: 43.4 XPO7 KIAA0745, RANBP16 ENSG00000130227 Exportin 7 8 21919671-22006585 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043727, HPA048153 Uncertain Approved Nucleus Expressed in all parathyroid gland: 77.3 XPOT XPO3 ENSG00000184575 Exportin, tRNA 12 64404350-64451127 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048067, HPA057602 Validated Nucleoplasm
Cytosol Expressed in all thyroid gland: 82.9 YIPF3 C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1 ENSG00000137207 Yip1 domain family, member 3 6 43511827-43516990 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014859, HPA063699 Supported Validated Nucleoplasm
Golgi apparatus Expressed in all parathyroid gland: 140.3 ZDHHC13 FLJ10852, FLJ10941, HIP14L ENSG00000177054 Zinc finger, DHHC-type containing 13 11 19117099-19176422 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016759, HPA018791 Uncertain Validated Vesicles Mixed esophagus: 40.5 ZDHHC17 HIP14, HYPH, KIAA0946 ENSG00000186908 Zinc finger, DHHC-type containing 17 12 76763588-76853696 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016807 Approved Supported Golgi apparatus
Vesicles
Cytosol Expressed in all cerebral cortex: 45.4 ZMPSTE24 FACE-1, HGPS, PRO1, STE24, Ste24p ENSG00000084073 Zinc metallopeptidase STE24 1 40258107-40294184 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006988 Approved Approved Golgi apparatus
Cytosol Expressed in all parathyroid gland: 89.0